"Report ID","Drug Identification Number","Report Type","Brand name","Company Name","Common or Proper name",Ingredients,Strength(s),"Packaging size","Route of administration","Shortage status","Dosage form(s)","ATC Code","ATC description","Anticipated start date","Actual start date","Estimated end date","Actual end date",Reason,"Date Created","Date Updated","Tier 3"
220614,02347695,Shortage,"4% CITANEST FORTE DENTAL WITH EPINEPHRINE 1:200,000","DENTSPLY CANADA LIMITED","Prilocaine Hydrochloride","EPINEPHRINE; PRILOCAINE HYDROCHLORIDE","0.005MG; 40MG","50 x 1.8 mL Cartridges","BLOCK/INFILTRATION; BLOCK/INFILTRATION",Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2024-02-26,2024-02-26,2024-04-30,2024-06-19,"Delay in shipping of the drug.",2024-02-26,2024-07-03,No
217948,02246859,Shortage,AA-FENO-SUPER,"AA PHARMA INC",FENOFIBRATE,FENOFIBRATE,100MG,"100 Bottle","ORAL; ORAL",Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",2024-02-01,,2024-04-03,2024-03-18,"Disruption of the manufacture of the drug.",2024-01-31,2024-03-21,No
219018,02246860,Shortage,AA-FENO-SUPER,"AA PHARMA INC",AA-FENO-SUPER,FENOFIBRATE,160MG,"100 BTL","ORAL; ORAL",Resolved,TABLET,C10AB,"LIPID MODIFYING AGENTS, PLAIN",2024-02-07,,2024-04-03,2024-03-19,"Disruption of the manufacture of the drug.",2024-02-08,2024-03-21,No
216767,02381494,Shortage,ACH-ALENDRONATE,"ACCORD HEALTHCARE INC",ALENDRONATE,"ALENDRONIC ACID",70MG,4,"ORAL; ORAL","Actual shortage",TABLET,M05BA,"DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",,2024-01-19,,,"Requirements related to complying with good manufacturing practices.",2024-01-20,2024-01-19,No
218339,02487713,Shortage,ACH-APIXABAN,"ACCORD HEALTHCARE INC",APIXABAN,APIXABAN,2.5MG,60,ORAL,Resolved,TABLET,B01AF,"ANTITHROMBOTIC AGENTS",,2024-02-02,2024-03-15,2024-03-15,"Disruption of the manufacture of the drug.",2024-02-02,2024-03-16,No
216770,02457768,Shortage,"ACH-ATORVASTATIN CALCIUM","ACCORD HEALTHCARE INC",ATORVASTATIN,ATORVASTATIN,20MG,"90 500","ORAL; ORAL",Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2024-01-19,2024-03-08,2024-03-08,"Disruption of the manufacture of the drug.",2024-01-20,2024-03-09,No
216773,02457776,Shortage,"ACH-ATORVASTATIN CALCIUM","ACCORD HEALTHCARE INC",ATORVASTATIN,ATORVASTATIN,40MG,500,"ORAL; ORAL",Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2024-01-19,2024-03-08,2024-03-08,"Disruption of the manufacture of the drug.",2024-01-20,2024-03-09,No
216776,02457784,Shortage,"ACH-ATORVASTATIN CALCIUM","ACCORD HEALTHCARE INC",ATORVASTATIN,ATORVASTATIN,80MG,90,"ORAL; ORAL",Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2024-01-19,2024-03-05,2024-03-07,"Disruption of the manufacture of the drug.",2024-01-20,2024-03-08,No
217342,02457741,Shortage,"ACH-ATORVASTATIN CALCIUM","ACCORD HEALTHCARE INC",ATORVASTATIN,ATORVASTATIN,10MG,90,"ORAL; ORAL",Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2024-01-26,2024-03-13,2024-03-15,"Demand increase for the drug.",2024-01-26,2024-03-16,No
217363,02379295,Shortage,ACH-CANDESARTAN,"ACCORD HEALTHCARE INC","CANDESARTAN CILEXETIL","CANDESARTAN CILEXETIL",32MG,100,"ORAL; ORAL","Actual shortage",TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2024-01-26,,,"Demand increase for the drug.",2024-01-26,2024-01-27,No
216779,02379279,Shortage,ACH-CANDESARTAN,"ACCORD HEALTHCARE INC","CANDESARTAN CILEXETIL","CANDESARTAN CILEXETIL",8MG,100,"ORAL; ORAL",Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2024-01-19,2024-03-15,2024-03-15,"Disruption of the manufacture of the drug.",2024-01-20,2024-03-16,No
216782,02425610,Shortage,ACH-EZETIMIBE,"ACCORD HEALTHCARE INC",Ézétimibe,EZETIMIBE,10MG,100,"ORAL; ORAL","Actual shortage",TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2024-01-19,,,"Requirements related to complying with good manufacturing practices.",2024-01-20,2024-01-19,No
217355,02338459,Shortage,ACH-LETROZOLE,"ACCORD HEALTHCARE INC",LETROZOLE,LETROZOLE,2.5MG,30,"ORAL; ORAL","Actual shortage",TABLET,L02BG,"HORMONE ANTAGONISTS AND RELATED AGENTS",,2024-01-26,,,"Requirements related to complying with good manufacturing practices.",2024-01-26,2024-06-11,No
216788,02399784,Shortage,ACH-LEVETIRACETAM,"ACCORD HEALTHCARE INC",Levetiracetam,LEVETIRACETAM,500MG,120,"ORAL; ORAL",Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2024-01-19,2024-03-05,2024-03-07,"Requirements related to complying with good manufacturing practices.",2024-01-20,2024-03-08,No
216791,02456338,Shortage,ACH-OLMESARTAN,"ACCORD HEALTHCARE INC","OLMESARTAN MEDOXOMIL","OLMESARTAN MEDOXOMIL",40MG,90,ORAL,"Actual shortage",TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2024-01-19,,,"Requirements related to complying with good manufacturing practices.",2024-01-20,2024-01-19,No
219792,02468948,Shortage,"ACH-OLMESARTAN HCTZ","ACCORD HEALTHCARE INC","OLMESARTAN HCTZ","OLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE","20MG; 12.5MG",30,"ORAL; ORAL","Actual shortage",TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2024-02-16,,,"Requirements related to complying with good manufacturing practices.",2024-02-16,2024-02-17,No
216797,02449854,Shortage,ACH-PREGABALIN,"ACCORD HEALTHCARE INC",PREGABALIN,PREGABALIN,75MG,100,ORAL,Resolved,CAPSULE,N02BF,,,2024-01-19,2024-03-06,2024-03-07,"Disruption of the manufacture of the drug.",2024-01-20,2024-03-08,No
217358,02438925,Shortage,ACH-ROSUVASTATIN,"ACCORD HEALTHCARE INC",ROSUVASTATIN,ROSUVASTATIN,10MG,90,"ORAL; ORAL",Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2024-01-26,2024-09-03,2024-09-06,"Disruption of the manufacture of the drug.",2024-01-26,2024-09-07,No
215056,02438941,Shortage,ACH-ROSUVASTATIN,"ACCORD HEALTHCARE INC",ROSUVASTATIN,ROSUVASTATIN,40MG,500,"ORAL; ORAL",Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2024-01-05,2024-09-16,2024-09-16,"Disruption of the manufacture of the drug.",2024-01-05,2024-09-20,No
218314,02438917,Shortage,ACH-ROSUVASTATIN,"ACCORD HEALTHCARE INC",ROSUVASTATIN,ROSUVASTATIN,5MG,"90 500","ORAL; ORAL",Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2024-02-02,2024-09-20,2024-09-19,"Disruption of the manufacture of the drug.",2024-02-02,2024-09-20,No
216814,02407485,Shortage,ACH-TELMISARTAN,"ACCORD HEALTHCARE INC",TELMISARTAN,TELMISARTAN,40MG,100,"ORAL; ORAL","Actual shortage",TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2024-01-19,,,"Requirements related to complying with good manufacturing practices.",2024-01-20,2024-01-19,No
216270,02389851,Shortage,ACH-TEMOZOLOMIDE,"ACCORD HEALTHCARE INC",TEMOZOLOMIDE,TEMOZOLOMIDE,250MG,5,"ORAL; ORAL",Resolved,CAPSULE,L01AX,ALKYLATINGAGENTS,,2024-01-17,2024-09-20,2024-09-19,"Disruption of the manufacture of the drug.",2024-01-17,2024-09-20,No
215737,02403196,Shortage,"ACT CLARITHROMYCIN XL","TEVA CANADA LIMITED","CLARITHROMYC FC TAB",CLARITHROMYCIN,500MG,60,"ORAL; ORAL",Resolved,"TABLET (EXTENDED-RELEASE)",J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2024-01-10,2024-05-20,2024-05-15,"Disruption of the manufacture of the drug.",2024-01-11,2024-05-16,No
218145,02448319,Shortage,"ACT DEXTROAMPHETAMINE SR","TEVA CANADA LIMITED","DEXTROAMPHETAMINE SRCAP 10MG","DEXTROAMPHETAMINE SULFATE",10MG,100,"ORAL; ORAL",Resolved,"CAPSULE (SUSTAINED-RELEASE)",N06BA,"PSYCHOSTIMULANTS AND NOOTROPICS",,2024-01-30,2024-04-30,2024-04-24,"Disruption of the manufacture of the drug.",2024-02-01,2024-04-25,No
217240,02448327,Shortage,"ACT DEXTROAMPHETAMINE SR","TEVA CANADA LIMITED","DEXTROAMPHETAMINE SRCAP 15MG","DEXTROAMPHETAMINE SULFATE",15MG,100,"ORAL; ORAL",Resolved,"CAPSULE (SUSTAINED-RELEASE)",N06BA,"PSYCHOSTIMULANTS AND NOOTROPICS",,2024-01-17,2024-04-30,2024-04-24,"Disruption of the manufacture of the drug.",2024-01-25,2024-04-25,No
216454,02302896,Shortage,"ACT PIOGLITAZONE","TEVA CANADA LIMITED","PIOGLITAZONE 45MG TAB",PIOGLITAZONE,45MG,100,"ORAL; ORAL",Resolved,TABLET,A10BG,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2024-01-17,,2025-01-14,"Disruption of the manufacture of the drug.",2024-01-18,2025-01-15,No
218974,02316099,Shortage,"ACT QUETIAPINE","TEVA CANADA LIMITED","QUETIAPINE 100MG FC TAB",QUETIAPINE,100MG,100,"ORAL; ORAL",Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2024-02-07,2024-04-10,2024-04-17,"Disruption of the manufacture of the drug.",2024-02-08,2024-04-18,No
215725,02316110,Shortage,"ACT QUETIAPINE","TEVA CANADA LIMITED","QUETIAPINE 200MG FC TAB",QUETIAPINE,200MG,100,"ORAL; ORAL",Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2024-01-10,2024-03-20,2024-03-09,"Disruption of the manufacture of the drug.",2024-01-11,2024-04-11,No
215434,02236926,Shortage,"ACYCLOVIR SODIUM INJECTION","FRESENIUS KABI CANADA LTD","ACYCLOVIR SODIUM INJECTION",ACYCLOVIR,50MG,"20 mL","INTRAVENOUS; INTRAVENOUS",Resolved,SOLUTION,J05AB,"DIRECT ACTING ANTIVIRALS",2023-12-15,2023-12-15,2024-03-01,2024-01-29,"Disruption of the manufacture of the drug.",2024-01-09,2024-01-31,No
217088,00893560,Shortage,ALOMIDE,"NOVARTIS PHARMACEUTICALS CANADA INC","ALOMIDE SOLN. 10ML",LODOXAMIDE,0.1%,10ML,"OPHTHALMIC; OPHTHALMIC",Resolved,SOLUTION,S01GX,"DECONGESTANTS AND ANTIALLERGICS",2024-01-24,2024-01-24,2024-04-15,2024-04-10,"Demand increase for the drug.",2024-01-24,2024-04-11,No
217816,02352753,Shortage,AMOXICILLIN,"SANIS HEALTH INC",AMOXICILLIN,AMOXICILLIN,250MG,ML150,"ORAL; ORAL",Resolved,"GRANULES FOR SUSPENSION",J01CA,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2024-01-29,2024-04-22,2024-04-22,"Disruption of the manufacture of the drug.",2024-01-30,2024-04-23,No
217972,02529904,Shortage,ANASTROZOLE,"SIVEM PHARMACEUTICALS ULC",Anastrozole,ANASTROZOLE,1MG,100,ORAL,"Actual shortage",TABLET,L02BG,"HORMONE ANTAGONISTS AND RELATED AGENTS",2024-02-05,2024-05-13,,,"Disruption of the manufacture of the drug.",2024-01-31,2024-11-20,No
217977,02529904,Shortage,ANASTROZOLE,"SIVEM PHARMACEUTICALS ULC",Anastrozole,ANASTROZOLE,1MG,30,ORAL,"Actual shortage",TABLET,L02BG,"HORMONE ANTAGONISTS AND RELATED AGENTS",2024-04-24,2024-08-10,2025-06-01,,"Disruption of the manufacture of the drug.",2024-01-31,2024-12-02,No
219747,02245345,Shortage,ANDROGEL,"BGP PHARMA ULC",TESTOSTERONE,TESTOSTERONE,1%,"30 UNIT TRADE CA","TRANSDERMAL; TRANSDERMAL",Resolved,GEL,G03BA,ANDROGENS,2024-03-14,2024-03-14,2024-03-27,2024-03-26,"Disruption of the manufacture of the drug.",2024-02-15,2024-04-01,No
215230,00550957,Shortage,"APO PREDNISONE TAB 50MG","APOTEX INC",PREDNISONE,PREDNISONE,50MG,"100 BTL","ORAL; ORAL",Resolved,TABLET,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2024-01-02,2024-01-19,2024-01-11,"Disruption of the manufacture of the drug.",2024-01-05,2024-01-12,No
220471,02491397,Shortage,"APO-ABIRATERONE FILM COATED TABLETS","APOTEX INC",ABIRATERONE,"ABIRATERONE ACETATE",250MG,"60 BLS",ORAL,Resolved,TABLET,L02BX,"HORMONE ANTAGONISTS AND RELATED AGENTS",,2024-02-20,2024-03-08,2024-02-29,"Disruption of the manufacture of the drug.",2024-02-23,2024-03-01,No
216656,02229873,Shortage,"APO-ACETAMINOPHEN CAPLETS","APOTEX INC",ACETAMINOPHEN,ACETAMINOPHEN,325MG,"1000 BTL","ORAL; ORAL",Resolved,TABLET,N02BE,"OTHER ANALGESICS AND ANTIPYRETICS",,2024-01-16,2024-02-23,2024-02-22,"Disruption of the manufacture of the drug.",2024-01-19,2024-02-23,No
215973,02315866,Shortage,APO-ALFUZOSIN,"APOTEX INC",ALFUZOSIN,"ALFUZOSIN HYDROCHLORIDE",10MG,"100 BTL","ORAL; ORAL",Resolved,"TABLET (EXTENDED-RELEASE)",G04CA,"DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",,2024-01-09,2024-03-22,2024-03-21,"Disruption of the manufacture of the drug.",2024-01-12,2024-03-22,No
219843,02411342,Shortage,APO-AMLODIPINE-ATORVASTATIN,"APOTEX INC",AMLODIPINE-ATORVASTATIN,"ATORVASTATIN; AMLODIPINE","80MG; 10MG","100 BTL","ORAL; ORAL",Resolved,TABLET,C10BX,"LIPID MODIFYING AGENTS, COMBINATIONS",,2024-02-13,2024-06-07,2024-06-06,"Disruption of the manufacture of the drug.",2024-02-16,2024-06-07,No
217490,02245623,Shortage,"APO-AMOXI CLAV","APOTEX INC","AMOXICILLIN CLAVULANIC ACID","CLAVULANIC ACID; AMOXICILLIN","125MG; 875MG","100 BTL","ORAL; ORAL",Resolved,TABLET,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2024-01-23,2024-03-15,2024-02-29,"Disruption of the manufacture of the drug.",2024-01-26,2024-03-01,No
216681,02445492,Shortage,"APO-AMPHETAMINE XR","APOTEX INC",AMPHETAMINE,"MIXED SALTS AMPHETAMINE",5MG,"100 BTL","ORAL; ORAL",Resolved,"CAPSULE (EXTENDED RELEASE)",N06BA,"PSYCHOSTIMULANTS AND NOOTROPICS",,2024-01-16,2024-03-01,2024-02-22,"Disruption of the manufacture of the drug.",2024-01-19,2024-02-23,No
215964,02445530,Shortage,"APO-AMPHETAMINE XR","APOTEX INC","DEXA,MPHETAMINE","MIXED SALTS AMPHETAMINE",25MG,"100 BTL","ORAL; ORAL",Resolved,"CAPSULE (EXTENDED RELEASE)",N06BA,"PSYCHOSTIMULANTS AND NOOTROPICS",,2024-01-09,2024-03-01,2024-02-29,"Disruption of the manufacture of the drug.",2024-01-12,2024-03-01,No
218373,02295296,Shortage,APO-ATORVASTATIN,"APOTEX INC",ATORVASTATIN,ATORVASTATIN,40MG,"30 BLS","ORAL; ORAL",Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2024-01-30,2024-03-22,2024-03-21,"Disruption of the manufacture of the drug.",2024-02-02,2024-03-22,No
217478,02295318,Shortage,APO-ATORVASTATIN,"APOTEX INC",ATORVASTATIN,ATORVASTATIN,80MG,"500 BTL","ORAL; ORAL",Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2024-01-23,2024-02-16,2024-02-15,"Disruption of the manufacture of the drug.",2024-01-26,2024-02-16,No
216678,02537788,Shortage,APO-BROMFENAC,"APOTEX INC",BROMFENAC,BROMFENAC,0.07%,"3 ML",OPHTHALMIC,Resolved,SOLUTION,S01BC,"ANTIINFLAMMATORY AGENTS",,2024-01-16,2024-03-22,2024-03-21,"Disruption of the manufacture of the drug.",2024-01-19,2024-03-22,No
217484,02211076,Shortage,APO-BUSPIRONE,"APOTEX INC",BUSPIRONE,"BUSPIRONE HYDROCHLORIDE",10MG,"100 BTL","ORAL; ORAL","Actual shortage",TABLET,N05BE,ANXIOLYTICS,,2024-01-23,,,"Disruption of the manufacture of the drug.",2024-01-26,2024-02-02,No
215982,02455897,Shortage,APO-CABERGOLINE,"APOTEX INC",CABERGOLINE,CABERGOLINE,0.5MG,"8 BTL",ORAL,Resolved,TABLET,G02CB,"OTHER GYNECOLOGICALS",,2024-05-28,2024-10-18,2024-10-07,"Disruption of the manufacture of the drug.",2024-01-12,2024-10-10,No
215952,02247936,Shortage,APO-CARVEDILOL,"APOTEX INC",CARVEDILOL,CARVEDILOL,25MG,"100 BTL","ORAL; ORAL","Actual shortage",TABLET,C07AG,"BETA BLOCKING AGENTS",,2024-01-09,,,"Disruption of the manufacture of the drug.",2024-01-12,2024-01-12,No
215955,02247935,Shortage,APO-CARVEDILOL,"APOTEX INC",CARVEDILOL,CARVEDILOL,12.5MG,"100 BTL","ORAL; ORAL","Actual shortage",TABLET,C07AG,"BETA BLOCKING AGENTS",2025-03-31,,,,"Disruption of the manufacture of the drug.",2024-01-12,2025-04-01,No
215958,02247933,Shortage,APO-CARVEDILOL,"APOTEX INC",CARVEDILOL,CARVEDILOL,3.125MG,"100 BTL","ORAL; ORAL","Actual shortage",TABLET,C07AG,"BETA BLOCKING AGENTS",2024-12-13,,,,"Disruption of the manufacture of the drug.",2024-01-12,2024-12-14,No
215961,02247934,Shortage,APO-CARVEDILOL,"APOTEX INC",CARVEDILOL,CARVEDILOL,6.25MG,"100 BTL","ORAL; ORAL","Actual shortage",TABLET,C07AG,"BETA BLOCKING AGENTS",2024-12-01,,,,"Disruption of the manufacture of the drug.",2024-01-12,2024-12-02,No
220444,02467518,Shortage,APO-CEFEPIME,"APOTEX INC",CEFEPIME,CEFEPIME,2G,"20 ML","INTRAVENOUS; INTRAVENOUS",Resolved,"POWDER FOR SOLUTION",J01DE,"OTHER BETA-LACTAM ANTIBACTERIALS",,2024-02-20,2024-03-01,2024-02-29,"Disruption of the manufacture of the drug.",2024-02-23,2024-03-01,No
216672,02467496,Shortage,APO-CEFEPIME,"APOTEX INC",CEFEPIME,CEFEPIME,1G,"20 ML","INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR",Resolved,"POWDER FOR SOLUTION",J01DE,"OTHER BETA-LACTAM ANTIBACTERIALS",,2024-01-16,2024-02-09,2024-02-07,"Disruption of the manufacture of the drug.",2024-01-19,2024-02-09,No
218382,02452707,Shortage,APO-CINACALCET,"APOTEX INC",CINACALCET,CINACALCET,60MG,"30 BTL","ORAL; ORAL",Resolved,TABLET,H05BX,"ANTI-PARATHYROID HORMONES",,2024-01-30,2024-03-29,2024-03-21,"Disruption of the manufacture of the drug.",2024-02-02,2024-03-22,No
220447,02452693,Shortage,APO-CINACALCET,"APOTEX INC",CINACALCET,CINACALCET,30MG,"30 BTL","ORAL; ORAL",Resolved,TABLET,H05BX,"ANTI-PARATHYROID HORMONES",,2024-02-20,2024-03-29,2024-03-21,"Disruption of the manufacture of the drug.",2024-02-23,2024-03-22,No
215970,02398591,Shortage,APO-CLOPIDOGREL,"APOTEX INC",CLOPIDOGREL,CLOPIDOGREL,300MG,"30 BLS","ORAL; ORAL",Resolved,TABLET,B01AC,"ANTITHROMBOTIC AGENTS",,2024-01-09,2024-03-22,2024-03-14,"Disruption of the manufacture of the drug.",2024-01-12,2024-03-15,No
216646,02494051,Shortage,APO-COLESEVELAM,"APOTEX INC",COLESEVELAM,"COLESEVELAM HYDROCHLORIDE",625MG,"180 BTL",ORAL,Resolved,TABLET,C10AC,"LIPID MODIFYING AGENTS, PLAIN",,2024-01-16,2024-06-28,2024-06-26,"Disruption of the manufacture of the drug.",2024-01-19,2025-04-15,No
219149,02468913,Shortage,APO-DABIGATRAN,"APOTEX INC",DABIGATRAN,"DABIGATRAN ETEXILATE",150MG,"60 BLS","ORAL; ORAL",Resolved,CAPSULE,B01AE,"ANTITHROMBOTIC AGENTS",,2024-02-06,2024-02-23,2024-02-22,"Disruption of the manufacture of the drug.",2024-02-09,2024-02-23,No
219152,02468905,Shortage,APO-DABIGATRAN,"APOTEX INC",DABIGATRAN,"DABIGATRAN ETEXILATE",110MG,"60 BLS","ORAL; ORAL",Resolved,CAPSULE,B01AE,"ANTITHROMBOTIC AGENTS",,2024-02-06,2024-03-01,2024-02-22,"Disruption of the manufacture of the drug.",2024-02-09,2024-02-23,No
219141,02485281,Shortage,"APO-DEFERASIROX (TYPE J)","APOTEX INC",DEFERASIROX,DEFERASIROX,360MG,"30 BLS","ORAL; ORAL",Resolved,TABLET,V03AC,"ALL OTHER THERAPEUTIC PRODUCTS",,2024-02-06,2024-03-22,2024-03-07,"Disruption of the manufacture of the drug.",2024-02-09,2024-03-08,No
220465,02467127,Shortage,"APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS","APOTEX INC","DESVENLAFAXINE SUCCINATE",DESVENLAFAXINE,100MG,"100 BTL",ORAL,Resolved,"TABLET (EXTENDED-RELEASE)",N06AX,ANTIDEPRESSANTS,,2024-02-20,2024-03-29,2024-03-28,"Disruption of the manufacture of the drug.",2024-02-23,2024-03-29,No
219177,02091194,Shortage,"APO-DICLO SR","APOTEX INC","DICLOFENAC NA","DICLOFENAC SODIUM",100MG,"100 BTL","ORAL; ORAL",Resolved,"TABLET (EXTENDED-RELEASE)",M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2024-02-06,2024-04-19,2024-04-18,"Disruption of the manufacture of the drug.",2024-02-09,2024-04-19,No
220441,02362279,Shortage,APO-DONEPEZIL,"APOTEX INC",DONEPEZIL,"DONEPEZIL HYDROCHLORIDE",10MG,"100 BTL","ORAL; ORAL",Resolved,TABLET,N06DA,"ANTI-DEMENTIA DRUGS",,2024-02-20,2024-05-17,2024-05-02,"Disruption of the manufacture of the drug.",2024-02-23,2024-05-03,No
218403,02512645,Shortage,"APO-DOXYCYCLINE MR","APOTEX INC",DOXYCYCLINE,DOXYCYCLINE,40MG,"28 BLS",ORAL,Resolved,"CAPSULE (IMMEDIATE AND DELAYED RELEASE)",J01AA,TETRACYCLINES,,2024-01-30,2024-03-15,2024-03-14,"Disruption of the manufacture of the drug.",2024-02-02,2024-03-15,No
215207,02512645,Shortage,"APO-DOXYCYCLINE MR","APOTEX INC",DOXYCYCLINE,DOXYCYCLINE,40MG,"28 BLS",ORAL,Resolved,"CAPSULE (IMMEDIATE AND DELAYED RELEASE)",J01AA,TETRACYCLINES,,2024-01-02,2024-01-19,2024-01-11,"Disruption of the manufacture of the drug.",2024-01-05,2024-01-12,No
220459,02413248,Shortage,APO-DOXYLAMINE/B6,"APOTEX INC",DOXYLAMINE/B6,"PYRIDOXINE HYDROCHLORIDE; DOXYLAMINE SUCCINATE","10MG; 10MG","100 BTL","ORAL; ORAL",Resolved,"TABLET (DELAYED-RELEASE)",R06AA,"ANTIHISTAMINES FOR SYSTEMIC USE",,2024-02-20,2024-03-22,2024-03-21,"Disruption of the manufacture of the drug.",2024-02-23,2024-03-22,No
219174,02440423,Shortage,APO-DULOXETINE,"APOTEX INC",DULOXETINE,DULOXETINE,30MG,"100 BTL","ORAL; ORAL",Resolved,"CAPSULE (DELAYED RELEASE)",N06AX,ANTIDEPRESSANTS,,2024-02-06,2024-03-15,2024-03-14,"Disruption of the manufacture of the drug.",2024-02-09,2024-03-15,No
216653,02440423,Shortage,APO-DULOXETINE,"APOTEX INC",DULOXETINE,DULOXETINE,30MG,"500 BTL","ORAL; ORAL",Resolved,"CAPSULE (DELAYED RELEASE)",N06AX,ANTIDEPRESSANTS,,2024-01-16,2024-03-22,2024-03-21,"Disruption of the manufacture of the drug.",2024-01-19,2024-03-22,No
219144,02295024,Shortage,APO-ESCITALOPRAM,"APOTEX INC",ESCITALOPRAM,ESCITALOPRAM,20MG,"100 BTL","ORAL; ORAL",Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2024-02-06,2024-03-08,2024-02-29,"Disruption of the manufacture of the drug.",2024-02-09,2024-03-01,No
215247,02427826,Shortage,APO-EZETIMIBE,"APOTEX INC",EZETIMIBE,EZETIMIBE,10MG,"100 BTL","ORAL; ORAL","Actual shortage",TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2024-01-02,,,"Disruption of the manufacture of the drug.",2024-01-05,2024-01-19,No
216662,02452367,Shortage,APO-FELODIPINE,"APOTEX INC",FELODIPINE,FELODIPINE,2.5MG,"100 BTL","ORAL; ORAL",Resolved,"TABLET (EXTENDED-RELEASE)",C08CA,"SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.",,2024-01-16,2024-02-09,2024-02-08,"Disruption of the manufacture of the drug.",2024-01-19,2024-02-09,No
216684,02365383,Shortage,APO-FINASTERIDE,"APOTEX INC",FINASTERIDE,FINASTERIDE,5MG,"30 BLS","ORAL; ORAL","Actual shortage",TABLET,G04CB,"DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",2024-03-15,2024-02-13,,,"Disruption of the manufacture of the drug.",2024-01-19,2024-02-16,No
216744,02469936,Shortage,APO-FINGOLIMOD,"APOTEX INC",FINGOLIMOD,FINGOLIMOD,0.5MG,"28 BLS","ORAL; ORAL","Actual shortage",CAPSULE,L04AA,IMMUNOSUPPRESSANTS,,2024-05-07,,,"Disruption of the manufacture of the drug.",2024-01-19,2024-05-10,No
215218,02275538,Shortage,APO-FLECAINIDE,"APOTEX INC",FLECAINIDE,"FLECAINIDE ACETATE",50MG,"100 BTL","ORAL; ORAL",Resolved,TABLET,C01BC,"ANTIARRHYTHMICS, CLASS I AND III",,2024-01-02,2024-02-16,2024-02-15,"Disruption of the manufacture of the drug.",2024-01-05,2024-02-16,No
220450,02216353,Shortage,APO-FLUOXETINE,"APOTEX INC",FLUOXETINE,FLUOXETINE,10MG,"100 BTL","ORAL; ORAL",Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2024-02-20,,2024-02-29,"Disruption of the manufacture of the drug.",2024-02-23,2024-03-01,No
220453,02216361,Shortage,APO-FLUOXETINE,"APOTEX INC",FLUOXETINE,FLUOXETINE,20MG,"500 BTL","ORAL; ORAL",Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2024-02-20,,2024-02-29,"Disruption of the manufacture of the drug.",2024-02-23,2024-03-01,No
220650,02216361,Shortage,APO-FLUOXETINE,"APOTEX INC",FLUOXETINE,FLUOXETINE,20MG,"100 BTL","ORAL; ORAL",Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2024-02-20,,2024-02-29,"Disruption of the manufacture of the drug.",2024-02-26,2024-03-01,No
219168,02266008,Shortage,APO-FOSINOPRIL,"APOTEX INC",FOSINOPRIL,"FOSINOPRIL SODIUM",10MG,"100 BTL","ORAL; ORAL",Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2024-02-06,2024-02-16,2024-02-15,"Disruption of the manufacture of the drug.",2024-02-09,2024-02-16,No
217487,02245247,Shortage,APO-GLICLAZIDE,"APOTEX INC",GLICLAZIDE,GLICLAZIDE,80MG,"500 BTL","ORAL; ORAL",Resolved,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2024-01-25,2024-03-15,2024-03-14,"Disruption of the manufacture of the drug.",2024-01-26,2024-03-15,No
217481,02407124,Shortage,"APO-GLICLAZIDE MR","APOTEX INC",GLICLAZIDE,GLICLAZIDE,60MG,"100 BTL","ORAL; ORAL",Resolved,"TABLET (EXTENDED-RELEASE)",A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2024-01-23,2024-08-02,2024-05-30,"Disruption of the manufacture of the drug.",2024-01-26,2024-05-31,No
216650,00441627,Shortage,APO-HYDRALAZINE,"APOTEX INC",HYDRALAZINE,"HYDRALAZINE HYDROCHLORIDE",25MG,"100 BTL","ORAL; ORAL",Resolved,"TABLET; TABLET",C02DB,"ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON",,2024-01-16,2024-04-05,2024-04-04,"Disruption of the manufacture of the drug.",2024-01-19,2024-04-05,No
215967,00585114,Shortage,"APO-IBUPROFEN TAB 600MG","APOTEX INC",IBUPROFEN,IBUPROFEN,600MG,"500 BTL","ORAL; ORAL",Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2024-01-09,2024-04-05,2024-03-28,"Disruption of the manufacture of the drug.",2024-01-12,2024-03-29,No
216659,02256495,Shortage,APO-LEFLUNOMIDE,"APOTEX INC",LEFLUNOMIDE,LEFLUNOMIDE,10MG,"30 BTL","ORAL; ORAL",Resolved,TABLET,L04AA,IMMUNOSUPPRESSANTS,,2024-01-16,2024-02-09,2024-02-08,"Disruption of the manufacture of the drug.",2024-01-19,2024-02-09,No
218370,02285940,Shortage,APO-LEVETIRACETAM,"APOTEX INC",LEVETIRACETAM,LEVETIRACETAM,750MG,"100 BTL","ORAL; ORAL",Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2024-01-30,2024-03-15,2024-03-14,"Disruption of the manufacture of the drug.",2024-02-02,2024-03-15,No
219156,02284707,Shortage,APO-LEVOFLOXACIN,"APOTEX INC",LEVOFLOXACIN,LEVOFLOXACIN,250MG,"50 BTL","ORAL; ORAL",Resolved,TABLET,J01MA,"QUINOLONE ANTIBACTERIALS",,2024-02-06,2025-03-01,2024-03-07,"Disruption of the manufacture of the drug.",2024-02-09,2024-03-08,No
218379,02396467,Shortage,APO-MELOXICAM,"APOTEX INC",MELOXICAM,MELOXICAM,1.5G,"180 mL","ORAL; ORAL",Resolved,SUSPENSION,,,,2024-01-30,,2024-06-26,"Disruption of the manufacture of the drug.",2024-02-02,2024-06-27,No
218376,02330377,Shortage,"APO-METHYLPHENIDATE ER","APOTEX INC",METHYLPHENIDATE,"METHYLPHENIDATE HYDROCHLORIDE",54MG,"100 BTL","ORAL; ORAL",Resolved,"TABLET (EXTENDED-RELEASE)",N06BA,"PSYCHOSTIMULANTS AND NOOTROPICS",,2024-01-30,2024-02-23,2024-02-22,"Disruption of the manufacture of the drug.",2024-02-02,2024-02-23,No
217300,02330377,Shortage,"APO-METHYLPHENIDATE ER","APOTEX INC",METHYLPHENIDATE,"METHYLPHENIDATE HYDROCHLORIDE",54MG,"100 BTL","ORAL; ORAL",Resolved,"TABLET (EXTENDED-RELEASE)",N06BA,"PSYCHOSTIMULANTS AND NOOTROPICS",,2024-01-26,2024-02-23,2024-02-22,"Disruption of the manufacture of the drug.",2024-01-26,2024-02-23,No
215233,02246010,Shortage,APO-METOPROLOL,"APOTEX INC",METOPROLOL,"METOPROLOL TARTRATE",25MG,"1000 BTL","ORAL; ORAL",Resolved,TABLET,C07AB,"BETA BLOCKING AGENTS",,2024-01-02,2024-03-22,2024-03-21,"Disruption of the manufacture of the drug.",2024-01-05,2024-03-22,No
219162,02278677,Shortage,APO-MIDODRINE,"APOTEX INC",MIDODRINE,"MIDODRINE HYDROCHLORIDE",2.5MG,"100 BTL","ORAL; ORAL",Resolved,TABLET,C01CA,"CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES",,2024-02-06,2024-05-31,2024-05-23,"Disruption of the manufacture of the drug.",2024-02-09,2024-05-24,No
217472,02278685,Shortage,APO-MIDODRINE,"APOTEX INC",MIDODRINE,"MIDODRINE HYDROCHLORIDE",5MG,"100 BTL","ORAL; ORAL",Resolved,TABLET,C01CA,"CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES",,2024-01-23,2024-05-24,2024-05-23,"Disruption of the manufacture of the drug.",2024-01-26,2024-05-24,No
216669,02403587,Shortage,APO-MOMETASONE,"APOTEX INC",MOMETASONE,"MOMETASONE FUROATE",50MCG,"140 MS","NASAL; NASAL",Resolved,"SPRAY, METERED DOSE",R01AD,"DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE",,2024-01-16,2024-05-31,2024-05-21,"Disruption of the manufacture of the drug.",2024-01-19,2024-05-22,No
220456,02374609,Shortage,APO-MONTELUKAST,"APOTEX INC",MONTELUKAST,MONTELUKAST,10MG,"90 BTL","ORAL; ORAL",Resolved,TABLET,R03DC,"OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",,2024-02-20,2024-04-05,2024-03-28,"Disruption of the manufacture of the drug.",2024-02-23,2024-03-29,No
219171,00592277,Shortage,APO-NAPROXEN,"APOTEX INC",NAPROXEN,NAPROXEN,500MG,"100 BTL","ORAL; ORAL",Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2024-02-06,2024-04-26,2024-04-25,"Disruption of the manufacture of the drug.",2024-02-09,2024-04-26,No
219165,02246699,Shortage,"APO-NAPROXEN EC TABLETS","APOTEX INC",NAPROXEN,NAPROXEN,250MG,"100 BTL","ORAL; ORAL",Resolved,"TABLET (ENTERIC-COATED)",M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2024-02-06,2024-03-29,2024-03-28,"Shortage of an inactive ingredient or component.",2024-02-09,2024-03-29,No
216711,02453452,Shortage,APO-OLMESARTAN,"APOTEX INC",OLMESARTAN,"OLMESARTAN MEDOXOMIL",20MG,"90 BTL","ORAL; ORAL","Actual shortage",TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2024-05-07,,,"Disruption of the manufacture of the drug.",2024-01-19,2024-05-10,No
216714,02453460,Shortage,APO-OLMESARTAN,"APOTEX INC",OLMESARTAN,"OLMESARTAN MEDOXOMIL",40MG,"90 BTL","ORAL; ORAL","Actual shortage",TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2024-11-12,,,"Disruption of the manufacture of the drug.",2024-01-19,2024-11-14,No
216717,02453622,Shortage,APO-OLMESARTAN/HCTZ,"APOTEX INC",OLMESARTAN/HCTZ,"HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL","25MG; 40MG","90 BTL",ORAL,"Actual shortage",TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2024-11-12,,,"Disruption of the manufacture of the drug.",2024-01-19,2024-11-14,No
216720,02453606,Shortage,APO-OLMESARTAN/HCTZ,"APOTEX INC",OLMESARTAN/HCTZ,"HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL","12.5MG; 20MG","90 BTL",ORAL,"Actual shortage",TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",2024-09-15,,,,"Disruption of the manufacture of the drug.",2024-01-19,2024-09-16,No
216723,02453614,Shortage,APO-OLMESARTAN/HCTZ,"APOTEX INC",OLMESARTAN/HCTZ,"HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL","12.5MG; 40MG","90 BTL",ORAL,"Actual shortage",TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2024-11-12,,,"Disruption of the manufacture of the drug.",2024-01-19,2024-11-14,No
219180,02245058,Shortage,APO-OMEPRAZOLE,"APOTEX INC",OMEPRAZOLE,OMEPRAZOLE,20MG,"500 BTL","ORAL; ORAL",Resolved,"CAPSULE (DELAYED RELEASE)",A02BC,"DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",,2024-02-06,2024-05-03,2024-04-18,"Disruption of the manufacture of the drug.",2024-02-09,2024-04-19,No
219840,02245058,Shortage,APO-OMEPRAZOLE,"APOTEX INC",OMEPRAZOLE,OMEPRAZOLE,20MG,"100 BTL","ORAL; ORAL",Resolved,"CAPSULE (DELAYED RELEASE)",A02BC,"DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",,2024-02-13,2024-04-05,2024-04-04,"Disruption of the manufacture of the drug.",2024-02-16,2024-04-05,No
219159,02284294,Shortage,APO-OXCARBAZEPINE,"APOTEX INC",OXCARBAZEPINE,OXCARBAZEPINE,150MG,"100 BTL","ORAL; ORAL",Resolved,TABLET,N03AF,ANTIEPILEPTICS,,2024-02-06,2024-05-17,2024-05-09,"Disruption of the manufacture of the drug.",2024-02-09,2024-05-10,No
218385,02289288,Shortage,APO-PERINDOPRIL,"APOTEX INC","PERINDOPRIL ERBUMINE","PERINDOPRIL ERBUMINE",4MG,"500 BTL","ORAL; ORAL",Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2024-01-30,2024-03-15,2024-03-07,"Disruption of the manufacture of the drug.",2024-02-02,2024-03-08,No
219837,02289288,Shortage,APO-PERINDOPRIL,"APOTEX INC",PERINDOPRIL,"PERINDOPRIL ERBUMINE",4MG,"100 BTL","ORAL; ORAL",Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2024-02-13,2024-03-15,2024-03-07,"Disruption of the manufacture of the drug.",2024-02-16,2024-03-08,No
218397,02243508,Shortage,APO-PRAVASTATIN,"APOTEX INC",PRAVASTATIN,"PRAVASTATIN SODIUM",40MG,"30 BLS","ORAL; ORAL",Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2024-01-30,2024-04-12,2024-04-11,"Disruption of the manufacture of the drug.",2024-02-02,2024-04-12,No
218400,02243506,Shortage,APO-PRAVASTATIN,"APOTEX INC",PRAVASTATIN,"PRAVASTATIN SODIUM",10MG,"30 BLS","ORAL; ORAL",Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2024-01-30,2024-04-12,2024-04-04,"Disruption of the manufacture of the drug.",2024-02-02,2024-04-05,No
216726,02394278,Shortage,APO-PREGABALIN,"APOTEX INC",PREGABALIN,PREGABALIN,150MG,"100 BTL","ORAL; ORAL","Actual shortage",CAPSULE,N02BF,,,2024-07-16,,,"Disruption of the manufacture of the drug.",2024-01-19,2024-07-18,No
216729,02394286,Shortage,APO-PREGABALIN,"APOTEX INC",PREGABALIN,PREGABALIN,225MG,"100 BTL","ORAL; ORAL","Actual shortage",CAPSULE,N02BF,,,2024-11-12,,,"Disruption of the manufacture of the drug.",2024-01-19,2024-11-14,No
216732,02394235,Shortage,APO-PREGABALIN,"APOTEX INC",PREGABALIN,PREGABALIN,25MG,"100 BTL","ORAL; ORAL","Actual shortage",CAPSULE,N02BF,,2024-05-07,2024-05-07,,,"Disruption of the manufacture of the drug.",2024-01-19,2024-12-05,No
216735,02394294,Shortage,APO-PREGABALIN,"APOTEX INC",PREGABALIN,PREGABALIN,300MG,"100 BTL","ORAL; ORAL","Actual shortage",CAPSULE,N02BF,,,2024-08-20,,,"Disruption of the manufacture of the drug.",2024-01-19,2024-08-22,No
216738,02394243,Shortage,APO-PREGABALIN,"APOTEX INC",PREGABALIN,PREGABALIN,50MG,"100 BTL","ORAL; ORAL","Actual shortage",CAPSULE,N02BF,,,2024-11-12,,,"Disruption of the manufacture of the drug.",2024-01-19,2024-11-14,No
216741,02394251,Shortage,APO-PREGABALIN,"APOTEX INC",PREGABALIN,PREGABALIN,75MG,"100 BTL","ORAL; ORAL","Actual shortage",CAPSULE,N02BF,,,2024-07-16,,,"Disruption of the manufacture of the drug.",2024-01-19,2024-07-18,No
219834,02491591,Shortage,APO-PRUCALOPRIDE,"APOTEX INC",PRUCALOPRIDE,PRUCALOPRIDE,1MG,"100 BTL","ORAL; ORAL",Resolved,TABLET,A06AX,"DRUGS FOR CONSTIPATION",,2024-02-13,2024-04-05,2024-03-28,"Disruption of the manufacture of the drug.",2024-02-16,2024-03-29,No
216699,02501635,Shortage,"APO-QUETIAPINE FUMARATE","APOTEX INC",QUETIAPINE,QUETIAPINE,25MG,"100 BTL",ORAL,"Actual shortage","TABLET (IMMEDIATE RELEASE)",N05AH,ANTIPSYCHOTICS,2024-02-09,2022-02-20,,,"Disruption of the manufacture of the drug.",2024-01-19,2024-02-23,No
216702,02501643,Shortage,"APO-QUETIAPINE FUMARATE","APOTEX INC",QUETIAPINE,QUETIAPINE,100MG,"100 BTL",ORAL,"Actual shortage","TABLET (IMMEDIATE RELEASE)",N05AH,ANTIPSYCHOTICS,2024-09-04,,,,"Disruption of the manufacture of the drug.",2024-01-19,2024-09-05,No
216705,02501651,Shortage,"APO-QUETIAPINE FUMARATE","APOTEX INC",QUETIAPINE,QUETIAPINE,200MG,"100 BTL",ORAL,"Actual shortage","TABLET (IMMEDIATE RELEASE)",N05AH,ANTIPSYCHOTICS,,2024-09-04,,,"Disruption of the manufacture of the drug.",2024-01-19,2024-09-05,No
216708,02501678,Shortage,"APO-QUETIAPINE FUMARATE","APOTEX INC",QUETIAPINE,QUETIAPINE,300MG,"100 BTL",ORAL,"Actual shortage","TABLET (IMMEDIATE RELEASE)",N05AH,ANTIPSYCHOTICS,2024-02-06,2024-02-20,,,"Disruption of the manufacture of the drug.",2024-01-19,2024-02-23,No
216687,02457229,Shortage,"APO-QUETIAPINE XR","APOTEX INC",QUETIAPINE,QUETIAPINE,50MG,"60 BTL","ORAL; ORAL","Actual shortage","TABLET (EXTENDED-RELEASE)",N05AH,ANTIPSYCHOTICS,,2024-11-12,,,"Disruption of the manufacture of the drug.",2024-01-19,2024-11-14,No
216690,02457245,Shortage,"APO-QUETIAPINE XR","APOTEX INC",QUETIAPINE,QUETIAPINE,200MG,"60 BTL","ORAL; ORAL","Actual shortage","TABLET (EXTENDED-RELEASE)",N05AH,ANTIPSYCHOTICS,,2024-05-28,,,"Disruption of the manufacture of the drug.",2024-01-19,2024-05-31,No
216693,02457253,Shortage,"APO-QUETIAPINE XR","APOTEX INC",QUETIAPINE,QUETIAPINE,300MG,"60 BTL",ORAL,"Actual shortage","TABLET (EXTENDED-RELEASE)",N05AH,ANTIPSYCHOTICS,,2024-11-12,,,"Disruption of the manufacture of the drug.",2024-01-19,2024-11-14,No
216696,02457261,Shortage,"APO-QUETIAPINE XR","APOTEX INC",QUETIAPINE,QUETIAPINE,400MG,"60 BTL","ORAL; ORAL","Actual shortage","TABLET (EXTENDED-RELEASE)",N05AH,ANTIPSYCHOTICS,,2024-07-16,,,"Disruption of the manufacture of the drug.",2024-01-19,2024-07-18,No
218388,02251515,Shortage,APO-RAMIPRIL,"APOTEX INC",RAMIPRIL,RAMIPRIL,1.25MG,"100 BTL","ORAL; ORAL",Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2024-01-30,2024-03-01,2024-02-29,"Disruption of the manufacture of the drug.",2024-02-02,2024-03-01,No
215221,02251531,Shortage,APO-RAMIPRIL,"APOTEX INC",RAMIPRIL,RAMIPRIL,2.5MG,"500 BTL","ORAL; ORAL",Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2024-01-04,2024-03-22,2024-02-01,"Disruption of the manufacture of the drug.",2024-01-05,2024-02-02,No
215979,02337983,Shortage,APO-ROSUVASTATIN,"APOTEX INC",ROSUVASTATIN,ROSUVASTATIN,10MG,"500 BTL","ORAL; ORAL",Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2024-01-09,2024-02-09,2024-02-08,"Disruption of the manufacture of the drug.",2024-01-12,2024-02-09,No
220462,02247014,Shortage,APO-SIMVASTATIN,"APOTEX INC",SIMVASTATIN,SIMVASTATIN,40MG,"30 BLS","ORAL; ORAL",Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2022-02-22,2024-04-05,2024-04-04,"Disruption of the manufacture of the drug.",2024-02-23,2024-04-05,No
215976,02167794,Shortage,APO-SOTALOL,"APOTEX INC",SOTALOL,"SOTALOL HYDROCHLORIDE",160MG,"100 BTL","ORAL; ORAL",Resolved,TABLET,C07AA,"BETA BLOCKING AGENTS",,2024-01-09,,2024-01-18,"Disruption of the manufacture of the drug.",2024-01-12,2024-01-19,No
215227,02422085,Shortage,APO-TADALAFIL,"APOTEX INC",TADALAFIL,TADALAFIL,2.5MG,"30 BLS","ORAL; ORAL",Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2024-01-02,2024-03-15,2024-03-07,"Disruption of the manufacture of the drug.",2024-01-05,2024-03-08,No
215239,02422107,Shortage,APO-TADALAFIL,"APOTEX INC",TADALAFIL,TADALAFIL,10MG,"4 BLS","ORAL; ORAL",Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2024-01-02,2024-03-15,2024-03-07,"Disruption of the manufacture of the drug.",2024-01-05,2024-03-08,No
215242,02422093,Shortage,APO-TADALAFIL,"APOTEX INC",TADALAFIL,TADALAFIL,5MG,"30 BLS","ORAL; ORAL",Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2024-01-02,2024-01-31,2024-01-25,"Disruption of the manufacture of the drug.",2024-01-05,2024-01-26,No
215212,02407590,Shortage,APO-TETRABENAZINE,"APOTEX INC",TETRABENZINE,TETRABENAZINE,25MG,"100 BTL","ORAL; ORAL",Resolved,TABLET,N07XX,"OTHER NERVOUS SYSTEM DRUGS",,2024-01-02,2024-02-02,2024-02-01,"Disruption of the manufacture of the drug.",2024-01-05,2024-02-02,No
216675,02482630,Shortage,APO-TICAGRELOR,"APOTEX INC",TICRAGELOR,TICAGRELOR,90MG,"180 BTL",ORAL,Resolved,TABLET,B01AC,"ANTITHROMBOTIC AGENTS",,2024-01-16,2024-04-05,2024-03-28,"Disruption of the manufacture of the drug.",2024-01-19,2024-03-29,No
215215,00755834,Shortage,APO-TIMOP,"APOTEX INC",TIMOLOL,TIMOLOL,0.5%,"10 ML","OPHTHALMIC; OPHTHALMIC",Resolved,SOLUTION,S01ED,"ANTIGLAUCOMA PREPARATIONS AND MIOTICS",,2024-01-02,2024-07-05,2024-06-27,"Disruption of the manufacture of the drug.",2024-01-05,2024-06-28,No
215224,02147653,Shortage,"APO-TRAZODONE D TABLETS 150MG","APOTEX INC",TRAZODONE,"TRAZODONE HYDROCHLORIDE",150MG,"100 BTL","ORAL; ORAL",Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2024-01-02,2024-03-01,2024-02-29,"Disruption of the manufacture of the drug.",2024-01-05,2024-03-01,No
219122,02147645,Shortage,"APO-TRAZODONE TABLETS 100MG","APOTEX INC",TRAZODONE,"TRAZODONE HYDROCHLORIDE",100MG,"100 BTL","ORAL; ORAL",Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2024-02-06,2024-03-01,2024-02-29,"Disruption of the manufacture of the drug.",2024-02-09,2024-03-01,No
220468,02248539,Shortage,APO-TRYPTOPHAN,"APOTEX INC",TRYPTOPHAN,TRYPTOPHAN,1G,"100 BTL","ORAL; ORAL",Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2024-02-20,2024-04-05,2024-04-04,"Disruption of the manufacture of the drug.",2024-02-23,2024-04-05,No
217469,02248538,Shortage,APO-TRYPTOPHAN,"APOTEX INC",TRYPTOPHAN,TRYPTOPHAN,500MG,"100 BTL","ORAL; ORAL",Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2024-01-23,2024-04-05,2024-04-04,"Disruption of the manufacture of the drug.",2024-01-26,2024-04-05,No
218394,00782483,Shortage,"APO-VERAP TAB 80MG","APOTEX INC",VERAPAMIL,"VERAPAMIL HYDROCHLORIDE",80MG,"100 BTL","ORAL; ORAL",Resolved,TABLET,C08DA,"SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",,2024-01-30,2024-04-19,2024-04-18,"Disruption of the manufacture of the drug.",2024-02-02,2024-04-19,No
219235,02500213,Shortage,AURO-BUSPIRONE,"AURO PHARMA INC",AURO-BUSPIRONE,"BUSPIRONE HYDROCHLORIDE",10MG,100's,ORAL,Resolved,TABLET,N05BE,ANXIOLYTICS,,2024-02-12,,2024-03-27,"Demand increase for the drug.",2024-02-12,2024-03-28,No
217630,02347253,Shortage,AURO-CEFPROZIL,"AURO PHARMA INC",AURO-CEFPROZIL,CEFPROZIL,500MG,100's,"ORAL; ORAL",Resolved,"TABLET; TABLET",J01DC,"OTHER BETA-LACTAM ANTIBACTERIALS",,2024-01-29,2024-05-31,2024-05-30,"Demand increase for the drug.",2024-01-29,2024-05-31,No
219262,02497743,Shortage,AURO-CEPHALEXIN,"AURO PHARMA INC",AURO-CEPHALEXIN,CEPHALEXIN,125MG,"100 ml",ORAL,"Actual shortage","POWDER FOR SUSPENSION",J01DB,"OTHER BETA-LACTAM ANTIBACTERIALS",,2024-02-12,,,"Demand increase for the drug.",2024-02-12,2024-05-24,No
217633,02381923,Shortage,AURO-CIPROFLOXACIN,"AURO PHARMA INC",AURO-CIPROFLOXACIN,CIPROFLOXACIN,500MG,500's,"ORAL; ORAL",Resolved,TABLET,J01MA,"QUINOLONE ANTIBACTERIALS",,2024-01-29,2024-03-29,2024-03-27,"Demand increase for the drug.",2024-01-29,2024-03-28,No
219267,02436647,Shortage,AURO-DULOXETINE,"AURO PHARMA INC",AURO-DULOXETINE,DULOXETINE,30MG,"100's and 500's","ORAL; ORAL",Resolved,"CAPSULE (DELAYED RELEASE)",N06AX,ANTIDEPRESSANTS,,2024-02-12,2024-07-31,2024-08-15,"Demand increase for the drug.",2024-02-12,2024-08-16,No
219270,02436655,Shortage,AURO-DULOXETINE,"AURO PHARMA INC",AURO-DULOXETINE,DULOXETINE,60MG,500's,"ORAL; ORAL",Resolved,"CAPSULE (DELAYED RELEASE)",N06AX,ANTIDEPRESSANTS,,2024-02-12,2024-06-15,2024-07-17,"Demand increase for the drug.",2024-02-12,2024-07-18,No
217636,02469308,Shortage,AURO-DUTASTERIDE,"AURO PHARMA INC",AURO-DUTASTERIDE,DUTASTERIDE,0.5MG,"3x10 Blst and 100's","ORAL; ORAL",Resolved,CAPSULE,G04CB,"DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",,2024-01-29,2024-06-15,2024-06-13,"Demand increase for the drug.",2024-01-29,2024-06-14,No
217639,02475359,Shortage,AURO-LACOSAMIDE,"AURO PHARMA INC",AURO-LACOSAMIDE,LACOSAMIDE,150MG,60's,"ORAL; ORAL",Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2024-01-29,2024-07-31,2024-07-16,"Demand increase for the drug.",2024-01-29,2024-07-17,No
217643,02475332,Shortage,AURO-LACOSAMIDE,"AURO PHARMA INC",AURO-LACOSAMIDE,LACOSAMIDE,50MG,60's,"ORAL; ORAL",Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2024-01-29,2024-02-15,2024-02-13,"Demand increase for the drug.",2024-01-29,2024-02-14,No
217646,02381370,Shortage,AURO-LAMOTRIGINE,"AURO PHARMA INC",AURO-LAMOTRIGINE,LAMOTRIGINE,150MG,100's,"ORAL; ORAL",Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2024-01-29,2024-03-29,2024-03-27,"Demand increase for the drug.",2024-01-29,2024-03-28,No
217649,02375249,Shortage,AURO-LEVETIRACETAM,"AURO PHARMA INC",AURO-LEVETIRACETAM,LEVETIRACETAM,250MG,100's,"ORAL; ORAL",Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2024-01-29,2024-03-15,2024-03-15,"Demand increase for the drug.",2024-01-29,2024-03-16,No
219291,02394480,Shortage,AURO-LISINOPRIL,"AURO PHARMA INC",AURO-LISINOPRIL,LISINOPRIL,10MG,100's,"ORAL; ORAL",Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2024-02-12,,2024-03-27,"Demand increase for the drug.",2024-02-12,2024-03-28,No
217652,02438275,Shortage,AURO-METFORMIN,"AURO PHARMA INC",AURO-METFORMIN,"METFORMIN HYDROCHLORIDE",500MG,360's,"ORAL; ORAL",Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2024-01-29,2024-04-17,2024-04-16,"Demand increase for the drug.",2024-01-29,2024-04-17,No
217655,02470284,Shortage,AURO-METRONIDAZOLE,"AURO PHARMA INC",AURO-METRONIDAZOLE,METRONIDAZOLE,500MG,100's,"ORAL; ORAL",Resolved,CAPSULE,P01AB,"AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DIS.",,2024-01-29,2024-05-15,2024-05-13,"Demand increase for the drug.",2024-01-29,2024-05-14,No
219302,02401274,Shortage,AURO-MONTELUKAST,"AURO PHARMA INC",AURO-MONTELUKAST,MONTELUKAST,10MG,90's,"ORAL; ORAL",Resolved,TABLET,R03DC,"OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",,2024-02-12,2024-02-29,2024-02-27,"Demand increase for the drug.",2024-02-12,2024-02-28,No
217658,02424096,Shortage,AURO-PRAMIPEXOLE,"AURO PHARMA INC",AURO-PRAMIPEXOLE,"PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",1MG,100's,"ORAL; ORAL",Resolved,TABLET,N04BC,"DOPAMINERGIC AGENTS",,2024-01-29,2024-03-15,2024-03-13,"Demand increase for the drug.",2024-01-29,2024-03-14,No
217661,02390248,Shortage,AURO-QUETIAPINE,"AURO PHARMA INC",AURO-QUETIAPINE,QUETIAPINE,200MG,"100's and 500's","ORAL; ORAL",Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2024-01-29,2024-09-15,2024-09-13,"Demand increase for the drug.",2024-01-29,2024-09-14,No
219319,02424266,Shortage,AURO-REPAGLINIDE,"AURO PHARMA INC",AURO-REPAGLINIDE,REPAGLINIDE,1MG,100's,"ORAL; ORAL",Resolved,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2024-02-12,2024-03-29,2024-03-27,"Demand increase for the drug.",2024-02-12,2024-03-28,No
219353,02424258,Shortage,AURO-REPAGLINIDE,"AURO PHARMA INC",AURO-REPAGLINIDE,REPAGLINIDE,0.5MG,100's,"ORAL; ORAL",Resolved,TABLET,A10BX,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2024-02-12,,2024-02-27,"Demand increase for the drug.",2024-02-12,2024-02-28,No
217664,02442574,Shortage,AURO-ROSUVASTATIN,"AURO PHARMA INC",AURO-ROSUVASTATIN,ROSUVASTATIN,5MG,90's,"ORAL; ORAL",Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2024-01-29,2024-09-30,2024-09-27,"Demand increase for the drug.",2024-01-29,2024-09-28,No
219324,02390906,Shortage,AURO-SERTRALINE,"AURO PHARMA INC",AURO-SERTRALINE,SERTRALINE,25MG,100's,"ORAL; ORAL",Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2024-02-12,2024-04-17,2024-04-16,"Demand increase for the drug.",2024-02-12,2024-04-19,No
217667,02529874,Shortage,AURO-SITAGLIPTIN,"AURO PHARMA INC",AURO-SITAGLIPTIN,SITAGLIPTIN,50MG,500's,ORAL,Resolved,TABLET,A10BH,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2024-01-29,,2024-07-16,"Demand increase for the drug.",2024-01-29,2024-07-17,No
217670,02460173,Shortage,AURO-TENOFOVIR,"AURO PHARMA INC",AURO-TENOFOVIR,"TENOFOVIR DISOPROXIL FUMARATE",300MG,30's,"ORAL; ORAL",Resolved,TABLET,J05AF,"DIRECT ACTING ANTIVIRALS",,2024-01-29,2024-11-15,2024-11-13,"Demand increase for the drug.",2024-01-29,2024-11-14,No
219339,02471884,Shortage,AURO-TRANDOLAPRIL,"AURO PHARMA INC",AURO-TRANDOLAPRIL,TRANDOLAPRIL,2MG,100's,"ORAL; ORAL",Resolved,CAPSULE,C09AA,"ACE INHIBITORS, PLAIN",,2024-02-12,,2024-02-27,"Demand increase for the drug.",2024-02-12,2024-02-28,No
217675,02414201,Shortage,AURO-VALSARTAN,"AURO PHARMA INC",AURO-VALSARTAN,VALSARTAN,40MG,100's,"ORAL; ORAL",Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2024-01-29,2024-02-28,2024-02-26,"Demand increase for the drug.",2024-01-29,2024-02-27,No
217678,02414228,Shortage,AURO-VALSARTAN,"AURO PHARMA INC",AURO-VALSARTAN,VALSARTAN,80MG,100's,"ORAL; ORAL",Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2024-01-29,2024-10-31,2024-10-28,"Demand increase for the drug.",2024-01-29,2024-10-29,No
219346,02452855,Shortage,"AURO-VENLAFAXINE XR","AURO PHARMA INC","AURO-VENLAFAXINE XR",VENLAFAXINE,150MG,500's,"ORAL; ORAL",Resolved,"CAPSULE (EXTENDED RELEASE)",N06AX,ANTIDEPRESSANTS,,2024-02-12,2024-04-04,2024-03-27,"Demand increase for the drug.",2024-02-12,2024-03-28,No
216069,02237792,Shortage,AVAXIM,"SANOFI PASTEUR LIMITED","HEPATITIS A VACCINE, INACTIVATED","HEPATITIS A VACCINE, INACTIVATED",160UNIT,"1 x 0.5 mL (single dose) syringe","INTRAMUSCULAR; INTRAMUSCULAR",Resolved,SUSPENSION,J07BC,"VIRAL VACCINES",2024-01-19,2024-01-22,2024-07-12,2024-06-27,"Demand increase for the drug.",2024-01-15,2024-06-28,No
220276,02492415,Shortage,BAQSIMI,"ELI LILLY CANADA INC",Glucagon,GLUCAGON,3MG,"3 mg per container","NASAL; NASAL",Resolved,POWDER,H04AA,"GLYCOGENOLYTIC HORMONES",,2024-02-21,2024-02-28,2024-02-27,"Delay in shipping of the drug.",2024-02-22,2024-02-28,No
220886,02496860,Shortage,"BENDAMUSTINE HYDROCHLORIDE FOR INJECTION","ACCORD HEALTHCARE INC","BENDAMUSTINE HYDROCHLORIDE","BENDAMUSTINE HYDROCHLORIDE",100MG,vial,INTRAVENOUS,"Actual shortage","POWDER FOR SOLUTION",L01AA,ALKYLATINGAGENTS,,2024-02-27,,,"Requirements related to complying with good manufacturing practices.",2024-02-28,2024-02-28,No
215070,00716618,Shortage,"BETADERM CRM 0.05%","TARO PHARMACEUTICALS INC",BETADERM,BETAMETHASONE,0.05%,454,"TOPICAL; TOPICAL",Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2023-11-29,2024-01-19,2024-02-06,"Disruption of the manufacture of the drug.",2024-01-05,2024-02-08,No
215839,02417030,Shortage,BEXSERO,"GLAXOSMITHKLINE INC","Multicomponent Meningococcal B Vaccine (recombinant, adsorbed)","OUTER MEMBRANE VESICLES; RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN; RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN; RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN","25MCG; 50MCG; 50MCG; 50MCG",10s,"INTRAMUSCULAR; INTRAMUSCULAR",Resolved,SUSPENSION,J07AH,"BACTERIAL VACCINES",,2024-01-10,2024-02-16,2024-02-09,"Delay in shipping of the drug.",2024-01-12,2024-02-10,No
215507,02244641,Shortage,BIAXIN,"BGP PHARMA ULC",CLARITHROMYCIN,CLARITHROMYCIN,250MG,105ML,"ORAL; ORAL",Resolved,"GRANULES FOR SUSPENSION",J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2024-01-04,2024-05-14,2024-05-14,"Disruption of the manufacture of the drug.",2024-01-10,2024-05-17,No
220833,02126710,Shortage,"BIAXIN BID","BGP PHARMA ULC",CLARITHROMYCIN,CLARITHROMYCIN,500MG,"100 BTL CA","ORAL; ORAL",Resolved,TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",2024-03-04,,2024-03-15,2024-03-04,"Shortage of an active ingredient.",2024-02-28,2024-03-06,No
220089,01984853,Shortage,"BIAXIN BID","BGP PHARMA ULC",CLARITHROMYCIN,CLARITHROMYCIN,250MG,"100 BTL","ORAL; ORAL","Avoided shortage",TABLET,J01FA,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",2024-04-07,,2024-05-14,2024-03-04,"Disruption of the manufacture of the drug.",2024-02-21,2024-03-06,No
218148,02399334,Shortage,"CALCITRIOL INJECTION USP","STERIMAX INC","CALCITRIOL INJECTION USP",CALCITRIOL,1MCG,"25 AMPOULES","INTRAVENOUS; INTRAVENOUS","Actual shortage",SOLUTION,A11CC,"VIT A AND D, INCL COMBINATIONS OF THE TWO",,2024-06-01,,,"Disruption of the manufacture of the drug.",2024-02-01,2025-01-23,No
217790,02388928,Shortage,CANDESARTAN,"SANIS HEALTH INC",CANDESARTAN,"CANDESARTAN CILEXETIL",8MG,100,"ORAL; ORAL",Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2024-01-29,2024-04-26,2024-04-22,"Disruption of the manufacture of the drug.",2024-01-30,2024-04-23,No
216273,02388936,Shortage,CANDESARTAN,"SANIS HEALTH INC",CANDESARTAN,"CANDESARTAN CILEXETIL",16MG,500,"ORAL; ORAL",Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2024-01-12,2024-08-30,2024-08-14,"Disruption of the manufacture of the drug.",2024-01-17,2024-08-15,No
220656,02388936,Shortage,CANDESARTAN,"SANIS HEALTH INC",CANDESARTAN,"CANDESARTAN CILEXETIL",16MG,100,"ORAL; ORAL",Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2024-02-26,2024-05-03,2024-04-22,"Disruption of the manufacture of the drug.",2024-02-27,2024-04-23,No
220663,02394804,Shortage,CANDESARTAN/HCTZ,"SANIS HEALTH INC",CANDESARTAN/HCTZ,"HYDROCHLOROTHIAZIDE; CANDESARTAN CILEXETIL","12.5MG; 16MG",100,"ORAL; ORAL",Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2024-02-26,2024-03-08,2024-03-08,"Disruption of the manufacture of the drug.",2024-02-27,2024-03-09,No
217832,02364921,Shortage,CARVEDILOL,"SANIS HEALTH INC",CARVEDILOL,CARVEDILOL,6.25MG,100,"ORAL; ORAL",Resolved,TABLET,C07AG,"BETA BLOCKING AGENTS",,2024-01-29,2024-02-09,2024-02-12,"Disruption of the manufacture of the drug.",2024-01-30,2024-02-13,No
217099,02237484,Shortage,CELLCEPT,"HOFFMANN-LA ROCHE LIMITED",CELLCEPT,"MYCOPHENOLATE MOFETIL",500MG,"500MG TABS","ORAL; ORAL",Resolved,TABLET,L04AA,IMMUNOSUPPRESSANTS,2024-01-24,,2024-03-11,2024-03-12,"Delay in shipping of the drug.",2024-01-24,2024-03-13,No
220032,02247459,Shortage,"CHORIONIC GONADOTROPIN FOR INJECTION, USP","FRESENIUS KABI CANADA LTD","CHORIONIC GONADOTROPIN FOR INJECTION, USP","CHORIONIC GONADOTROPIN",10000UNIT,10000UNIT,"SUBCUTANEOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAMUSCULAR",Resolved,"POWDER FOR SOLUTION",G03GA,"GONADOTROPHINS AND OTHER OVULATION STIMULANTS",,2024-02-26,2024-03-25,2024-03-22,"Disruption of the manufacture of the drug.",2024-02-20,2024-03-23,No
216222,00487872,Shortage,CIMETIDINE,"AA PHARMA INC",CIMETIDINE,CIMETIDINE,300MG,"100 BTL","ORAL; ORAL",Resolved,TABLET,A02BA,"DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",2024-02-09,,2024-04-22,2024-04-19,"Disruption of the manufacture of the drug.",2024-01-17,2024-04-24,No
217270,02494574,Shortage,"CLADRIBINE INJECTION","GENERIC MEDICAL PARTNERS INC","CLADRIBINE INJECTION",CLADRIBINE,1MG,"1mg/ml 10ml Vial",INTRAVENOUS,Resolved,SOLUTION,L01BB,ANTIMETABOLITES,2024-01-25,2024-01-25,2024-02-15,2024-02-26,"Demand increase for the drug.",2024-01-25,2024-02-27,No
220112,02494574,Shortage,"CLADRIBINE INJECTION","GENERIC MEDICAL PARTNERS INC","CLADRIBINE INJECTION",CLADRIBINE,1MG,"1mg/ml 10ml Vial",INTRAVENOUS,"Actual shortage",SOLUTION,L01BB,ANTIMETABOLITES,2024-01-25,2024-01-25,2024-02-26,,"Demand increase for the drug.",2024-02-21,2024-02-21,No
216236,02247499,Shortage,"CLIMARA 25","BAYER INC",ESTRADIOL,ESTRADIOL,25MCG,4'S,"TRANSDERMAL; TRANSDERMAL",Resolved,PATCH,G03CA,ESTROGENS,2024-02-09,2024-02-07,2024-06-20,2024-05-30,"Other (Please describe in comments)",2024-01-17,2024-06-03,No
217037,02408538,Shortage,"CLINDAMYCIN IV INFUSION","SANDOZ CANADA INCORPORATED","CLINDAMYCIN IV INFUSION",CLINDAMYCIN,18MG,10LIIF,"INTRAVENOUS; INTRAVENOUS",Resolved,SOLUTION,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2024-01-23,2024-04-05,2024-04-03,"Delay in shipping of the drug.",2024-01-23,2024-04-04,No
218165,02472945,Shortage,CONTRAVE,"BAUSCH HEALTH, CANADA INC.",CONTRAVE,"BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE","90MG; 8MG",n/a,"ORAL; ORAL","Avoided shortage","TABLET (EXTENDED-RELEASE)",A08AA,,2024-02-29,,2024-03-08,2024-02-01,"Delay in shipping of the drug.",2024-02-01,2024-02-05,No
220039,02301482,Shortage,CYMBALTA,"ELI LILLY CANADA INC","Duloxetine hydrochloride delayed release capsules",DULOXETINE,30MG,"Carton containing 28 capsules in blister packaging","ORAL; ORAL",Resolved,"CAPSULE (DELAYED RELEASE)",N06AX,ANTIDEPRESSANTS,2024-04-26,2024-04-25,,2024-09-25,"Other (Please describe in comments)",2024-02-20,2024-10-09,No
220042,02301490,Shortage,CYMBALTA,"ELI LILLY CANADA INC","Duloxetine hydrochloride delayed release capsules",DULOXETINE,60MG,"Carton containing 28 capsules in blister packaging","ORAL; ORAL",Resolved,"CAPSULE (DELAYED RELEASE)",N06AX,ANTIDEPRESSANTS,2024-04-19,2024-04-12,,2024-09-25,"Other (Please describe in comments)",2024-02-20,2024-10-09,No
215589,01997602,Shortage,"DANTRIUM CAPSULES","ENDO PAR INNOVATION COMPANY, LLC","DANTROLENE SODIUM","DANTROLENE SODIUM",25MG,"100 Capsules","ORAL; ORAL",Resolved,CAPSULE,M03CA,"MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS",2023-12-15,,2024-01-31,2024-02-01,"Delay in shipping of the drug.",2024-01-11,2024-02-07,No
216889,00029246,Shortage,DELATESTRYL,"BAUSCH HEALTH, CANADA INC.",DELATESTRYL,"TESTOSTERONE ENANTHATE",200MG,5ML,"INTRAMUSCULAR; INTRAMUSCULAR",Resolved,SOLUTION,G03BA,ANDROGENS,,2024-01-03,2024-01-26,2024-01-30,"Other (Please describe in comments)",2024-01-22,2024-02-01,No
219719,02216256,Shortage,DESIPRAMINE,"AA PHARMA INC",DESIPRAMINE,"DESIPRAMINE HYDROCHLORIDE",25MG,"100 BTL","ORAL; ORAL",Resolved,TABLET,N06AA,ANTIDEPRESSANTS,2024-02-15,,2024-04-09,2024-04-09,"Disruption of the manufacture of the drug.",2024-02-15,2024-04-11,No
219750,02239064,Shortage,DETROL,"BGP PHARMA ULC","TOLTERODINE TARTRATE","TOLTERODINE TARTRATE",1MG,"1x60 BTL CA","ORAL; ORAL",Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2024-02-23,2024-02-23,,2024-08-26,"Disruption of the manufacture of the drug.",2024-02-15,2024-08-27,No
220374,01924567,Shortage,"DEXEDRINE SPANSULE SRC 15MG","PALADIN LABS INC.","DEXTROAMPHETAMINE SULFATE","DEXTROAMPHETAMINE SULFATE",15MG,"100 Capsules","ORAL; ORAL",Resolved,"CAPSULE (SUSTAINED-RELEASE)",N06BA,"PSYCHOSTIMULANTS AND NOOTROPICS",,2024-01-31,2024-03-25,2024-03-27,"Delay in shipping of the drug.",2024-02-23,2024-03-28,No
215477,00362158,Shortage,DIAZEPAM,"AA PHARMA INC",DIAZEPAM,DIAZEPAM,5MG,"100 BTL","ORAL; ORAL",Resolved,TABLET,N05BA,ANXIOLYTICS,2024-01-10,,2024-01-23,2024-01-24,"Disruption of the manufacture of the drug.",2024-01-10,2024-01-25,No
215518,01950592,Shortage,DICETEL,"BGP PHARMA ULC","PINAVERIUM BROMIDE","PINAVERIUM BROMIDE",50MG,"4x25 CA","ORAL; ORAL",Resolved,TABLET,A03AX,"DRUGS FOR FUNCTIONAL BOWEL DISORDERS",,2024-01-05,2024-02-13,2024-02-21,"Disruption of the manufacture of the drug.",2024-01-10,2024-02-29,No
219753,00022772,Shortage,DILANTIN,"BGP PHARMA ULC","PHENYTOIN SODIUM","PHENYTOIN SODIUM",30MG,"100 BTL CA","ORAL; ORAL",Resolved,CAPSULE,N03AB,ANTIEPILEPTICS,2024-02-20,2024-02-26,2024-03-12,2024-03-07,"Disruption of the manufacture of the drug.",2024-02-15,2024-03-12,No
215330,02439336,Shortage,"DOCETAXEL INJECTION","SANDOZ CANADA INCORPORATED",DOCETAXEL,DOCETAXEL,10MG,1ML,"INTRAVENOUS; INTRAVENOUS","Avoided shortage",SOLUTION,L01CD,"PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",,2024-01-08,2024-02-09,2024-01-05,"Demand increase for the drug.",2024-01-08,2024-02-05,No
217980,02420597,Shortage,DONEPEZIL,"SIVEM PHARMACEUTICALS ULC",Donepezil,"DONEPEZIL HYDROCHLORIDE",5MG,100,"ORAL; ORAL","Actual shortage",TABLET,N06DA,"ANTI-DEMENTIA DRUGS",2024-08-05,2024-09-10,2025-06-01,,"Disruption of the manufacture of the drug.",2024-01-31,2024-12-02,No
217983,02420600,Shortage,DONEPEZIL,"SIVEM PHARMACEUTICALS ULC",Donepezil,"DONEPEZIL HYDROCHLORIDE",10MG,100,"ORAL; ORAL","Actual shortage",TABLET,N06DA,"ANTI-DEMENTIA DRUGS",2024-08-05,2024-09-10,2025-06-01,,"Disruption of the manufacture of the drug.",2024-01-31,2024-12-02,No
216058,02475278,Shortage,DONEPEZIL,"LABORATOIRE RIVA INC.","Donepezil 5mg","DONEPEZIL HYDROCHLORIDE",5MG,100,"ORAL; ORAL","Actual shortage",TABLET,N06DA,"ANTI-DEMENTIA DRUGS",2024-01-12,2024-01-12,,,"Requirements related to complying with good manufacturing practices.",2024-01-15,2024-01-15,No
216061,02475286,Shortage,DONEPEZIL,"LABORATOIRE RIVA INC.","Donepezil 10mg","DONEPEZIL HYDROCHLORIDE",10MG,100,"ORAL; ORAL",Resolved,TABLET,N06DA,"ANTI-DEMENTIA DRUGS",2024-01-12,2024-01-12,,2024-01-17,"Requirements related to complying with good manufacturing practices.",2024-01-15,2024-01-18,No
217075,01947923,Shortage,DUVOID,"PALADIN LABS INC.","BETHANECHOL CHLORIDE","BETHANECHOL CHLORIDE",50MG,"100 Tab","ORAL; ORAL","Actual shortage",TABLET,N07AB,PARASYMPATHOMIMETICS,,2023-12-11,,,"Disruption of the manufacture of the drug.",2024-01-24,2024-01-24,No
220923,01947958,Shortage,DUVOID,"PALADIN LABS INC.","Duvoid 10mg tabs","BETHANECHOL CHLORIDE",10MG,"100 Tabs","ORAL; ORAL",Resolved,TABLET,N07AB,PARASYMPATHOMIMETICS,,2024-02-15,2024-03-27,2024-03-27,"Delay in shipping of the drug.",2024-02-29,2024-03-27,No
217264,02247238,Shortage,ELIDEL,"BAUSCH HEALTH, CANADA INC.",ELIDEL,PIMECROLIMUS,1%,30g,"TOPICAL; TOPICAL","Avoided shortage",CREAM,D11AH,"OTHER DERMATOLOGICAL PREPARATIONS",2024-03-15,,2024-03-29,2024-02-19,"Other (Please describe in comments)",2024-01-25,2024-02-22,No
218192,02491060,Shortage,EMGALITY,"ELI LILLY CANADA INC","galcanezumab injection",GALCANEZUMAB,120MG,"Carton package containing one 120 mg/mL single-use prefilled syringe","SUBCUTANEOUS; SUBCUTANEOUS",Resolved,SOLUTION,N02CD,,,2024-02-02,2024-03-08,2024-03-07,"Demand increase for the drug.",2024-02-02,2024-03-08,No
220681,02431173,Shortage,ESOMEPRAZOLE,"SANIS HEALTH INC",ESOMEPRAZOLE,ESOMEPRAZOLE,40MG,100,"ORAL; ORAL",Resolved,"TABLET (DELAYED-RELEASE)",A02BC,"DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",,2024-02-26,2024-06-07,2024-06-04,"Disruption of the manufacture of the drug.",2024-02-27,2024-06-05,No
218836,02520699,Shortage,ESOMEPRAZOLE,"JAMP PHARMA CORPORATION","Esomeprazole Magnesium Delayed Release Tablets",ESOMEPRAZOLE,20MG,100,ORAL,Resolved,"TABLET (DELAYED-RELEASE)",A02BC,"DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",,2024-02-05,2024-08-31,2024-09-04,"Disruption of the manufacture of the drug.",2024-02-08,2024-09-05,No
217837,02431173,Shortage,ESOMEPRAZOLE,"SANIS HEALTH INC",ESOMEPRAZOLE,ESOMEPRAZOLE,40MG,100,"ORAL; ORAL",Resolved,"TABLET (DELAYED-RELEASE)",A02BC,"DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",,2024-01-29,2024-02-02,2024-02-08,"Disruption of the manufacture of the drug.",2024-01-30,2024-02-09,No
217041,02241835,Shortage,"ESTALIS 140/50 MCG","SANDOZ CANADA INCORPORATED","ESTALIS 140/50 MCG","NORETHINDRONE ACETATE; ESTRADIOL","140MCG; 50MCG",8TTSM,"TRANSDERMAL; TRANSDERMAL",Resolved,PATCH,G03FA,"PROGESTOGENS AND ESTROGENS IN COMBINATION",,2024-01-23,2024-02-16,2024-02-19,"Requirements related to complying with good manufacturing practices.",2024-01-23,2024-02-19,No
216175,02241837,Shortage,"ESTALIS 250/50 MCG","SANDOZ CANADA INCORPORATED","ESTALIS 250/50 MCG","NORETHINDRONE ACETATE; ESTRADIOL","250MCG; 50MCG",8TTSM,"TRANSDERMAL; TRANSDERMAL",Resolved,PATCH,G03FA,"PROGESTOGENS AND ESTROGENS IN COMBINATION",,2024-01-16,2024-04-19,2024-04-23,"Disruption of the manufacture of the drug.",2024-01-16,2024-04-24,No
214774,02245676,Shortage,"ESTRADOT 25","SANDOZ CANADA INCORPORATED","ESTRADOT 25",ESTRADIOL,25MCG,8TTS,"TRANSDERMAL; TRANSDERMAL",Resolved,PATCH,G03CA,ESTROGENS,,2024-01-03,2024-02-23,2024-02-26,"Disruption of the manufacture of the drug.",2024-01-03,2024-02-27,No
217044,02243999,Shortage,"ESTRADOT 37.5","SANDOZ CANADA INCORPORATED","ESTRADOT 37.5",ESTRADIOL,37.5MCG,8TTS,"TRANSDERMAL; TRANSDERMAL",Resolved,PATCH,G03CA,ESTROGENS,,2024-01-23,2024-05-03,2024-04-30,"Disruption of the manufacture of the drug.",2024-01-23,2024-05-01,No
216178,02244000,Shortage,"ESTRADOT 50","SANDOZ CANADA INCORPORATED","ESTRADOT 50",ESTRADIOL,50MCG,8TTS,"TRANSDERMAL; TRANSDERMAL",Resolved,PATCH,G03CA,ESTROGENS,,2024-01-16,2024-03-08,2024-02-26,"Disruption of the manufacture of the drug.",2024-01-16,2024-02-27,No
219977,02244001,Shortage,"ESTRADOT 75","SANDOZ CANADA INCORPORATED","ESTRADOT 75",ESTRADIOL,75MCG,8TTS,"TRANSDERMAL; TRANSDERMAL",Resolved,PATCH,G03CA,ESTROGENS,,2024-02-20,2024-02-23,2024-02-26,"Disruption of the manufacture of the drug.",2024-02-20,2024-02-27,No
218436,02469456,Shortage,"ETHACRYNATE SODIUM FOR INJECTION USP","STERIMAX INC","ETHACRYNATE SODIUM FOR INJECTION USP","ETHACRYNIC ACID",50MG,"1 VIAL","INTRAVENOUS; INTRAVENOUS",Resolved,"POWDER FOR SOLUTION",C03CC,"HIGH-CEILING DIURETICS",,2023-11-30,,2024-06-27,"Shortage of an inactive ingredient or component.",2024-02-05,2024-06-28,No
218689,02247521,Shortage,EZETROL,"ORGANON CANADA INC.","ezetimibe tablets",EZETIMIBE,10MG,30Tab,"ORAL; ORAL",Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",2024-02-05,2024-02-05,2024-02-23,2024-02-19,"Delay in shipping of the drug.",2024-02-06,2024-02-21,No
220624,02247521,Shortage,EZETROL,"ORGANON CANADA INC.","ezetimibe tablets",EZETIMIBE,10MG,30TAB,"ORAL; ORAL",Resolved,TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2024-02-23,2024-03-01,2024-02-27,"Delay in shipping of the drug.",2024-02-26,2024-02-28,No
218659,02247735,Shortage,"FAMOTIDINE OMEGA  -(WITHOUT PRESERVATIVE)","OMEGA LABORATORIES LIMITED","Famotidine Injection",FAMOTIDINE,10MG,"10 x 2 mL vial / fiole","INTRAVENOUS; INTRAVENOUS",Resolved,SOLUTION,A02BA,"DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",,2024-02-06,2024-03-08,2024-03-07,"Disruption of the manufacture of the drug.",2024-02-06,2024-03-08,No
219224,02384124,Shortage,"FENTANYL CITRATE INJECTION SDZ","SANDOZ CANADA INCORPORATED","FENTANYL CITRATE INJECTION",FENTANYL,50MCG,"10 LIAM","EPIDURAL; INTRAVENOUS; INTRAMUSCULAR; EPIDURAL; INTRAVENOUS; INTRAMUSCULAR",Resolved,"SOLUTION; LIQUID",N01AH,"ANESTHETICS, GENERAL",,2024-02-12,2024-03-08,2024-03-11,"Disruption of the manufacture of the drug.",2024-02-12,2024-03-12,No
215793,01926861,Shortage,FLAGYL,"SANOFI-AVENTIS CANADA INC",Flagyl,METRONIDAZOLE,10%,60g,"VAGINAL; VAGINAL",Resolved,CREAM,G01AF,"ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.",,2024-01-10,2024-06-21,2024-06-03,"Other (Please describe in comments)",2024-01-12,2024-06-04,No
215796,01926829,Shortage,FLAGYSTATIN,"SANOFI-AVENTIS CANADA INC","Flagystatin Ovules","NYSTATIN; METRONIDAZOLE","100000UNIT; 500MG",10,"VAGINAL; VAGINAL",Resolved,"OVULE; SUPPOSITORY",G01AA,"ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.",,2024-01-10,2024-02-09,2024-01-29,"Other (Please describe in comments)",2024-01-12,2024-01-30,No
220338,02230848,Shortage,FLOLAN,"GLAXOSMITHKLINE INC","Epoprostenol Powder for Injection",EPOPROSTENOL,1.5MG,1s,"INTRAVENOUS; INTRAVENOUS",Resolved,"POWDER FOR SOLUTION",B01AC,"ANTITHROMBOTIC AGENTS",,2024-02-21,2024-05-31,2024-05-16,"Disruption of the manufacture of the drug.",2024-02-23,2024-05-17,No
219434,02244293,Shortage,"FLOVENT HFA","GLAXOSMITHKLINE INC","fluticasone propionate inhalation aerosol","FLUTICASONE PROPIONATE",250MCG,1x120,"ORAL; INHALATION; ORAL; INHALATION",Resolved,"METERED-DOSE AEROSOL",R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2024-02-08,2024-02-23,2024-02-21,"Delay in shipping of the drug.",2024-02-13,2024-02-22,No
217406,02244292,Shortage,"FLOVENT HFA","GLAXOSMITHKLINE INC","fluticasone propionate inhalation aerosol","FLUTICASONE PROPIONATE",125MCG,1x60,"ORAL; INHALATION; ORAL; INHALATION",Resolved,"METERED-DOSE AEROSOL",R03BA,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",,2024-01-23,2024-03-08,2024-03-07,"Demand increase for the drug.",2024-01-26,2024-03-08,No
215437,02404567,Shortage,FYCOMPA,"EISAI LIMITED",perampanel,PERAMPANEL,12.0MG,28,"ORAL; ORAL",Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2024-01-09,2024-02-05,2024-01-31,"Demand increase for the drug.",2024-01-09,2024-02-01,No
216471,02404524,Shortage,FYCOMPA,"EISAI LIMITED",perampanel,PERAMPANEL,4.0MG,28,"ORAL; ORAL",Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2024-01-25,2024-02-05,2024-01-31,"Demand increase for the drug.",2024-01-18,2024-02-01,No
216474,02404540,Shortage,FYCOMPA,"EISAI LIMITED",perampanel,PERAMPANEL,8.0MG,28,"ORAL; ORAL",Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2024-01-18,2024-02-05,2024-01-31,"Demand increase for the drug.",2024-01-18,2024-02-01,No
217766,02353245,Shortage,GABAPENTIN,"SANIS HEALTH INC",GABAPENTIN,GABAPENTIN,100MG,500,"ORAL; ORAL",Resolved,CAPSULE,N02BF,,,2024-01-29,2024-03-16,2024-03-14,"Disruption of the manufacture of the drug.",2024-01-30,2024-03-14,No
220627,02353253,Shortage,GABAPENTIN,"SANIS HEALTH INC",GABAPENTIN,GABAPENTIN,300MG,700,"ORAL; ORAL",Resolved,CAPSULE,N02BF,,,2024-02-26,2024-06-21,2024-06-18,"Demand increase for the drug.",2024-02-26,2024-06-19,No
216785,02416840,Shortage,"GABAPENTIN CAPSULES USP","ACCORD HEALTHCARE INC",GABAPENTIN,GABAPENTIN,100MG,100,"ORAL; ORAL","Actual shortage",CAPSULE,N02BF,,,2024-01-19,,,"Requirements related to complying with good manufacturing practices.",2024-01-20,2024-01-19,No
219378,02443015,Shortage,"GALANTAMINE ER","SANIS HEALTH INC","GALANTAMINE ER",GALANTAMINE,8MG,100,"ORAL; ORAL",Resolved,"CAPSULE (EXTENDED RELEASE)",N06DA,"ANTI-DEMENTIA DRUGS",2024-02-12,2024-02-12,2024-04-05,2024-04-03,"Disruption of the manufacture of the drug.",2024-02-13,2024-04-04,No
215600,02327813,Shortage,"GALLIUM (GA67) CITRATE INJECTION","CURIUM CANADA INC","Gallium (Ga 67) Citrate injection","GALLIUM CITRATE GA 67",74MBq,"6 & 12 mCi","INTRAVENOUS; INTRAVENOUS",Resolved,SOLUTION,V09HX,,2024-01-14,2024-01-14,2024-01-21,2024-01-21,"Disruption of the manufacture of the drug.",2024-01-11,2024-01-26,No
220932,02341689,Shortage,"GD-DICLOFENAC/MISOPROSTOL 50","GENMED A DIVISION OF PFIZER CANADA ULC",GD-DICLOFENAC/MISOPROSTOL,"MISOPROSTOL; DICLOFENAC SODIUM","200MCG; 50MG",250's,"ORAL; ORAL",Resolved,"TABLET (DELAYED-RELEASE)",M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2024-05-20,2024-05-20,2024-11-12,2024-11-06,"Demand increase for the drug.",2024-02-29,2024-11-07,No
215535,02402831,Shortage,"GEMCITABINE INJECTION","PFIZER CANADA ULC","GEMCITABINE INJECTION",GEMCITABINE,38MG,"1 X 26.3ML","INTRAVENOUS; INTRAVENOUS",Resolved,SOLUTION,L01BC,ANTIMETABOLITES,,2024-01-10,,2024-01-24,"Disruption of the manufacture of the drug.",2024-01-10,2024-01-25,No
215539,02402831,Shortage,"GEMCITABINE INJECTION","PFIZER CANADA ULC","GEMCITABINE INJECTION",GEMCITABINE,38MG,"1 X 5.3ML","INTRAVENOUS; INTRAVENOUS","Avoided shortage",SOLUTION,L01BC,ANTIMETABOLITES,2024-01-30,,,2024-01-24,"Disruption of the manufacture of the drug.",2024-01-10,2024-01-24,No
220131,02401746,Shortage,GENOTROPIN,"PFIZER CANADA ULC",GENOTROPIN,SOMATROPIN,0.2MG,"7 pack",SUBCUTANEOUS,Resolved,"POWDER FOR SOLUTION",H01AC,"ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES",,2024-02-21,,2024-11-11,"Demand increase for the drug.",2024-02-22,2024-11-12,No
220134,02401754,Shortage,GENOTROPIN,"PFIZER CANADA ULC",GENOTROPIN,SOMATROPIN,0.4MG,"7 pack",SUBCUTANEOUS,Resolved,"POWDER FOR SOLUTION",H01AC,"ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES",,2024-02-21,2024-12-20,2024-10-03,"Demand increase for the drug.",2024-02-22,2024-10-04,No
220137,02401789,Shortage,GENOTROPIN,"PFIZER CANADA ULC",GENOTROPIN,SOMATROPIN,1MG,"7 pack","SUBCUTANEOUS; SUBCUTANEOUS",Resolved,"POWDER FOR SOLUTION",H01AC,"ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES",,2024-02-21,2024-12-20,2024-10-03,"Demand increase for the drug.",2024-02-22,2024-10-04,No
220140,02401800,Shortage,GENOTROPIN,"PFIZER CANADA ULC",GENOTROPIN,SOMATROPIN,1.4MG,"7 pack","SUBCUTANEOUS; SUBCUTANEOUS",Resolved,"POWDER FOR SOLUTION",H01AC,"ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES",,2024-02-21,2024-12-20,2024-10-03,"Demand increase for the drug.",2024-02-22,2024-10-04,No
220144,02401835,Shortage,GENOTROPIN,"PFIZER CANADA ULC",GENOTROPIN,SOMATROPIN,2MG,"7 pack","SUBCUTANEOUS; SUBCUTANEOUS",Resolved,"POWDER FOR SOLUTION",H01AC,"ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES",,2024-02-21,2024-12-20,2024-10-03,"Demand increase for the drug.",2024-02-22,2024-10-04,No
217902,02322765,Shortage,"GRANISETRON HYDROCHLORIDE INJECTION","OMEGA LABORATORIES LIMITED","Granisetron Hydrochloride Injection",GRANISETRON,1MG,"1 x 4 mL vial / fiole","INTRAVENOUS; INTRAVENOUS",Resolved,LIQUID,A04AA,"ANTIEMETICS AND ANTINAUSEANTS",,2024-02-06,2024-03-15,2024-03-08,"Demand increase for the drug.",2024-01-30,2024-03-09,No
220335,02231056,Shortage,"HAVRIX 720 JUNIOR","GLAXOSMITHKLINE INC","hepatitis A vaccine, inactivated",,720UNIT,"1's (prefilled syringe / seringue préremplie)","INTRAMUSCULAR; INTRAMUSCULAR",Resolved,SUSPENSION,J07BC,"VIRAL VACCINES",,2024-02-21,2024-05-17,2024-04-24,"Demand increase for the drug.",2024-02-23,2024-04-25,No
217049,02303086,Shortage,"HEPARIN SODIUM INJECTION USP        (MULTIDOSE VIAL-WITH PRESERVATIVE)","SANDOZ CANADA INCORPORATED","HEPARIN SODIUM INJECTION USP        (MULTIDOSE VIAL-WITH PRESERVATIVE)","HEPARIN SODIUM",1000UNIT,30ML,"SUBCUTANEOUS; INTRAVENOUS; SUBCUTANEOUS; INTRAVENOUS",Resolved,SOLUTION,B01AB,"ANTITHROMBOTIC AGENTS",,2024-01-23,2024-02-23,2024-02-26,"Disruption of the manufacture of the drug.",2024-01-23,2024-02-27,No
215339,02145901,Shortage,"HYDROMORPHONE HYDROCHLORIDE INJECTION USP","SANDOZ CANADA INCORPORATED",HYDROMORPHONE,"HYDROMORPHONE HYDROCHLORIDE",2MG,1ML,"SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR",Resolved,SOLUTION,N02AA,OPIOIDS,,2024-01-08,2024-02-02,2024-01-31,"Disruption of the manufacture of the drug.",2024-01-08,2024-02-01,No
216641,02382636,Shortage,"HYDROMORPHONE HYDROCHLORIDE INJECTION USP","PFIZER CANADA ULC","HYDROMORPHONE HYDROCHLORIDE INJECTION USP","HYDROMORPHONE HYDROCHLORIDE",10MG,"10 x 5mL vial","SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR","Avoided shortage",SOLUTION,N02AA,OPIOIDS,2024-04-08,,,2024-02-14,"Disruption of the manufacture of the drug.",2024-01-19,2024-02-15,No
219006,02220105,Shortage,"HYMENOPTERA VENOM PRODUCT-WHITE-FACED HORNET VENOM PROTEIN (550 MCG)","JUBILANT HOLLISTERSTIER LLC","White Faced Hornet Extract","WHITE FACED HORNET VENOM PROTEIN",550MCG,20mL,"SUBCUTANEOUS; SUBCUTANEOUS",Resolved,"POWDER FOR SOLUTION; POWDER FOR SOLUTION",V01AA,ALLERGENS,,2024-02-08,2024-10-31,2024-10-31,"Shortage of an active ingredient.",2024-02-08,2024-11-07,No
219730,02410028,Shortage,IDARUBICIN,"PFIZER CANADA ULC",IDARUBICIN,"IDARUBICIN HYDROCHLORIDE",1MG,"1X20 ML","INTRAVENOUS; INTRAVENOUS",Resolved,SOLUTION,L01DB,"CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES",2024-04-15,,,2025-01-08,"Disruption of the manufacture of the drug.",2024-02-15,2025-01-09,Yes
217120,02306778,Shortage,INTELENCE,"JANSSEN INC","Intelence 100 MG",ETRAVIRINE,100MG,"120 Tablets","ORAL; ORAL",Resolved,TABLET,J05AG,"DIRECT ACTING ANTIVIRALS",2024-01-24,2024-01-24,2024-02-14,2024-02-14,"Demand increase for the drug.",2024-01-24,2024-02-15,No
217829,02372908,Shortage,IRBESARTAN/HCTZ,"SANIS HEALTH INC",IRBESARTAN/HCTZ,"HYDROCHLOROTHIAZIDE; IRBESARTAN","25MG; 300MG",100,"ORAL; ORAL",Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2024-01-29,2024-03-18,2024-03-17,"Disruption of the manufacture of the drug.",2024-01-30,2024-03-17,No
219467,02501279,Shortage,"IRINOTECAN HYDROCHLORIDE INJECTION","AURO PHARMA INC","IRINOTECAN HYDROCHLORIDE INJECTION","IRINOTECAN HYDROCHLORIDE",100MG,"5 ml",INTRAVENOUS,Resolved,SOLUTION,L01CE,,,2024-02-13,,2025-02-18,"Demand increase for the drug.",2024-02-13,2025-02-19,No
219470,02501295,Shortage,"IRINOTECAN HYDROCHLORIDE INJECTION","AURO PHARMA INC","IRINOTECAN HYDROCHLORIDE INJECTION","IRINOTECAN HYDROCHLORIDE",500MG,"25 ml",INTRAVENOUS,Resolved,SOLUTION,L01CE,,,2024-02-13,,2024-02-14,"Demand increase for the drug.",2024-02-13,2024-02-15,No
219700,02258218,Shortage,"IRINOTECAN HYDROCHLORIDE INJECTION USP","PFIZER CANADA ULC","IRINOTECAN HYDROCHLORIDE INJECTION USP","IRINOTECAN HYDROCHLORIDE",20MG,"2mL vial","INTRAVENOUS; INTRAVENOUS",Resolved,SOLUTION,L01CE,,,2024-02-15,,2024-03-22,"Disruption of the manufacture of the drug.",2024-02-15,2024-03-23,No
218700,02473240,Shortage,"JAMP CANDESARTAN-HCT","JAMP PHARMA CORPORATION","Candesartan Cilexetil and Hydrochlorothiazide Tablets","HYDROCHLOROTHIAZIDE; CANDESARTAN CILEXETIL","12.5MG; 16MG",3x10,ORAL,Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2024-02-05,2024-07-15,2024-05-24,"Demand increase for the drug.",2024-02-07,2024-05-25,No
215865,02500094,Shortage,"JAMP CINACALCET TABLETS","JAMP PHARMA CORPORATION","Cinacalcet Tablets",CINACALCET,30MG,30,ORAL,"Actual shortage",TABLET,H05BX,"ANTI-PARATHYROID HORMONES",,2024-01-12,2025-12-31,,"Disruption of the manufacture of the drug.",2024-01-12,2024-12-03,No
215416,02498189,Shortage,"JAMP DIENOGEST","JAMP PHARMA CORPORATION","Dienogest Tablets",DIENOGEST,2MG,2x14,ORAL,Resolved,TABLET,G03DB,PROGESTOGENS,,2024-01-09,2024-01-26,2024-01-26,"Demand increase for the drug.",2024-01-09,2024-01-27,No
218847,02474816,Shortage,"JAMP ENALAPRIL","JAMP PHARMA CORPORATION","Enalapril Maleate Tablets","ENALAPRIL MALEATE",20MG,100,"ORAL; ORAL",Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2024-02-05,2024-03-15,2024-03-18,"Disruption of the manufacture of the drug.",2024-02-08,2024-03-19,No
218852,02474808,Shortage,"JAMP ENALAPRIL","JAMP PHARMA CORPORATION","Enalapril Maleate Tablets","ENALAPRIL MALEATE",10MG,100,"ORAL; ORAL",Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2024-02-05,2024-03-15,2024-03-18,"Disruption of the manufacture of the drug.",2024-02-08,2024-03-19,No
218861,02474794,Shortage,"JAMP ENALAPRIL","JAMP PHARMA CORPORATION","Enalapril Maleate Tablets","ENALAPRIL MALEATE",5MG,100,"ORAL; ORAL",Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2024-02-05,2024-03-15,2024-04-15,"Disruption of the manufacture of the drug.",2024-02-08,2024-04-17,No
218874,02474786,Shortage,"JAMP ENALAPRIL","JAMP PHARMA CORPORATION","Enalapril Maleate Tablets","ENALAPRIL MALEATE",2.5MG,100,"ORAL; ORAL",Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2024-02-05,2024-03-15,2024-07-03,"Disruption of the manufacture of the drug.",2024-02-08,2024-07-04,No
218839,02495066,Shortage,"JAMP IMATINIB","JAMP PHARMA CORPORATION",Imatinib Mesylate Tablets,IMATINIB,100MG,3x10,ORAL,"Actual shortage",TABLET,L01EA,,,2024-02-05,2025-12-31,,"Disruption of the manufacture of the drug.",2024-02-08,2025-01-23,No
218844,02495074,Shortage,"JAMP IMATINIB","JAMP PHARMA CORPORATION",Imatinib Mesylate Tablets,IMATINIB,400MG,3x10,ORAL,"Actual shortage",TABLET,L01EA,,,2024-02-05,2025-12-31,,"Disruption of the manufacture of the drug.",2024-02-08,2025-01-23,No
218697,02514877,Shortage,"JAMP MONTELUKAST CHEWABLE TABLETS","JAMP PHARMA CORPORATION","Montelukast Chewable Tablets",MONTELUKAST,4MG,30,ORAL,Resolved,"TABLET (CHEWABLE)",R03DC,"OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",,2024-02-05,2024-03-15,2024-03-15,"Disruption of the manufacture of the drug.",2024-02-07,2024-03-18,No
218723,02352419,Shortage,"JAMP TAMSULOSIN","JAMP PHARMA CORPORATION","Tamsulosin hydrochloride","TAMSULOSIN HYDROCHLORIDE",0.4MG,100,ORAL,Resolved,"CAPSULE (SUSTAINED-RELEASE)",G04CA,"DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",,2024-02-05,2024-05-06,2024-05-13,"Demand increase for the drug.",2024-02-07,2024-05-14,No
218709,02386534,Shortage,JAMP-CANDESARTAN,"JAMP PHARMA CORPORATION","Candesartan Cilexetil Tablets","CANDESARTAN CILEXETIL",32MG,100,"ORAL; ORAL",Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2024-02-05,2024-06-30,2024-05-31,"Demand increase for the drug.",2024-02-07,2024-06-03,No
218712,02386526,Shortage,JAMP-CANDESARTAN,"JAMP PHARMA CORPORATION","Candesartan Cilexetil Tablets","CANDESARTAN CILEXETIL",16MG,100,"ORAL; ORAL",Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2024-02-05,2024-05-31,2024-05-31,"Demand increase for the drug.",2024-02-07,2024-06-03,No
218717,02386518,Shortage,JAMP-CANDESARTAN,"JAMP PHARMA CORPORATION","Candesartan Cilexetil Tablets","CANDESARTAN CILEXETIL",8MG,100,"ORAL; ORAL",Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2024-02-05,2024-04-15,2024-04-15,"Demand increase for the drug.",2024-02-07,2024-04-17,No
218706,02401894,Shortage,JAMP-FLUOXETINE,"JAMP PHARMA CORPORATION","Fluoxetine Capsules BP (as fluoxetine hydrochloride)",FLUOXETINE,10MG,100,"ORAL; ORAL","Actual shortage",CAPSULE,N06AB,ANTIDEPRESSANTS,,2024-02-05,2025-06-30,,"Disruption of the manufacture of the drug.",2024-02-07,2025-03-03,No
218703,02398834,Shortage,JAMP-LOSARTAN,"JAMP PHARMA CORPORATION","Losartan Potassium Tablets","LOSARTAN POTASSIUM",25MG,3x10,"ORAL; ORAL",Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2024-02-05,2024-12-06,2024-12-09,"Disruption of the manufacture of the drug.",2024-02-07,2024-12-10,No
215880,02356848,Shortage,JAMP-METOPROLOL-L,"JAMP PHARMA CORPORATION","Metoprolol Tartrate Tablets USP","METOPROLOL TARTRATE",100MG,100,"ORAL; ORAL","Actual shortage",TABLET,C07AB,"BETA BLOCKING AGENTS",,2024-01-12,2025-04-11,,"Disruption of the manufacture of the drug.",2024-01-12,2025-03-03,No
215883,02356848,Shortage,JAMP-METOPROLOL-L,"JAMP PHARMA CORPORATION","Metoprolol Tartrate Tablets USP","METOPROLOL TARTRATE",100MG,500,"ORAL; ORAL","Actual shortage",TABLET,C07AB,"BETA BLOCKING AGENTS",,2024-01-12,2025-04-11,,"Disruption of the manufacture of the drug.",2024-01-12,2025-03-03,No
215886,02356821,Shortage,JAMP-METOPROLOL-L,"JAMP PHARMA CORPORATION","Metoprolol Tartrate Tablets USP","METOPROLOL TARTRATE",50MG,100,"ORAL; ORAL","Actual shortage",TABLET,C07AB,"BETA BLOCKING AGENTS",,2024-01-12,2025-05-15,,"Disruption of the manufacture of the drug.",2024-01-12,2025-03-03,No
215889,02356821,Shortage,JAMP-METOPROLOL-L,"JAMP PHARMA CORPORATION","Metoprolol Tartrate Tablets USP","METOPROLOL TARTRATE",50MG,500,"ORAL; ORAL","Actual shortage",TABLET,C07AB,"BETA BLOCKING AGENTS",,2024-01-12,2025-05-15,,"Disruption of the manufacture of the drug.",2024-01-12,2025-03-03,No
218879,02443929,Shortage,JAMP-MOXIFLOXACIN,"JAMP PHARMA CORPORATION","Moxifloxacin Tablets",MOXIFLOXACIN,400MG,30,"ORAL; ORAL","Actual shortage",TABLET,J01MA,"QUINOLONE ANTIBACTERIALS",,2024-02-05,2025-12-31,,"Disruption of the manufacture of the drug.",2024-02-08,2025-01-23,No
218720,02380382,Shortage,JAMP-MYCOPHENOLATE,"JAMP PHARMA CORPORATION","Mycophenolate Mofetil Tablets","MYCOPHENOLATE MOFETIL",500MG,5x10,"ORAL; ORAL",Resolved,TABLET,L04AA,IMMUNOSUPPRESSANTS,,2024-02-05,2024-03-15,2024-03-15,"Disruption of the manufacture of the drug.",2024-02-07,2024-03-18,No
218727,02386399,Shortage,"JAMP-MYCOPHENOLATE CAPSULES","JAMP PHARMA CORPORATION","Mycophenolate Mofetil Capsules","MYCOPHENOLATE MOFETIL",250MG,100,"ORAL; ORAL",Resolved,CAPSULE,L04AA,IMMUNOSUPPRESSANTS,,2024-02-05,2024-03-15,2024-03-15,"Disruption of the manufacture of the drug.",2024-02-07,2024-03-18,No
216850,02420198,Shortage,"JAMP-OMEPRAZOLE DR","JAMP PHARMA CORPORATION","Omeprazole Magnesium Delayed Release Tablets",OMEPRAZOLE,20MG,2x14,"ORAL; ORAL","Actual shortage","TABLET (DELAYED-RELEASE)",A02BC,"DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",,2024-01-19,2025-12-31,,"Disruption of the manufacture of the drug.",2024-01-20,2025-01-23,No
216853,02420198,Shortage,"JAMP-OMEPRAZOLE DR","JAMP PHARMA CORPORATION","Omeprazole Magnesium Delayed Release Tablets",OMEPRAZOLE,20MG,100,"ORAL; ORAL","Actual shortage","TABLET (DELAYED-RELEASE)",A02BC,"DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",,2024-01-19,2025-12-31,,"Disruption of the manufacture of the drug.",2024-01-20,2025-01-23,No
216856,02420198,Shortage,"JAMP-OMEPRAZOLE DR","JAMP PHARMA CORPORATION","Omeprazole Magnesium Delayed Release Tablets",OMEPRAZOLE,20MG,500,"ORAL; ORAL","Actual shortage","TABLET (DELAYED-RELEASE)",A02BC,"DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",,2024-01-19,2025-12-31,,"Disruption of the manufacture of the drug.",2024-01-20,2025-01-23,No
218725,02330423,Shortage,JAMP-QUETIAPINE,"JAMP PHARMA CORPORATION","Quetiapine Tablets",QUETIAPINE,100MG,100,"ORAL; ORAL",Resolved,"TABLET (IMMEDIATE RELEASE); TABLET",N05AH,ANTIPSYCHOTICS,,2024-02-05,2025-01-01,2024-04-15,"Other (Please describe in comments)",2024-02-07,2024-04-17,No
215310,02379007,Shortage,"JAMP-VITAMIN D","JAMP PHARMA CORPORATION","Vitamin D3 Tablets","VITAMIN D3",10000UNIT,60,"ORAL; ORAL",Resolved,TABLET,A11CC,"VIT A AND D, INCL COMBINATIONS OF THE TWO",,2024-01-08,2024-11-30,2025-01-21,"Disruption of the manufacture of the drug.",2024-01-08,2025-01-23,No
215313,02379007,Shortage,"JAMP-VITAMIN D","JAMP PHARMA CORPORATION","Vitamin D3 Tablets","VITAMIN D3",10000UNIT,250,"ORAL; ORAL",Resolved,TABLET,A11CC,"VIT A AND D, INCL COMBINATIONS OF THE TWO",,2024-01-08,2024-11-30,2025-01-21,"Disruption of the manufacture of the drug.",2024-01-08,2025-01-23,No
215316,02379007,Shortage,"JAMP-VITAMIN D","JAMP PHARMA CORPORATION","Vitamin D3 Tablets","VITAMIN D3",10000UNIT,500,"ORAL; ORAL",Resolved,TABLET,A11CC,"VIT A AND D, INCL COMBINATIONS OF THE TWO",,2024-01-08,2024-11-30,2025-01-21,"Disruption of the manufacture of the drug.",2024-01-08,2025-01-23,No
215627,00224391,Shortage,KETALAR,"SEARCHLIGHT PHARMA INC",Ketalar,KETAMINE,10MG,20ml,"INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR",Resolved,SOLUTION,N01AX,"ANESTHETICS, GENERAL",2024-03-01,,2024-03-21,2024-03-18,"Delay in shipping of the drug.",2024-01-11,2024-03-19,No
217938,02244947,Shortage,"KETOROLAC TROMETHAMINE INJECTION, USP","FRESENIUS KABI CANADA LTD","KETOROLAC TROMETHAMINE INJECTION, USP","KETOROLAC TROMETHAMINE",30MG,"1 ML","INTRAMUSCULAR; INTRAMUSCULAR",Resolved,LIQUID,M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",2024-02-01,,2024-02-20,2024-02-16,"Disruption of the manufacture of the drug.",2024-01-31,2024-02-20,No
218522,02459973,Shortage,LANCORA,"SERVIER CANADA INC",Ivabradine,IVABRADINE,5MG,56's,"ORAL; ORAL",Resolved,TABLET,C01EB,"OTHER CARDIAC PREPARATIONS",2024-02-06,,2024-02-21,2024-02-21,"Other (Please describe in comments)",2024-02-05,2024-02-26,No
217986,02524244,Shortage,LETROZOLE,"SIVEM PHARMACEUTICALS ULC",Letrozole,LETROZOLE,2.5MG,30,ORAL,"Actual shortage",TABLET,L02BG,"HORMONE ANTAGONISTS AND RELATED AGENTS",2024-05-01,2024-08-15,,,"Disruption of the manufacture of the drug.",2024-01-31,2024-11-20,No
220361,02182998,Shortage,"LEUCOVORIN CALCIUM INJECTION USP","PFIZER CANADA ULC","LEUCOVORIN CALCIUM INJECTION USP",LEUCOVORIN,10MG,"1 X 50ML","INTRAVENOUS; INTRAVENOUS",Resolved,SOLUTION,V03AF,"ALL OTHER THERAPEUTIC PRODUCTS",,2024-03-06,,2024-12-03,"Disruption of the manufacture of the drug.",2024-02-23,2024-12-04,No
217793,02353342,Shortage,LEVETIRACETAM,"SANIS HEALTH INC",LEVETIRACETAM,LEVETIRACETAM,250MG,100,"ORAL; ORAL",Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2024-01-29,2024-03-15,2024-03-01,"Disruption of the manufacture of the drug.",2024-01-30,2024-03-02,No
216276,02353350,Shortage,LEVETIRACETAM,"SANIS HEALTH INC",LEVETIRACETAM,LEVETIRACETAM,500MG,100,"ORAL; ORAL",Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2024-01-12,2024-04-12,2024-04-10,"Disruption of the manufacture of the drug.",2024-01-17,2024-04-11,No
215527,02243097,Shortage,LIPITOR,"BGP PHARMA ULC",ATORVASTATIN,ATORVASTATIN,80MG,"3x10 BL","ORAL; ORAL",Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",2024-01-11,2024-01-10,2024-02-28,2024-02-27,"Disruption of the manufacture of the drug.",2024-01-10,2024-03-06,No
217261,02373955,Shortage,LODALIS,"BAUSCH HEALTH, CANADA INC.",LODALIS,"COLESEVELAM HYDROCHLORIDE",625MG,n/a,"ORAL; ORAL",Resolved,TABLET,C10AC,"LIPID MODIFYING AGENTS, PLAIN",2024-02-19,2024-02-06,2024-03-27,2024-03-25,"Delay in shipping of the drug.",2024-01-25,2025-04-15,No
216518,02469170,Shortage,LUPIN-CEPHALEXIN,"LUPIN PHARMA CANADA LIMITED",LUPIN-CEPHALEXIN,CEPHALEXIN,125MG,"100mL and 150mL","ORAL; ORAL",Resolved,"POWDER FOR SUSPENSION",J01DB,"OTHER BETA-LACTAM ANTIBACTERIALS",,2024-01-18,2024-04-01,2024-04-29,"Demand increase for the drug.",2024-01-19,2024-04-30,No
220371,02046210,Shortage,"LUTREPULSE PWS 0.8MG/VIAL","FERRING INC","GONADORELIN ACETATE","GONADORELIN ACETATE",0.8MG,"1 x 10 mL vial of 0.8 mg","SUBCUTANEOUS; INTRAVENOUS; SUBCUTANEOUS; INTRAVENOUS","Actual shortage","POWDER FOR SOLUTION",H01CA,"HYPOTHALAMIC HORMONES",2024-06-30,2024-06-30,,,"Other (Please describe in comments)",2024-02-23,2024-10-01,No
217935,02139499,Shortage,"MAGNESIUM SULFATE INJECTION, USP","FRESENIUS KABI CANADA LTD","MAGNESIUM SULFATE INJECTION, USP","MAGNESIUM SULFATE",500MG,"50 ML","INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR",Resolved,SOLUTION,B05XA,"I.V. SOLUTION ADDITIVES",2024-02-02,2024-02-02,2024-04-30,2024-05-01,"Disruption of the manufacture of the drug.",2024-01-31,2024-05-02,No
216012,02524198,Shortage,MAR-CLONIDINE,"MARCAN PHARMACEUTICALS INC",CLONIDINE,"CLONIDINE HYDROCHLORIDE",0.025MG,100,ORAL,Resolved,TABLET,C02AC,"ANTIADRENERGIC AGENTS, CENTRALLY ACTING",2024-02-01,,2024-03-31,2024-03-11,"Demand increase for the drug.",2024-01-15,2024-03-12,No
219424,02247699,Shortage,METADOL,"PALADIN LABS INC.","Metadol 5 mg Tabs","METHADONE HYDROCHLORIDE",5MG,"100 Tabs","ORAL; ORAL",Resolved,TABLET,N07BC,"DRUGS USED IN ADDICTIVE DISORDERS",,2024-02-07,2024-03-25,2024-03-26,"Delay in shipping of the drug.",2024-02-13,2024-03-27,No
220799,02247701,Shortage,METADOL,"PALADIN LABS INC.","Metadol 25mg Tabs","METHADONE HYDROCHLORIDE",25MG,"100 Tabs","ORAL; ORAL",Resolved,TABLET,N07BC,"DRUGS USED IN ADDICTIVE DISORDERS",,2024-02-26,2024-03-25,2024-03-25,"Delay in shipping of the drug.",2024-02-27,2024-03-26,No
214966,02241377,Shortage,METADOL,"PALADIN LABS INC.","Metadol 10 mg/mL 100mL","METHADONE HYDROCHLORIDE",10MG,"100 mL","ORAL; ORAL",Resolved,SOLUTION,N07BC,"DRUGS USED IN ADDICTIVE DISORDERS",,2023-12-08,2024-03-25,2024-03-27,"Delay in shipping of the drug.",2024-01-05,2024-03-27,No
214969,02247698,Shortage,METADOL,"PALADIN LABS INC.","Metadol 1 mg Tabs","METHADONE HYDROCHLORIDE",1MG,"100 Tabs","ORAL; ORAL",Resolved,TABLET,N07BC,"DRUGS USED IN ADDICTIVE DISORDERS",,2023-12-20,2024-02-29,2024-02-29,"Delay in shipping of the drug.",2024-01-05,2024-03-01,No
218309,02464365,Shortage,"METHOTREXATE INJECTION BP","ACCORD HEALTHCARE INC","METHOTREXATE (METHOTREXATE SODIUM)",METHOTREXATE,25MG,2ml,"INTRAVENOUS; INTRAMUSCULAR; INTRA-ARTERIAL","Actual shortage",SOLUTION,L01BA,ANTIMETABOLITES,,2024-02-02,,,"Delay in shipping of the drug.",2024-02-02,2025-03-06,No
215532,02182955,Shortage,"METHOTREXATE INJECTION USP","PFIZER CANADA ULC","METHOTREXATE INJECTION USP",METHOTREXATE,25MG,"1 X 2ML","INTRAVENOUS; INTRATHECAL; INTRAMUSCULAR; INTRA-ARTERIAL; INTRACEREBROVENTRICULAR; INTRACEREBROVENTRICULAR; INTRAVENOUS; INTRATHECAL; INTRAMUSCULAR; INTRA-ARTERIAL",Resolved,SOLUTION,L01BA,ANTIMETABOLITES,,2024-01-10,,2024-01-22,"Disruption of the manufacture of the drug.",2024-01-10,2024-01-23,No
218656,00870420,Shortage,"METRONIDAZOLE INJECTION, USP","BAXTER CORPORATION","Metronidazole Injection",METRONIDAZOLE,5MG,"100 mL (JB3401P)","INTRAVENOUS; INTRAVENOUS",Resolved,SOLUTION,J01XD,"OTHER ANTIBACTERIALS",2024-02-06,2024-02-06,2024-02-14,2024-02-07,"Disruption of the manufacture of the drug.",2024-02-06,2024-02-08,No
220718,00870420,Shortage,"METRONIDAZOLE INJECTION, USP","BAXTER CORPORATION","Metronidazole Injection",METRONIDAZOLE,5MG,"500 mg (JB3401P)","INTRAVENOUS; INTRAVENOUS",Resolved,SOLUTION,J01XD,"OTHER ANTIBACTERIALS",2024-02-26,2024-02-26,2024-03-15,2024-03-15,"Disruption of the manufacture of the drug.",2024-02-27,2024-03-19,No
215362,02148447,Shortage,"MINIMS PHENYLEPHRINE HYDROCHLORIDE","BAUSCH & LOMB INC","Minims® - Phenylephrine HCL 2.5%","PHENYLEPHRINE HYDROCHLORIDE",2.5%,1,"OPHTHALMIC; OPHTHALMIC",Resolved,"SOLUTION; DROPS",S01FB,"MYDRIATICSAND CYCLOPLEGICS",,2024-01-08,2024-01-25,2024-01-16,"Requirements related to complying with good manufacturing practices.",2024-01-09,2024-02-05,No
215365,02148455,Shortage,"MINIMS PHENYLEPHRINE HYDROCHLORIDE","BAUSCH & LOMB INC","Phenylephrine HCL 10%","PHENYLEPHRINE HYDROCHLORIDE",10%,1,"OPHTHALMIC; OPHTHALMIC",Resolved,"SOLUTION; DROPS",S01FB,"MYDRIATICSAND CYCLOPLEGICS",,2024-01-08,2024-01-25,2024-01-16,"Requirements related to complying with good manufacturing practices.",2024-01-09,2024-02-05,No
217366,02394871,Shortage,MINT-ALENDRONATE,"MINT PHARMACEUTICALS INC",Alendronate,"ALENDRONIC ACID",70.0MG,"4 count Blisters","ORAL; ORAL","Actual shortage",TABLET,M05BA,"DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",,2024-01-18,2025-09-30,,"Disruption of the manufacture of the drug.",2024-01-26,2025-05-20,No
217369,02393573,Shortage,MINT-ANASTROZOLE,"MINT PHARMACEUTICALS INC",Anastrazole,ANASTROZOLE,1MG,"30 count blisters","ORAL; ORAL",Resolved,TABLET,L02BG,"HORMONE ANTAGONISTS AND RELATED AGENTS",,2024-01-18,2024-04-30,2024-03-25,"Disruption of the manufacture of the drug.",2024-01-26,2024-03-26,No
217690,02479508,Shortage,MINT-ATORVASTATIN,"MINT PHARMACEUTICALS INC",Atorvastatin,ATORVASTATIN,10MG,"500 count bottle","ORAL; ORAL",Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2024-01-18,2024-04-30,2024-01-29,"Disruption of the manufacture of the drug.",2024-01-29,2024-01-30,No
217693,02479516,Shortage,MINT-ATORVASTATIN,"MINT PHARMACEUTICALS INC",Atorvastatin,ATORVASTATIN,20MG,"500 count bottle","ORAL; ORAL",Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2024-01-18,2024-04-30,2024-01-29,"Disruption of the manufacture of the drug.",2024-01-29,2024-01-30,No
217696,02479524,Shortage,MINT-ATORVASTATIN,"MINT PHARMACEUTICALS INC",Atorvastatin,ATORVASTATIN,40MG,"500 count bottle","ORAL; ORAL",Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2024-01-18,2024-04-30,2024-01-29,"Disruption of the manufacture of the drug.",2024-01-29,2024-01-30,No
217372,02508109,Shortage,MINT-LETROZOLE,"MINT PHARMACEUTICALS INC",Letrozole,LETROZOLE,2.5MG,"30 count blisters",ORAL,"Actual shortage",TABLET,L02BG,"HORMONE ANTAGONISTS AND RELATED AGENTS",,2024-01-18,2025-09-30,,"Disruption of the manufacture of the drug.",2024-01-26,2025-05-20,No
217375,02317451,Shortage,MINT-PRAVASTATIN,"MINT PHARMACEUTICALS INC",Pravastatin,"PRAVASTATIN SODIUM",10MG,"100 count bottle","ORAL; ORAL",Resolved,"TABLET; TABLET",C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2024-01-18,2024-04-30,2024-03-25,"Delay in shipping of the drug.",2024-01-26,2024-03-26,No
217378,02317478,Shortage,MINT-PRAVASTATIN,"MINT PHARMACEUTICALS INC",Pravastatin,"PRAVASTATIN SODIUM",20MG,"100 count bottle","ORAL; ORAL",Resolved,"TABLET; TABLET",C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2024-01-18,2024-09-30,2024-08-19,"Delay in shipping of the drug.",2024-01-26,2024-12-05,No
217381,02317486,Shortage,MINT-PRAVASTATIN,"MINT PHARMACEUTICALS INC",Pravastatin,"PRAVASTATIN SODIUM",40MG,"100 count bottle","ORAL; ORAL",Resolved,"TABLET; TABLET",C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2024-01-18,2024-04-30,2024-03-25,"Delay in shipping of the drug.",2024-01-26,2024-03-26,No
217384,02522187,Shortage,"MINT-QUETIAPINE XR","MINT PHARMACEUTICALS INC",quetiapine,QUETIAPINE,50MG,"100 count bottle",ORAL,"Actual shortage","TABLET (EXTENDED-RELEASE)",N05AH,ANTIPSYCHOTICS,,2024-01-18,2025-04-30,,"Disruption of the manufacture of the drug.",2024-01-26,2025-04-11,No
217387,02522195,Shortage,"MINT-QUETIAPINE XR","MINT PHARMACEUTICALS INC",Quetiapine,QUETIAPINE,150MG,"100 count bottle",ORAL,"Actual shortage","TABLET (EXTENDED-RELEASE)",N05AH,ANTIPSYCHOTICS,,2024-01-18,2025-09-30,,"Disruption of the manufacture of the drug.",2024-01-26,2025-05-20,No
217390,02522209,Shortage,"MINT-QUETIAPINE XR","MINT PHARMACEUTICALS INC",Quetiapine,QUETIAPINE,200MG,"100 count bottle",ORAL,Resolved,"TABLET (EXTENDED-RELEASE)",N05AH,ANTIPSYCHOTICS,,2024-01-18,2024-04-30,2024-03-25,"Disruption of the manufacture of the drug.",2024-01-26,2024-03-26,No
217393,02522217,Shortage,"MINT-QUETIAPINE XR","MINT PHARMACEUTICALS INC",Quetiapine,QUETIAPINE,300MG,"100 count bottle",ORAL,Resolved,"TABLET (EXTENDED-RELEASE)",N05AH,ANTIPSYCHOTICS,,2024-01-18,2024-04-30,2024-03-25,"Disruption of the manufacture of the drug.",2024-01-26,2024-03-26,No
217396,02522225,Shortage,"MINT-QUETIAPINE XR","MINT PHARMACEUTICALS INC",Quetiapine,QUETIAPINE,400MG,"100 count bottle",ORAL,"Actual shortage","TABLET (EXTENDED-RELEASE)",N05AH,ANTIPSYCHOTICS,,2024-01-18,2025-05-30,,"Disruption of the manufacture of the drug.",2024-01-26,2025-04-11,No
217681,02315645,Shortage,MINT-TOPIRAMATE,"MINT PHARMACEUTICALS INC",Topiramate,TOPIRAMATE,25MG,"100 count bottle","ORAL; ORAL",Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2024-01-18,2024-04-30,2024-03-25,"Disruption of the manufacture of the drug.",2024-01-29,2024-03-26,No
217684,02315653,Shortage,MINT-TOPIRAMATE,"MINT PHARMACEUTICALS INC",Topiramate,TOPIRAMATE,100MG,"100 count bottle","ORAL; ORAL",Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2024-01-18,2024-09-30,2024-10-21,"Disruption of the manufacture of the drug.",2024-01-29,2024-12-05,No
217687,02315661,Shortage,MINT-TOPIRAMATE,"MINT PHARMACEUTICALS INC",Topiramate,TOPIRAMATE,200MG,"100 count bottle","ORAL; ORAL",Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2024-01-18,2024-09-30,2024-10-21,"Disruption of the manufacture of the drug.",2024-01-29,2024-12-05,No
216225,00511528,Shortage,MOGADON,"AA PHARMA INC",MOGADON,NITRAZEPAM,5MG,"100 BTL","ORAL; ORAL",Resolved,TABLET,N05CD,"HYPNOTICS AND SEDATIVES",2024-02-05,,2024-04-18,2024-04-10,"Disruption of the manufacture of the drug.",2024-01-17,2024-04-11,No
216971,00586315,Shortage,"MULTI 1000","SANDOZ CANADA INCORPORATED","MULTI 1000","VITAMIN B6; NICOTINAMIDE; VITAMIN B2; VITAMIN B1; VITAMIN E; VITAMIN D; VITAMIN A; ASCORBIC ACID; D-PANTOTHENIC ACID","1.2MG; 10MG; 1MG; 4.5MG; 1UNIT; 100UNIT; 1000UNIT; 100MG; 2.6MG",10LIVI,"INTRAVENOUS; INTRAVENOUS",Resolved,SOLUTION,A11BA,"MULTIVITAMINS, PLAIN",,2024-01-23,2024-03-29,2024-04-05,"Requirements related to complying with good manufacturing practices.",2024-01-22,2024-04-06,No
217399,02100606,Shortage,"MULTI 12 INJECTION","SANDOZ CANADA INCORPORATED","MULTI 12 INJECTION","VITAMIN B12; FOLIC ACID; BIOTIN; VITAMIN E; DEXPANTHENOL; PYRIDOXINE HYDROCHLORIDE; NICOTINAMIDE; VITAMIN B2; VITAMIN B1; VITAMIN D; VITAMIN A; ASCORBIC ACID","1MCG; 80MCG; 12MCG; 2UNIT; 3MG; 0.8MG; 8MG; 0.72MG; 0.6MG; 40UNIT; 660UNIT; 20MG",25ML,"INTRAVENOUS; INTRAVENOUS",Resolved,LIQUID,B05XC,"I.V. SOLUTION ADDITIVES",2024-05-15,,,2024-05-21,"Requirements related to complying with good manufacturing practices.",2024-01-26,2024-05-22,No
215358,02242529,Shortage,"MULTI-12/K1 PEDIATRIC","SANDOZ CANADA INCORPORATED","MULTI-12/K1 PED","VITAMIN B12; FOLIC ACID; BIOTIN; VITAMIN K1; VITAMIN E; DEXPANTHENOL; NICOTINAMIDE; PYRIDOXINE HYDROCHLORIDE; VITAMIN B2; VITAMIN B1; VITAMIN D; VITAMIN A; ASCORBIC ACID","1MCG; 140MCG; 20MCG; 0.2MG; 7UNIT; 5MG; 17MG; 1MG; 1.4MG; 1.2MG; 400UNIT; 2300UNIT; 80MG","SINGLE DOSE 10LIVI","INTRAVENOUS; INTRAVENOUS",Resolved,LIQUID,B05XC,"I.V. SOLUTION ADDITIVES",,2024-01-08,2024-01-26,2024-02-05,"Disruption of the manufacture of the drug.",2024-01-08,2024-02-06,No
217798,02457377,Shortage,"MYCOPHENOLATE MOFETIL","SANIS HEALTH INC","MYCOPHENOLATE MOFETIL","MYCOPHENOLATE MOFETIL",500MG,50,"ORAL; ORAL",Resolved,TABLET,L04AA,IMMUNOSUPPRESSANTS,,2024-01-29,2024-02-09,2024-02-12,"Disruption of the manufacture of the drug.",2024-01-30,2024-02-13,No
217876,02362821,Shortage,MYLAN-AMLODIPINE/ATORVASTATIN,"MYLAN PHARMACEUTICALS ULC","ATORVASTATIN AMLODIPINE","ATORVASTATIN; AMLODIPINE","80MG; 10MG","1x90 BTL","ORAL; ORAL",Resolved,TABLET,C10BX,"LIPID MODIFYING AGENTS, COMBINATIONS",,2023-08-07,,2024-08-22,"Disruption of the manufacture of the drug.",2024-01-30,2024-08-27,No
217870,02024187,Shortage,"MYLAN-CLOBETASOL CREAM","MYLAN PHARMACEUTICALS ULC","CLOBETASOL PROPIONATE","CLOBETASOL PROPIONATE",0.05%,50G,"TOPICAL; TOPICAL","Avoided shortage",CREAM,D07AD,"CORTICOSTEROIDS, PLAIN",2024-06-03,,2024-07-02,2024-04-01,"Disruption of the manufacture of the drug.",2024-01-30,2024-04-01,No
217873,02216213,Shortage,"MYLAN-CLOBETASOL SCALP APPLICATION","MYLAN PHARMACEUTICALS ULC","CLOBETASOL PROPIONATE","CLOBETASOL PROPIONATE",0.05%,1BT,"TOPICAL; TOPICAL",Resolved,LOTION,D07AD,"CORTICOSTEROIDS, PLAIN",2024-06-19,2024-06-14,,2024-11-13,"Disruption of the manufacture of the drug.",2024-01-30,2024-11-18,No
216953,02256118,Shortage,MYLAN-MIRTAZAPINE,"MYLAN PHARMACEUTICALS ULC",MIRTAZAPINE,MIRTAZAPINE,30MG,100BT,"ORAL; ORAL",Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2024-01-22,2024-05-02,2024-05-02,"Disruption of the manufacture of the drug.",2024-01-22,2024-05-09,No
217867,02443449,Shortage,"MYLAN-NAPROXEN/ESOMEPRAZOLE MR","MYLAN PHARMACEUTICALS ULC","NAPROXEN ESOMEPRAZOLE","ESOMEPRAZOLE; NAPROXEN","20MG; 500MG",60BT,"ORAL; ORAL",Resolved,"TABLET (IMMEDIATE AND DELAYED-RELEASE)",M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2024-01-24,2024-02-01,2024-02-01,"Disruption of the manufacture of the drug.",2024-01-30,2024-02-29,No
220296,00500895,Shortage,NALCROM,"SANOFI-AVENTIS CANADA INC",Nalcrom,"CROMOLYN SODIUM",100MG,"Bottle of 100 capsules","ORAL; ORAL",Resolved,CAPSULE,A07EB,"INTESTINALANTIINFLAMMATORY AGENTS",2024-03-01,2024-03-01,2024-10-31,2024-10-04,"Other (Please describe in comments)",2024-02-22,2024-10-07,No
218262,02439557,Shortage,NAT-DONEPEZIL,"NATCO PHARMA (CANADA) INC",DONEPEZIL,"DONEPEZIL HYDROCHLORIDE",5MG,"100 BTL","ORAL; ORAL",Resolved,TABLET,N06DA,"ANTI-DEMENTIA DRUGS",,2024-02-02,,2024-02-20,"Other (Please describe in comments)",2024-02-02,2024-02-21,No
218258,02440318,Shortage,NAT-ESCITALOPRAM,"NATCO PHARMA (CANADA) INC",ESCITALOPRAM,ESCITALOPRAM,20MG,"100 BTL","ORAL; ORAL",Resolved,TABLET,N06AB,ANTIDEPRESSANTS,,2024-02-02,,2024-05-09,"Delay in shipping of the drug.",2024-02-02,2024-05-10,No
216886,02245397,Shortage,NOVORAPID,"NOVO NORDISK CANADA INC",Novorapid,"INSULIN ASPART",100UNIT,"1x10 mL","SUBCUTANEOUS; SUBCUTANEOUS",Resolved,SOLUTION,A10AB,"INSULINS AND ANALOGUES",2024-01-22,,2024-02-09,2024-02-05,"Disruption of the manufacture of the drug.",2024-01-22,2024-02-06,No
214713,02415577,Shortage,"NUCYNTA EXTENDED-RELEASE","ENDO VENTURES LTD.",TAPENTADOL,TAPENTADOL,50MG,"60 tabs","ORAL; ORAL",Resolved,"TABLET (EXTENDED-RELEASE)",N02AX,OPIOIDS,,2023-12-15,2024-03-22,2024-03-25,"Delay in shipping of the drug.",2024-01-03,2024-03-26,No
216132,02329271,Shortage,OCTREOSCAN,"CURIUM CANADA INC","Kit for the preparation of Indium In 111 Pentetreotide","PENTETREOTIDE; INDIUM IN 111 CHLORIDE","10MCG; 111MBq","10ml vial","INTRAVENOUS; INTRAVENOUS",Resolved,"POWDER FOR SOLUTION; KIT; SOLUTION",V09IB,,2024-01-28,,,2024-02-22,"Shortage of an inactive ingredient or component.",2024-01-16,2024-03-07,No
217532,02143291,Shortage,OCUFLOX,"ABBVIE CORPORATION",Ocuflox,OFLOXACIN,0.3%,"5mL  bottle","OPHTHALMIC; OPHTHALMIC",Resolved,SOLUTION,S01AE,ANTIINFECTIVES,2024-02-10,2024-02-13,2024-05-24,2024-05-24,"Demand increase for the drug.",2024-01-29,2024-05-27,No
218231,02311992,Shortage,OLANZAPINE,"PRO DOC LIMITEE",OLANZAPINE,OLANZAPINE,10MG,100,"ORAL; ORAL",Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2024-01-23,2024-02-21,2024-02-21,"Delay in shipping of the drug.",2024-02-02,2024-02-26,No
216794,02416549,Shortage,"OMEPRAZOLE MAGNESIUM DELAYED RELEASE TABLETS","ACCORD HEALTHCARE INC",OMEPRAZOLE,OMEPRAZOLE,20MG,100,"ORAL; ORAL",Resolved,"TABLET (DELAYED-RELEASE)",A02BC,"DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",,2024-01-19,2024-03-08,2024-03-07,"Disruption of the manufacture of the drug.",2024-01-20,2024-03-08,No
217288,02172739,Shortage,"OMNIPAQUE 240","GE HEALTHCARE CANADA INC","iohexol injection USP",IOHEXOL,518MG,"20 mL","RECTAL; ORAL; INTRA-ARTICULAR; INTRAVASCULAR; SUBARACHNOIDAL; INTRAVASCULAR; SUBARACHNOIDAL",Resolved,SOLUTION,V08AB,"X-RAY CONTRAST MEDIA, IODINATED",2024-01-26,2024-01-26,2024-02-18,2024-02-12,"Other (Please describe in comments)",2024-01-26,2024-02-13,No
217411,02172747,Shortage,"OMNIPAQUE 300","GE HEALTHCARE CANADA INC","iohexol injection USP",IOHEXOL,647MG,"20 mL","RECTAL; ORAL; INTRA-ARTICULAR; INTRAVASCULAR; SUBARACHNOIDAL",Resolved,SOLUTION,V08AB,"X-RAY CONTRAST MEDIA, IODINATED",2024-02-12,2024-02-13,2024-02-20,2024-02-14,"Demand increase for the drug.",2024-01-26,2024-02-15,No
217417,02172747,Shortage,"OMNIPAQUE 300","GE HEALTHCARE CANADA INC","iohexol injection USP",IOHEXOL,647MG,"200 mL","RECTAL; ORAL; INTRA-ARTICULAR; INTRAVASCULAR; SUBARACHNOIDAL",Resolved,SOLUTION,V08AB,"X-RAY CONTRAST MEDIA, IODINATED",2024-01-29,2024-01-30,2024-02-21,2024-02-23,"Demand increase for the drug.",2024-01-26,2024-02-24,No
217731,02172755,Shortage,"OMNIPAQUE 350","GE HEALTHCARE CANADA INC","Iohexal Injection USP",IOHEXOL,755MG,"500 mL","ORAL; INTRAVASCULAR; INTRAVASCULAR","Avoided shortage",SOLUTION,V08AB,"X-RAY CONTRAST MEDIA, IODINATED",2024-02-15,,2024-02-20,2024-02-14,"Demand increase for the drug.",2024-01-30,2024-02-14,No
215446,02249685,Shortage,"PAMIDRONATE DISODIUM OMEGA 9 MG/ML","OMEGA LABORATORIES LIMITED","Pamidronate Disodium For Injection","PAMIDRONATE DISODIUM",9.0MG,"1 x 10mL vial /fiole","INTRAVENOUS; INTRAVENOUS",Resolved,SOLUTION,M05BA,"DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",,2024-01-16,2024-02-16,2024-02-12,"Disruption of the manufacture of the drug.",2024-01-09,2024-02-13,No
220548,02306727,Shortage,"PANTOPRAZOLE SODIUM FOR INJECTION","SANDOZ CANADA INCORPORATED","PANTOPRAZOLE SODIUM FOR INJECTION",PANTOPRAZOLE,40MG,10LYVI,"INTRAVENOUS; INTRAVENOUS",Resolved,"POWDER FOR SOLUTION",A02BC,"DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",,2024-02-26,2025-04-04,2024-10-29,"Disruption of the manufacture of the drug.",2024-02-26,2024-10-30,Yes
220290,02229323,Shortage,PDP-DESONIDE,"PENDOPHARM DIVISION OF PHARMASCIENCE INC",PDP-Desonide,DESONIDE,0.05%,60G,"TOPICAL; TOPICAL","Actual shortage",OINTMENT,D07AB,"CORTICOSTEROIDS, PLAIN",,2024-02-05,2026-03-09,,"Disruption of the manufacture of the drug.",2024-02-22,2025-05-14,No
220840,02481634,Shortage,"PERINDOPRIL ERBUMINE","SANIS HEALTH INC","PERINDOPRIL ERBUMINE","PERINDOPRIL ERBUMINE",2MG,1800,"ORAL; ORAL",Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2024-02-28,2024-02-28,2024-03-16,2024-03-07,"Disruption of the manufacture of the drug.",2024-02-28,2024-03-08,No
216247,02481650,Shortage,"PERINDOPRIL ERBUMINE","SANIS HEALTH INC",PERINDOPRIL,"PERINDOPRIL ERBUMINE",8MG,100,"ORAL; ORAL",Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2024-01-12,2024-02-12,2024-02-14,"Disruption of the manufacture of the drug.",2024-01-17,2024-02-15,No
215343,02304082,Shortage,"PHENOBARBITAL SODIUM INJECTION, USP","SANDOZ CANADA INCORPORATED",PHENOBARBITAL,"PHENOBARBITAL SODIUM",30MG,1ML,"INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR",Resolved,SOLUTION,N03AA,ANTIEPILEPTICS,,2024-01-08,2024-03-22,2024-04-03,"Demand increase for the drug.",2024-01-08,2024-04-04,No
218216,02504545,Shortage,"PHENYLEPHRINE HYDROCHLORIDE INJECTION USP","STERIMAX INC","PHENYLEPHRINE HYDROCHLORIDE INJECTION USP","PHENYLEPHRINE HYDROCHLORIDE",10MG,"25 VIALS X 1 ML","SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR",Resolved,SOLUTION,C01CA,"CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES",,2024-01-31,2024-03-29,2024-03-22,"Delay in shipping of the drug.",2024-02-02,2024-03-23,No
218776,02328534,Shortage,PMS-IRBESARTAN-HCTZ,"PHARMASCIENCE INC",IRBESARTAN-HCTZ,"HYDROCHLOROTHIAZIDE; IRBESARTAN","25MG; 300MG",100,"ORAL; ORAL",Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2024-02-02,2024-06-12,2024-05-23,"Disruption of the manufacture of the drug.",2024-02-07,2024-05-24,No
217128,02309114,Shortage,PMS-LETROZOLE,"PHARMASCIENCE INC",LETROZOLE,LETROZOLE,2.5MG,30,"ORAL; ORAL",Resolved,TABLET,L02BG,"HORMONE ANTAGONISTS AND RELATED AGENTS",,2024-01-24,2024-02-27,2024-02-23,"Disruption of the manufacture of the drug.",2024-01-24,2024-02-28,No
218779,02409429,Shortage,PMS-TADALAFIL,"PHARMASCIENCE INC",TADALAFIL,TADALAFIL,5MG,30,"ORAL; ORAL",Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2024-02-02,2024-04-16,2024-04-02,"Disruption of the manufacture of the drug.",2024-02-07,2024-04-25,No
218782,02409437,Shortage,PMS-TADALAFIL,"PHARMASCIENCE INC",TADALAFIL,TADALAFIL,10MG,4,"ORAL; ORAL",Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2024-02-02,2024-03-19,2024-04-05,"Disruption of the manufacture of the drug.",2024-02-07,2024-04-12,No
219866,02436442,Shortage,"PNEUMOVAX 23","MERCK CANADA INC","(pneumococcal vaccine, polyvalent) Solution for injection","PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1","25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG","10X1DOSE SYRINGE","SUBCUTANEOUS; INTRAMUSCULAR",Resolved,SOLUTION,J07AL,,2024-03-11,2024-03-04,2024-03-31,2024-03-28,"Demand increase for the drug.",2024-02-16,2024-03-29,No
219869,02436442,Shortage,"PNEUMOVAX 23","MERCK CANADA INC","(pneumococcal vaccine, polyvalent) Solution for injection","PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2; PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1","25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG; 25MCG","1DOSE SYRINGE","SUBCUTANEOUS; INTRAMUSCULAR",Resolved,SOLUTION,J07AL,,2024-03-11,2024-02-26,2024-03-31,2024-03-28,"Demand increase for the drug.",2024-02-16,2024-03-29,No
219437,02424622,Shortage,POSANOL,"MERCK CANADA INC","posaconazole Delayed-Release Tablets",POSACONAZOLE,100MG,100MG/60TAB,"ORAL; ORAL",Resolved,"TABLET (DELAYED-RELEASE)",J02AC,"ANTIMYCOTICS FOR SYSTEMIC USE",,2024-02-13,2024-03-05,2024-02-27,"Demand increase for the drug.",2024-02-13,2024-02-28,No
216966,00402206,Shortage,"POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE","OMEGA LABORATORIES LIMITED","Potassium Chloride for Injection Concentrate","POTASSIUM CHLORIDE",20mEq,"10 x 20mL, 10 x 10mL","INTRAVENOUS; INTRAVENOUS","Anticipated shortage","SOLUTION; SOLUTION",B05XA,"I.V. SOLUTION ADDITIVES",2025-07-15,,2025-08-31,,"Disruption of the manufacture of the drug.",2024-01-22,2025-05-16,No
216968,00402206,Shortage,"POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE","OMEGA LABORATORIES LIMITED","Potassium Chloride for Injection Concentrate","POTASSIUM CHLORIDE",20mEq,"10 x 20mL vial / fiole","INTRAVENOUS; INTRAVENOUS",Resolved,"SOLUTION; SOLUTION",B05XA,"I.V. SOLUTION ADDITIVES",,2024-01-22,2024-05-31,2024-05-31,"Disruption of the manufacture of the drug.",2024-01-22,2024-06-01,No
218224,02241677,Shortage,"POTASSIUM CHLORIDE INJECTION","BAXTER CORPORATION","20 mmol Potassium Chloride in 100 mL Sterile Water for Injection","POTASSIUM CHLORIDE",20mEq,"100 mL (JB0827P)","INTRAVENOUS; INTRAVENOUS",Resolved,"SOLUTION; LIQUID",B05XA,"I.V. SOLUTION ADDITIVES",2024-01-26,2024-01-26,2024-02-14,2024-02-14,"Disruption of the manufacture of the drug.",2024-02-02,2024-02-15,No
217583,02241800,Shortage,PROCYTOX,"BAXTER CORPORATION","Cyclophosphamide for injection, 2G powdered vial",CYCLOPHOSPHAMIDE,2000MG,"2000 mg (20 mg/mL) (2638B5035)","INTRAVENOUS; INTRAVENOUS",Resolved,"POWDER FOR SOLUTION",L01AA,ALKYLATINGAGENTS,2024-01-29,2024-01-29,2024-03-15,2024-02-27,"Disruption of the manufacture of the drug.",2024-01-29,2024-02-28,No
220045,02018985,Shortage,"PROZAC CAPSULES 10MG","ELI LILLY CANADA INC","Fluoxetine hydrochloride capsules",FLUOXETINE,10MG,"Bottle containing 100 capsules","ORAL; ORAL",Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2024-05-17,2024-05-15,,2024-09-25,"Other (Please describe in comments)",2024-02-20,2024-10-09,No
220048,00636622,Shortage,"PROZAC CAPSULES 20MG","ELI LILLY CANADA INC","Fluoxetine hydrochloride capsules",FLUOXETINE,20MG,"Bottle containing 100 capsules","ORAL; ORAL",Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2024-03-18,2024-03-18,,2024-09-25,"Other (Please describe in comments)",2024-02-20,2024-10-09,No
216802,02387808,Shortage,"QUETIAPINE TABLETS","ACCORD HEALTHCARE INC","QUETIAPINE FUMARATE",QUETIAPINE,100MG,100,"ORAL; ORAL",Resolved,"TABLET (IMMEDIATE RELEASE); TABLET",N05AH,ANTIPSYCHOTICS,,2024-01-19,2024-03-08,2024-03-07,"Disruption of the manufacture of the drug.",2024-01-20,2024-03-08,No
216805,02387816,Shortage,"QUETIAPINE TABLETS","ACCORD HEALTHCARE INC","QUETIAPINE FUMARATE",QUETIAPINE,150MG,100,"ORAL; ORAL",Resolved,"TABLET (IMMEDIATE RELEASE); TABLET",N05AH,ANTIPSYCHOTICS,,2024-01-19,2024-03-13,2024-03-15,"Disruption of the manufacture of the drug.",2024-01-20,2024-03-16,No
216808,02387824,Shortage,"QUETIAPINE TABLETS","ACCORD HEALTHCARE INC","QUETIAPINE FUMARATE",QUETIAPINE,200MG,100,"ORAL; ORAL",Resolved,"TABLET (IMMEDIATE RELEASE); TABLET",N05AH,ANTIPSYCHOTICS,,2024-01-19,2024-03-12,2024-03-15,"Disruption of the manufacture of the drug.",2024-01-20,2024-03-16,No
216811,02387794,Shortage,"QUETIAPINE TABLETS","ACCORD HEALTHCARE INC","QUETIAPINE FUMARATE",QUETIAPINE,25MG,100,"ORAL; ORAL","Actual shortage","TABLET (IMMEDIATE RELEASE); TABLET",N05AH,ANTIPSYCHOTICS,,2024-01-19,,,"Requirements related to complying with good manufacturing practices.",2024-01-20,2024-01-19,No
216835,02519615,Shortage,"QUETIAPINE XR","JAMP PHARMA CORPORATION","Quetiapine Fumarate Extended-Release Tablets",QUETIAPINE,150MG,100,ORAL,"Actual shortage","TABLET (EXTENDED-RELEASE)",N05AH,ANTIPSYCHOTICS,,2024-01-19,2025-12-31,,"Disruption of the manufacture of the drug.",2024-01-20,2025-01-04,No
216838,02519623,Shortage,"QUETIAPINE XR","JAMP PHARMA CORPORATION","Quetiapine Fumarate Extended-Release Tablets",QUETIAPINE,200MG,100,ORAL,"Actual shortage","TABLET (EXTENDED-RELEASE)",N05AH,ANTIPSYCHOTICS,,2024-01-19,2025-12-31,,"Disruption of the manufacture of the drug.",2024-01-20,2025-01-04,No
216841,02519747,Shortage,"QUETIAPINE XR","JAMP PHARMA CORPORATION","Quetiapine Fumarate Extended-Release Tablets",QUETIAPINE,300MG,100,ORAL,"Actual shortage","TABLET (EXTENDED-RELEASE)",N05AH,ANTIPSYCHOTICS,,2024-01-19,2025-12-31,,"Disruption of the manufacture of the drug.",2024-01-20,2025-01-04,No
216844,02519763,Shortage,"QUETIAPINE XR","JAMP PHARMA CORPORATION","Quetiapine Fumarate Extended-Release Tablets",QUETIAPINE,400MG,100,ORAL,"Actual shortage","TABLET (EXTENDED-RELEASE)",N05AH,ANTIPSYCHOTICS,,2024-01-19,2025-12-31,,"Disruption of the manufacture of the drug.",2024-01-20,2025-01-04,No
216847,02519607,Shortage,"QUETIAPINE XR","JAMP PHARMA CORPORATION","Quetiapine Fumarate Extended-Release Tablets",QUETIAPINE,50MG,100,ORAL,"Actual shortage","TABLET (EXTENDED-RELEASE)",N05AH,ANTIPSYCHOTICS,,2024-01-19,2025-12-31,,"Disruption of the manufacture of the drug.",2024-01-20,2025-01-04,No
217989,02417359,Shortage,"QUETIAPINE XR","SIVEM PHARMACEUTICALS ULC","Qutiapine XR",QUETIAPINE,50MG,60,"ORAL; ORAL","Actual shortage","TABLET (EXTENDED-RELEASE)",N05AH,ANTIPSYCHOTICS,2024-07-01,2024-09-10,,,"Disruption of the manufacture of the drug.",2024-01-31,2025-04-24,No
217992,02417367,Shortage,"QUETIAPINE XR","SIVEM PHARMACEUTICALS ULC","Qutiapine XR",QUETIAPINE,150MG,60,"ORAL; ORAL","Actual shortage","TABLET (EXTENDED-RELEASE)",N05AH,ANTIPSYCHOTICS,2024-08-29,2024-09-28,,,"Disruption of the manufacture of the drug.",2024-01-31,2025-04-24,No
217995,02417375,Shortage,"QUETIAPINE XR","SIVEM PHARMACEUTICALS ULC","Qutiapine XR",QUETIAPINE,200MG,60,"ORAL; ORAL","Actual shortage","TABLET (EXTENDED-RELEASE)",N05AH,ANTIPSYCHOTICS,2024-07-01,2024-09-10,,,"Disruption of the manufacture of the drug.",2024-01-31,2025-04-24,No
217998,02417383,Shortage,"QUETIAPINE XR","SIVEM PHARMACEUTICALS ULC","QUETIAPINE XR",QUETIAPINE,300MG,60,"ORAL; ORAL","Actual shortage","TABLET (EXTENDED-RELEASE)",N05AH,ANTIPSYCHOTICS,2024-07-01,2024-09-10,,,"Disruption of the manufacture of the drug.",2024-01-31,2025-04-24,No
218001,02417391,Shortage,"QUETIAPINE XR","SIVEM PHARMACEUTICALS ULC","QUETIAPINE XR",QUETIAPINE,400MG,60,"ORAL; ORAL","Actual shortage","TABLET (EXTENDED-RELEASE)",N05AH,ANTIPSYCHOTICS,2024-05-01,2024-09-10,,,"Disruption of the manufacture of the drug.",2024-01-31,2025-04-24,No
216283,02356538,Shortage,"RABEPRAZOLE EC","SANIS HEALTH INC","RABEPRAZOLE EC","RABEPRAZOLE SODIUM",20MG,500,"ORAL; ORAL",Resolved,"TABLET (ENTERIC-COATED)",A02BC,"DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",,2024-01-12,2024-09-06,2024-09-04,"Disruption of the manufacture of the drug.",2024-01-17,2024-09-05,No
216463,02245688,Shortage,RATIO-TOPISALIC,"TEVA CANADA LIMITED","TOPISALIC LOTION","SALICYLIC ACID; BETAMETHASONE","20MG; 0.5MG",30ml,"TOPICAL; TOPICAL",Resolved,LOTION,D07XC,"CORTICOSTEROIDS, OTHER COMBINATIONS",,2024-01-17,2024-05-31,2024-06-28,"Disruption of the manufacture of the drug.",2024-01-18,2024-06-29,No
215470,02243676,Shortage,"RECOMBIVAX HB","MERCK CANADA INC","(hepatitis B vaccine [recombinant])","HEPATITIS B SURFACE ANTIGEN",10MCG,"10MCG/1ML 1DOSE VIAL","INTRAMUSCULAR; INTRAMUSCULAR",Resolved,"SUSPENSION; SOLUTION",J07BC,"VIRAL VACCINES",,2024-01-10,2024-03-29,2024-02-13,"Demand increase for the drug.",2024-01-10,2024-02-14,No
219863,02354586,Shortage,RENVELA,"SANOFI-AVENTIS CANADA INC",Renvela,"SEVELAMER CARBONATE",800MG,180,"ORAL; ORAL",Resolved,TABLET,V03AE,"ALL OTHER THERAPEUTIC PRODUCTS",,2024-02-13,2024-05-17,2024-05-14,"Other (Please describe in comments)",2024-02-16,2024-05-15,No
220170,00443816,Shortage,RETIN-A,"BAUSCH HEALTH, CANADA INC.",RETIN-A,TRETINOIN,0.025%,30g,"TOPICAL; TOPICAL",Resolved,GEL,D10AD,"ANTI-ACNE PREPARATIONS FOR TOPICAL USE",2024-03-18,2024-03-05,2024-04-02,2024-04-02,"Other (Please describe in comments)",2024-02-22,2024-04-03,No
217267,02264633,Shortage,"RETIN-A MICRO","BAUSCH HEALTH, CANADA INC.","RETIN-A MICRO",TRETINOIN,0.04%,n/a,"TOPICAL; TOPICAL",Resolved,GEL,D10AD,"ANTI-ACNE PREPARATIONS FOR TOPICAL USE",2024-04-16,2024-04-15,2024-04-28,2024-04-25,"Other (Please describe in comments)",2024-01-25,2024-04-30,No
215710,02213826,Shortage,REVIA,"TEVA CANADA LIMITED","REVIA 50MG TAB","NALTREXONE HYDROCHLORIDE",50MG,50,"ORAL; ORAL",Resolved,TABLET,N07BB,"DRUGS USED IN ADDICTIVE DISORDERS",,2024-01-10,2024-02-10,2024-02-12,"Disruption of the manufacture of the drug.",2024-01-11,2024-02-13,No
215855,02270889,Shortage,RIVA-ALENDRONATE,"LABORATOIRE RIVA INC.","Riva-Alendronate 70mg","ALENDRONIC ACID",70MG,4,"ORAL; ORAL",Resolved,TABLET,M05BA,"DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",2024-01-12,2024-01-12,,2024-01-17,"Requirements related to complying with good manufacturing practices.",2024-01-12,2024-01-18,No
215859,02392259,Shortage,RIVA-ANASTROZOLE,"LABORATOIRE RIVA INC.","Riva-Anastrozole 1mg",ANASTROZOLE,1MG,30,"ORAL; ORAL",Resolved,TABLET,L02BG,"HORMONE ANTAGONISTS AND RELATED AGENTS",2024-01-12,2024-01-12,,2024-01-17,"Requirements related to complying with good manufacturing practices.",2024-01-12,2024-01-18,No
217917,02392259,Shortage,RIVA-ANASTROZOLE,"LABORATOIRE RIVA INC.",Riva-Anastrozole,ANASTROZOLE,1MG,30,"ORAL; ORAL","Actual shortage",TABLET,L02BG,"HORMONE ANTAGONISTS AND RELATED AGENTS",2024-05-21,,,,"Requirements related to complying with good manufacturing practices.",2024-01-31,2024-05-22,No
216064,02455013,Shortage,RIVA-FINASTERIDE,"LABORATOIRE RIVA INC.","Riva-Finasteride 5mg",FINASTERIDE,5MG,"30 & 100","ORAL; ORAL",Resolved,TABLET,G04CB,"DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",2024-01-12,2024-01-12,,2024-01-17,"Requirements related to complying with good manufacturing practices.",2024-01-15,2024-01-18,No
215862,02398656,Shortage,RIVA-LETROZOLE,"LABORATOIRE RIVA INC.",Riva-Letrozole,LETROZOLE,2.5MG,30,"ORAL; ORAL",Resolved,TABLET,L02BG,"HORMONE ANTAGONISTS AND RELATED AGENTS",2024-01-12,2024-01-12,,2024-01-17,"Requirements related to complying with good manufacturing practices.",2024-01-12,2024-01-18,No
216506,02398656,Shortage,RIVA-LETROZOLE,"LABORATOIRE RIVA INC.",Riva-Letrozole,LETROZOLE,2.5MG,30,"ORAL; ORAL",Resolved,TABLET,L02BG,"HORMONE ANTAGONISTS AND RELATED AGENTS",2024-01-18,2024-01-18,2025-02-21,2025-03-27,"Requirements related to complying with good manufacturing practices.",2024-01-18,2025-05-16,No
220668,02442906,Shortage,"RIZATRIPTAN ODT","SANIS HEALTH INC","RIZATRIPTAN ODT",RIZATRIPTAN,5MG,6,"ORAL; ORAL",Resolved,"TABLET (ORALLY DISINTEGRATING)",N02CC,"ANTIMIGRAINE PREPARATIONS",,2024-02-26,2024-04-10,2024-04-03,"Disruption of the manufacture of the drug.",2024-02-27,2024-04-04,No
220173,00343617,Shortage,ROFACT,"BAUSCH HEALTH, CANADA INC.",ROFACT,RIFAMPIN,300MG,n/a,"ORAL; ORAL","Avoided shortage",CAPSULE,J04AB,"DRUGS FOR TREATMENT OF TUBERCULOSIS",2024-03-08,,2024-03-28,2024-02-19,"Other (Please describe in comments)",2024-02-22,2024-02-22,No
214716,02497581,Shortage,RYBELSUS,"NOVO NORDISK CANADA INC",RYBELSUS,SEMAGLUTIDE,3MG,30,ORAL,Resolved,TABLET,A10BJ,,2024-01-05,2024-01-05,2024-01-09,2024-01-09,"Delay in shipping of the drug.",2024-01-03,2024-01-10,No
214721,02497611,Shortage,RYBELSUS,"NOVO NORDISK CANADA INC",RYBELSUS,SEMAGLUTIDE,14MG,30,ORAL,Resolved,TABLET,A10BJ,,2024-01-05,2024-01-05,2024-01-09,2024-01-09,"Delay in shipping of the drug.",2024-01-03,2024-01-10,No
217970,02237971,Shortage,SAIZEN,"EMD SERONO, A DIVISION OF EMD INC., CANADA","somatropin for injection",SOMATROPIN,5MG,vial,"SUBCUTANEOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAMUSCULAR",Resolved,"POWDER FOR SOLUTION",H01AC,"ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES",2024-02-01,2024-02-01,2024-03-01,2024-02-28,"Delay in shipping of the drug.",2024-01-31,2024-02-29,No
218624,00839205,Shortage,SANDOSTATIN,"NOVARTIS PHARMACEUTICALS CANADA INC","SANDOSTATIN 100UG 1ML 1X5",OCTREOTIDE,100MCG,1X5,"SUBCUTANEOUS; INTRAVENOUS; SUBCUTANEOUS; INTRAVENOUS","Actual shortage",SOLUTION,H01CB,"HYPOTHALAMIC HORMONES",2024-02-06,2024-02-06,,,"Disruption of the manufacture of the drug.",2024-02-06,2024-03-21,No
218447,02517205,Shortage,"SANDOZ ADAPALENE / BENZOYL PEROXIDE FORTE","SANDOZ CANADA INCORPORATED","ADAPALENE / BENZOYL PEROXIDE FORTE","BENZOYL PEROXIDE; ADAPALENE","2.5%; 0.3%",70G,TOPICAL,Resolved,GEL,D10AD,"ANTI-ACNE PREPARATIONS FOR TOPICAL USE",,2024-02-05,2024-03-08,2024-03-11,"Delay in shipping of the drug.",2024-02-05,2024-03-12,No
217887,02526875,Shortage,"SANDOZ AMBRISENTAN TABLETS","SANDOZ CANADA INCORPORATED","AMBRISENTAN TABLETS",AMBRISENTAN,5MG,30FCT,ORAL,Resolved,TABLET,C02KX,"OTHER ANTIHYPERTENSIVES",,2024-01-30,2024-04-19,2024-04-23,"Requirements related to complying with good manufacturing practices.",2024-01-30,2024-04-24,No
218454,02526883,Shortage,"SANDOZ AMBRISENTAN TABLETS","SANDOZ CANADA INCORPORATED","AMBRISENTAN TABLETS",AMBRISENTAN,10MG,"10MG 30FCT",ORAL,Resolved,TABLET,C02KX,"OTHER ANTIHYPERTENSIVES",,2024-02-05,2024-04-19,2024-04-23,"Disruption of the manufacture of the drug.",2024-02-05,2024-04-24,No
219213,02482584,Shortage,"SANDOZ AMOXI-CLAV TABLET","SANDOZ CANADA INCORPORATED",AMOXI-CLAV,"CLAVULANIC ACID; AMOXICILLIN","125MG; 875MG","100 FCT BO","ORAL; ORAL",Resolved,TABLET,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2024-02-12,2024-03-15,2024-04-03,"Delay in shipping of the drug.",2024-02-12,2024-04-04,No
217029,02482584,Shortage,"SANDOZ AMOXI-CLAV TABLET","SANDOZ CANADA INCORPORATED","AMOXI-CLAV TABLET","CLAVULANIC ACID; AMOXICILLIN","125MG; 875MG",100FCT,"ORAL; ORAL",Resolved,TABLET,J01CR,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",,2024-01-23,2024-02-09,2024-02-05,"Disruption of the manufacture of the drug.",2024-01-23,2024-02-06,No
219970,02324946,Shortage,"SANDOZ ATORVASTATIN","SANDOZ CANADA INCORPORATED",ATORVASTATIN,ATORVASTATIN,10MG,30FCT,"ORAL; ORAL",Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2024-02-20,2024-03-08,2024-02-26,"Demand increase for the drug.",2024-02-20,2024-02-27,No
214771,02324946,Shortage,"SANDOZ ATORVASTATIN","SANDOZ CANADA INCORPORATED",ATORVASTATIN,ATORVASTATIN,10MG,100FCT,"ORAL; ORAL",Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2024-01-03,2024-03-15,2024-03-11,"Disruption of the manufacture of the drug.",2024-01-03,2024-03-12,No
219974,02417340,Shortage,"SANDOZ CANDESARTAN","SANDOZ CANADA INCORPORATED",CANDESARTAN,"CANDESARTAN CILEXETIL",32MG,100TAB,"ORAL; ORAL",Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2024-02-20,2024-03-29,2024-03-25,"Disruption of the manufacture of the drug.",2024-02-20,2024-03-26,No
220544,02326973,Shortage,"SANDOZ CANDESARTAN","SANDOZ CANADA INCORPORATED",CANDESARTAN,"CANDESARTAN CILEXETIL",16MG,"100TAB BO","ORAL; ORAL",Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2024-02-26,2024-03-29,2024-03-11,"Disruption of the manufacture of the drug.",2024-02-26,2024-03-12,No
217033,02248758,Shortage,"SANDOZ CIPROFLOXACIN","SANDOZ CANADA INCORPORATED",CIPROFLOXACIN,CIPROFLOXACIN,750MG,50FCT,"ORAL; ORAL",Resolved,TABLET,J01MA,"QUINOLONE ANTIBACTERIALS",,2024-01-23,2024-02-02,2024-01-31,"Disruption of the manufacture of the drug.",2024-01-23,2024-02-01,No
216164,02506882,Shortage,"SANDOZ CIPROFLOXACIN / DEXAMETHASONE","SANDOZ CANADA INCORPORATED","CIPROFLOXACIN / DEXAMETHASONE","DEXAMETHASONE; CIPROFLOXACIN","0.1%; 0.3%",7.5ML,OTIC,Resolved,SUSPENSION,S02CA,"CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION",,2024-01-16,2024-02-02,2024-01-30,"Disruption of the manufacture of the drug.",2024-01-16,2024-01-31,No
219217,02515784,Shortage,"SANDOZ CLONIDINE","SANDOZ CANADA INCORPORATED",CLONIDINE,"CLONIDINE HYDROCHLORIDE",0.1MG,"100 TAB BO",ORAL,Resolved,TABLET,C02AC,"ANTIADRENERGIC AGENTS, CENTRALLY ACTING",,2024-02-12,2024-03-01,2024-03-01,"Delay in shipping of the drug.",2024-02-12,2024-03-06,No
216168,02518740,Shortage,"SANDOZ DAPAGLIFLOZIN","SANDOZ CANADA INCORPORATED",DAPAGLIFLOZIN,DAPAGLIFLOZIN,10MG,500FCT,ORAL,Resolved,TABLET,A10BK,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2024-01-16,2024-02-02,2024-02-05,"Delay in shipping of the drug.",2024-01-16,2024-02-06,No
216171,02513781,Shortage,"SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES","SANDOZ CANADA INCORPORATED","DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES","DIMETHYL FUMARATE",120MG,56GRC,ORAL,Resolved,"CAPSULE (DELAYED RELEASE)",L04AX,,,2024-01-16,,2024-12-10,"Disruption of the manufacture of the drug.",2024-01-16,2024-12-11,No
219987,02247385,Shortage,"SANDOZ DOCUSATE SODIUM","SANDOZ CANADA INCORPORATED","DOCUSATE SODIUM","DOCUSATE SODIUM",100MG,1000SGC,"ORAL; ORAL",Resolved,CAPSULE,A06AA,"DRUGS FOR CONSTIPATION",,2024-02-20,,2024-05-01,"Disruption of the manufacture of the drug.",2024-02-20,2024-05-02,No
219220,02439948,Shortage,"SANDOZ DULOXETINE","SANDOZ CANADA INCORPORATED",DULOXETINE,DULOXETINE,30MG,"30 GRC","ORAL; ORAL",Resolved,"CAPSULE (DELAYED RELEASE)",N06AX,ANTIDEPRESSANTS,,2024-02-12,2024-03-29,2024-04-02,"Disruption of the manufacture of the drug.",2024-02-12,2024-04-03,No
215335,02299968,Shortage,"SANDOZ ENALAPRIL","SANDOZ CANADA INCORPORATED",ENALAPRIL,"ENALAPRIL SODIUM",8MG,100TAB,"ORAL; ORAL",Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",,2024-01-08,2024-10-11,2024-10-07,"Disruption of the manufacture of the drug.",2024-01-08,2024-10-07,No
217890,02461331,Shortage,"SANDOZ GLICLAZIDE MR","SANDOZ CANADA INCORPORATED","GLICLAZIDE MR",GLICLAZIDE,60MG,100MRT,"ORAL; ORAL",Resolved,"TABLET (EXTENDED-RELEASE)",A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2024-01-30,,2024-04-02,"Disruption of the manufacture of the drug.",2024-01-30,2024-04-03,No
214777,02337428,Shortage,"SANDOZ IRBESARTAN HCT","SANDOZ CANADA INCORPORATED","IRBESARTAN HCT","HYDROCHLOROTHIAZIDE; IRBESARTAN","12.5MG; 150MG",500FCT,"ORAL; ORAL",Resolved,TABLET,C09DA,"ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",,2024-01-03,2024-03-08,2024-02-19,"Disruption of the manufacture of the drug.",2024-01-03,2024-02-19,No
216205,02283964,Shortage,"SANDOZ LEFLUNOMIDE","SANDOZ CANADA INCORPORATED",LEFLUNOMIDE,LEFLUNOMIDE,10MG,30FCT,"ORAL; ORAL",Resolved,TABLET,L04AA,IMMUNOSUPPRESSANTS,,2024-01-17,2024-02-02,2024-02-05,"Delay in shipping of the drug.",2024-01-17,2024-02-06,No
218012,02462028,Shortage,"SANDOZ LEVETIRACETAM","SANDOZ CANADA INCORPORATED",LEVETIRACETAM,LEVETIRACETAM,1000MG,100FCT,"ORAL; ORAL",Resolved,TABLET,N03AX,ANTIEPILEPTICS,,2024-01-31,2024-02-16,2024-02-02,"Disruption of the manufacture of the drug.",2024-01-31,2024-02-20,No
218465,02302381,Shortage,"SANDOZ LISINOPRIL HCT","SANDOZ CANADA INCORPORATED","LISINOPRIL HCT","HYDROCHLOROTHIAZIDE; LISINOPRIL","25MG; 20MG","100TAB BO","ORAL; ORAL",Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2024-02-05,2025-03-28,2025-03-24,"Shortage of an active ingredient.",2024-02-05,2025-03-25,No
219228,02521113,Shortage,"SANDOZ LURASIDONE","SANDOZ CANADA INCORPORATED",LURASIDONE,"LURASIDONE HYDROCHLORIDE",80MG,"30FCT BO",ORAL,Resolved,TABLET,N05AE,ANTIPSYCHOTICS,,2024-02-12,2024-03-08,2024-03-01,"Delay in shipping of the drug.",2024-02-12,2024-03-02,No
218474,02246820,Shortage,"SANDOZ METFORMIN FC","SANDOZ CANADA INCORPORATED","METFORMIN FC","METFORMIN HYDROCHLORIDE",500MG,"100FCT BO","ORAL; ORAL",Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2024-02-05,2024-03-01,2024-03-01,"Disruption of the manufacture of the drug.",2024-02-05,2024-03-06,No
214781,02246820,Shortage,"SANDOZ METFORMIN FC","SANDOZ CANADA INCORPORATED","METFORMIN FC","METFORMIN HYDROCHLORIDE",500MG,100FCT,"ORAL; ORAL",Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2024-01-03,2024-02-09,2024-01-31,"Disruption of the manufacture of the drug.",2024-01-03,2024-02-01,No
218015,02449811,Shortage,"SANDOZ MOMETASONE","SANDOZ CANADA INCORPORATED",MOMETASONE,"MOMETASONE FUROATE",50MCG,140DOS,"NASAL; NASAL",Resolved,"SPRAY, METERED DOSE",R01AD,"DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE",,2024-01-31,2024-03-16,2024-03-11,"Disruption of the manufacture of the drug.",2024-01-31,2024-03-12,No
215347,02296446,Shortage,"SANDOZ OMEPRAZOLE","SANDOZ CANADA INCORPORATED",OMEPRAZOLE,OMEPRAZOLE,20MG,500GRC,"ORAL; ORAL",Resolved,"CAPSULE (DELAYED RELEASE)",A02BC,"DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",,2024-01-08,,2024-04-02,"Disruption of the manufacture of the drug.",2024-01-08,2024-04-03,No
218020,02301075,Shortage,"SANDOZ PANTOPRAZOLE","SANDOZ CANADA INCORPORATED",PANTOPRAZOLE,PANTOPRAZOLE,20MG,100GRT,"ORAL; ORAL",Resolved,"TABLET (DELAYED-RELEASE)",A02BC,"DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",,2024-01-31,2024-03-08,2024-03-11,"Requirements related to complying with good manufacturing practices.",2024-01-31,2024-03-12,No
218024,02496259,Shortage,"SANDOZ POSACONAZOLE","SANDOZ CANADA INCORPORATED",POSACONAZOLE,POSACONAZOLE,100MG,60GRT,ORAL,Resolved,"TABLET (DELAYED-RELEASE)",J02AC,"ANTIMYCOTICS FOR SYSTEMIC USE",,2024-01-31,2024-04-19,2024-04-23,"Disruption of the manufacture of the drug.",2024-01-31,2024-04-24,No
219980,02314177,Shortage,"SANDOZ RABEPRAZOLE","SANDOZ CANADA INCORPORATED",RABEPRAZOLE,"RABEPRAZOLE SODIUM",10MG,100GRT,"ORAL; ORAL",Resolved,"TABLET (ENTERIC-COATED)",A02BC,"DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",,2024-02-20,2024-05-31,2024-06-03,"Disruption of the manufacture of the drug.",2024-02-20,2024-06-04,No
220555,02327295,Shortage,"SANDOZ RISEDRONATE","SANDOZ CANADA INCORPORATED",RISEDRONATE,"RISEDRONATE SODIUM",35MG,"30FCT BO","ORAL; ORAL",Resolved,TABLET,M05BA,"DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",,2024-02-26,2024-03-08,2024-03-11,"Demand increase for the drug.",2024-02-26,2024-03-12,No
219984,02351889,Shortage,"SANDOZ RIZATRIPTAN ODT","SANDOZ CANADA INCORPORATED","RIZATRIPTAN ODT",RIZATRIPTAN,10MG,6ODT,"ORAL; ORAL",Resolved,"TABLET (ORALLY DISINTEGRATING)",N02CC,"ANTIMIGRAINE PREPARATIONS",,2024-02-20,2024-03-22,2024-03-11,"Disruption of the manufacture of the drug.",2024-02-20,2024-03-12,No
217053,02351870,Shortage,"SANDOZ RIZATRIPTAN ODT","SANDOZ CANADA INCORPORATED","RIZATRIPTAN ODT",RIZATRIPTAN,5MG,6ODT,"ORAL; ORAL",Resolved,"TABLET (ORALLY DISINTEGRATING)",N02CC,"ANTIMIGRAINE PREPARATIONS",,2024-01-23,2024-03-23,2024-04-03,"Disruption of the manufacture of the drug.",2024-01-23,2024-04-04,No
219991,02247390,Shortage,"SANDOZ SENNA S","SANDOZ CANADA INCORPORATED","SENNA S","DOCUSATE SODIUM; SENNOSIDES","50MG; 8.6MG",60FCT,"ORAL; ORAL",Resolved,TABLET,A06AB,"DRUGS FOR CONSTIPATION",,2024-02-20,,2024-04-02,"Disruption of the manufacture of the drug.",2024-02-20,2024-04-03,No
220558,02503956,Shortage,"SANDOZ SITAGLIPTIN-METFORMIN","SANDOZ CANADA INCORPORATED",SITAGLIPTIN-METFORMIN,"METFORMIN HYDROCHLORIDE; SITAGLIPTIN","500MG; 50MG","60FCT BO",ORAL,Resolved,TABLET,A10BD,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2024-02-26,2024-03-01,2024-03-01,"Delay in shipping of the drug.",2024-02-26,2024-03-06,No
217056,02399032,Shortage,"SANDOZ SOLIFENACIN","SANDOZ CANADA INCORPORATED",SOLIFENACIN,"SOLIFENACIN SUCCINATE",5MG,30FCT,"ORAL; ORAL",Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2024-01-23,2024-02-09,2024-02-05,"Disruption of the manufacture of the drug.",2024-01-23,2024-02-06,No
216208,02340208,Shortage,"SANDOZ TAMSULOSIN CR","SANDOZ CANADA INCORPORATED","TAMSULOSIN CR","TAMSULOSIN HYDROCHLORIDE",0.4MG,500PRT,"ORAL; ORAL",Resolved,"TABLET (EXTENDED-RELEASE)",G04CA,"DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",,2024-01-17,2024-04-12,2024-04-08,"Disruption of the manufacture of the drug.",2024-01-17,2025-05-21,No
218477,02356759,Shortage,"SANDOZ VALSARTAN","SANDOZ CANADA INCORPORATED",VALSARTAN,VALSARTAN,80MG,"500FCT BO","ORAL; ORAL",Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2024-02-05,2024-02-23,2024-02-26,"Delay in shipping of the drug.",2024-02-05,2024-02-27,No
215326,02261928,Shortage,SANDOZ-DICLOFENAC,"SANDOZ CANADA INCORPORATED",DICLOFENAC,"DICLOFENAC SODIUM",50MG,30SUP,"RECTAL; RECTAL",Resolved,SUPPOSITORY,M01AB,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2024-01-08,2024-04-19,2024-04-23,"Disruption of the manufacture of the drug.",2024-01-08,2024-04-24,No
218664,02242810,Shortage,"SCOPOLAMINE HYDROBROMIDE INJECTION","OMEGA LABORATORIES LIMITED","Scopolamine Hydrobromide Injection","SCOPOLAMINE HYDROBROMIDE",0.4MG,"10 x 1 mL vial / fiole","SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR",Resolved,LIQUID,N05CM,"HYPNOTICS AND SEDATIVES",2024-02-13,2024-02-13,,2024-02-19,"Demand increase for the drug.",2024-02-06,2024-02-20,No
218675,02242811,Shortage,"SCOPOLAMINE HYDROBROMIDE INJECTION","OMEGA LABORATORIES LIMITED","Scopolamine Hydrobromide Injection","SCOPOLAMINE HYDROBROMIDE",0.6MG,"10 x 1 mL vial / fiole","SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR",Resolved,LIQUID,N05CM,"HYPNOTICS AND SEDATIVES",,2024-02-20,,2024-02-28,"Demand increase for the drug.",2024-02-06,2024-02-29,No
216097,01976168,Shortage,SENSORCAINE,"ASPEN PHARMACARE CANADA INC.","bupivacaine HCI 0.5% Plain 50x10mL Plain SU Polyamp® Duofit®","BUPIVACAINE HYDROCHLORIDE",5MG,"50 PE Polyamp","EPIDURAL; BLOCK/INFILTRATION; EPIDURAL; BLOCK/INFILTRATION",Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2024-01-16,2024-02-26,2024-02-26,"Delay in shipping of the drug.",2024-01-16,2024-02-27,No
219442,01976206,Shortage,"SENSORCAINE WITH EPINEPHRINE","ASPEN PHARMACARE CANADA INC.","bupivacaine HCI 0.5% w/epin. 1:200M 10x20mL SU Vial","EPINEPHRINE; BUPIVACAINE HYDROCHLORIDE","5MCG; 5MG","10 vials","EPIDURAL; BLOCK/INFILTRATION; EPIDURAL; BLOCK/INFILTRATION",Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2024-03-01,2024-03-05,2024-05-01,2024-03-26,"Disruption of the manufacture of the drug.",2024-02-13,2024-03-27,No
217783,02353539,Shortage,SERTRALINE,"SANIS HEALTH INC",SERTRALINE,SERTRALINE,50MG,250,"ORAL; ORAL",Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2024-01-29,2024-05-29,2024-05-16,"Disruption of the manufacture of the drug.",2024-01-30,2024-05-17,No
216254,02353547,Shortage,SERTRALINE,"SANIS HEALTH INC",SERTRALINE,SERTRALINE,100MG,800,"ORAL; ORAL",Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2024-01-12,2024-05-31,2024-05-16,"Disruption of the manufacture of the drug.",2024-01-17,2024-05-17,No
216259,02353547,Shortage,SERTRALINE,"SANIS HEALTH INC",SERTRALINE,SERTRALINE,100MG,800,"ORAL; ORAL",Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2024-01-12,2024-02-09,2024-02-12,"Disruption of the manufacture of the drug.",2024-01-17,2024-02-13,No
216264,02353520,Shortage,SERTRALINE,"SANIS HEALTH INC",SERTRALINE,SERTRALINE,25MG,100,"ORAL; ORAL",Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2024-01-12,2024-05-17,2024-05-16,"Disruption of the manufacture of the drug.",2024-01-17,2024-05-17,No
216267,02353539,Shortage,SERTRALINE,"SANIS HEALTH INC",SERTRALINE,SERTRALINE,50MG,1400,"ORAL; ORAL",Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2024-01-12,2024-06-24,2024-06-03,"Disruption of the manufacture of the drug.",2024-01-17,2024-06-06,No
220633,02353547,Shortage,SERTRALINE,"SANIS HEALTH INC","SERTRALINE HCL",SERTRALINE,100MG,250,"ORAL; ORAL",Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,2024-02-23,2024-02-26,2024-05-03,2024-05-01,"Disruption of the manufacture of the drug.",2024-02-26,2024-05-02,No
220643,02353539,Shortage,SERTRALINE,"SANIS HEALTH INC","SERTRALINE HCL",SERTRALINE,50MG,1400,"ORAL; ORAL",Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2024-02-26,2024-06-20,2024-06-18,"Disruption of the manufacture of the drug.",2024-02-26,2024-06-19,No
216108,00402249,Shortage,"SODIUM CHLORIDE BACTERIOSTATIC INJ","OMEGA LABORATORIES LIMITED","Sodium Chloride Bacteriostatic For Injection USP","SODIUM CHLORIDE",9MG,"10 x 30mL vial / fiole","SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR",Resolved,LIQUID,V07AB,"ALL OTHER NON-THERAPEUTIC PRODUCTS",2024-02-13,2024-02-13,2024-03-29,2024-03-22,"Disruption of the manufacture of the drug.",2024-01-16,2024-03-27,No
217425,00037826,Shortage,"SODIUM CHLORIDE IRRIGATION USP","ICU MEDICAL CANADA INC","Sodium Chloride Irrigation USP","SODIUM CHLORIDE",9MG,"3000 mL","IRRIGATION; INTRAPERITONEAL; INTRAPERITONEAL; IRRIGATION",Resolved,SOLUTION,B05CB,"IRRIGATING SOLUTIONS",2024-03-01,2024-02-18,2024-04-15,2024-04-16,"Disruption of the manufacture of the drug.",2024-01-26,2024-04-24,No
218770,01994344,Shortage,"SOFLAX CAPSULES 100MG","PHARMASCIENCE INC",SOFLAX,"DOCUSATE SODIUM",100MG,100,"ORAL; ORAL",Resolved,CAPSULE,A06AA,"DRUGS FOR CONSTIPATION",,2024-02-02,2024-03-28,2024-04-02,"Disruption of the manufacture of the drug.",2024-02-07,2024-04-12,No
218773,01994344,Shortage,"SOFLAX CAPSULES 100MG","PHARMASCIENCE INC",SOFLAX,"DOCUSATE SODIUM",100MG,1000,"ORAL; ORAL",Resolved,CAPSULE,A06AA,"DRUGS FOR CONSTIPATION",,2024-02-02,2024-04-16,2024-04-17,"Disruption of the manufacture of the drug.",2024-02-07,2024-04-25,No
220673,02458268,Shortage,SOLIFENACIN,"SANIS HEALTH INC",SOLIFENACIN,"SOLIFENACIN SUCCINATE",10MG,30,"ORAL; ORAL",Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2024-02-26,2024-03-08,2024-03-07,"Disruption of the manufacture of the drug.",2024-02-27,2024-03-08,No
217809,02458241,Shortage,SOLIFENACIN,"SANIS HEALTH INC",SOLIFENACIN,"SOLIFENACIN SUCCINATE",5MG,100,"ORAL; ORAL",Resolved,TABLET,G04BD,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2024-01-29,2024-07-26,2024-06-26,"Disruption of the manufacture of the drug.",2024-01-30,2024-06-27,No
219585,00030619,Shortage,SOLU-CORTEF,"PFIZER CANADA ULC",SOLU-CORTEF,HYDROCORTISONE,250MG,"10X2 ML","INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR",Resolved,"POWDER FOR SOLUTION",H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2024-02-15,,2024-02-26,"Disruption of the manufacture of the drug.",2024-02-15,2024-02-27,No
219588,00030600,Shortage,SOLU-CORTEF,"PFIZER CANADA ULC",SOLU-CORTEF,HYDROCORTISONE,100MG,"10X2 ML","INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR","Avoided shortage","POWDER FOR SOLUTION",H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",2024-04-10,,,2024-03-06,"Disruption of the manufacture of the drug.",2024-02-15,2024-03-06,No
220618,02367971,Shortage,SOLU-MEDROL,"PFIZER CANADA ULC",SOLU-MEDROL,METHYLPREDNISOLONE,1G,"1 X 8ML","INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR",Resolved,"POWDER FOR SOLUTION; KIT",H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",,2024-05-15,,2024-06-14,"Disruption of the manufacture of the drug.",2024-02-26,2024-06-15,No
220621,02367955,Shortage,SOLU-MEDROL,"PFIZER CANADA ULC",SOLU-MEDROL,METHYLPREDNISOLONE,125MG,"10 X 2ML","INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR",Resolved,"POWDER FOR SOLUTION; KIT",H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",2024-03-18,,,2024-04-10,"Disruption of the manufacture of the drug.",2024-02-26,2024-04-11,No
216127,00594644,Shortage,"STATEX TAB 10MG","PALADIN LABS INC.","Statex 10mg","MORPHINE SULFATE",10MG,"100 Tabs","ORAL; ORAL",Resolved,TABLET,N02AA,OPIOIDS,,2024-01-09,2024-03-25,2024-03-27,"Delay in shipping of the drug.",2024-01-16,2024-03-28,No
216182,02247228,Shortage,"STIEPROX SHAMPOO","GLAXOSMITHKLINE INC","ciclopirox olamine shampoo","CICLOPIROX OLAMINE",1.5%,150ML,"TOPICAL; TOPICAL",Resolved,SHAMPOO,D01AE,"ANTIFUNGALS FOR TOPICAL USE",,2024-01-11,,2024-01-22,"Disruption of the manufacture of the drug.",2024-01-17,2024-01-23,No
220741,02225166,Shortage,SUPREFACT,"CHEPLAPHARM ARZNEIMITTEL GMBH","Buserelin acetate injection",BUSERELIN,1MG,"2 x 5.5 ml","SUBCUTANEOUS; SUBCUTANEOUS",Resolved,SOLUTION,L02AE,"HORMONES AND RELATED AGENTS",2024-02-28,,2024-06-30,2024-06-28,"Disruption of the manufacture of the drug.",2024-02-27,2024-06-29,No
218433,02429667,Shortage,"TAMSULOSIN CR","SIVEM PHARMACEUTICALS ULC","Sivem Tamsulosin CR","TAMSULOSIN HYDROCHLORIDE",0.4MG,100,"ORAL; ORAL",Resolved,"TABLET (EXTENDED-RELEASE)",G04CA,"DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",,2024-02-05,2024-07-02,2024-07-02,"Disruption of the manufacture of the drug.",2024-02-05,2024-07-03,No
216290,02427117,Shortage,"TAMSULOSIN CR","SANIS HEALTH INC","TAMSULOSIN CR","TAMSULOSIN HYDROCHLORIDE",0.4MG,500,"ORAL; ORAL",Resolved,"TABLET (EXTENDED-RELEASE)",G04CA,"DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",,2024-01-12,2024-04-20,2024-02-28,"Disruption of the manufacture of the drug.",2024-01-17,2025-05-21,No
215019,02413612,Shortage,"TAMSULOSIN CR","PRO DOC LIMITEE","TAMSULOSIN CR","TAMSULOSIN HYDROCHLORIDE",0.4MG,"30, 500","ORAL; ORAL",Resolved,"TABLET (EXTENDED-RELEASE)",G04CA,"DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",2024-08-31,2024-08-31,2024-12-03,2024-09-19,"Shortage of an active ingredient.",2024-01-05,2025-05-21,No
215061,02466074,Shortage,TARO-ACITRETIN,"TARO PHARMACEUTICALS INC",ACITRETIN,ACITRETIN,10MG,30,"ORAL; ORAL","Actual shortage",CAPSULE,D05BB,"ANTIPSORIATICS FOR SYSTEMIC USE",,2023-09-15,,,"Disruption of the manufacture of the drug.",2024-01-05,2025-05-20,No
215064,02466082,Shortage,TARO-ACITRETIN,"TARO PHARMACEUTICALS INC",ACITRETIN,ACITRETIN,25MG,30,"ORAL; ORAL","Actual shortage",CAPSULE,D05BB,"ANTIPSORIATICS FOR SYSTEMIC USE",,2023-11-27,,,"Disruption of the manufacture of the drug.",2024-01-05,2025-05-20,No
215067,02365650,Shortage,TARO-ANASTROZOLE,"TARO PHARMACEUTICALS INC",ANASTROZOLE,ANASTROZOLE,1MG,30,"ORAL; ORAL",Resolved,TABLET,L02BG,"HORMONE ANTAGONISTS AND RELATED AGENTS",,2023-12-19,2024-01-19,2024-01-09,"Disruption of the manufacture of the drug.",2024-01-05,2024-02-08,No
215073,02511932,Shortage,TARO-BORTEZOMIB,"TARO PHARMACEUTICALS INC",BORTEZOMIB,BORTEZOMIB,2.5MG,2.5,"SUBCUTANEOUS; INTRAVENOUS",Resolved,"POWDER FOR SOLUTION",L01XG,,,2023-12-01,2024-06-28,2024-07-26,"Other (Please describe in comments)",2024-01-05,2024-07-27,No
215076,02367394,Shortage,TARO-CARBAMAZEPINE,"TARO PHARMACEUTICALS INC",CARBAMAZEPINE,CARBAMAZEPINE,100MG,450,"ORAL; ORAL",Resolved,SUSPENSION,N03AF,ANTIEPILEPTICS,,2023-08-03,2024-01-19,2024-01-09,"Disruption of the manufacture of the drug.",2024-01-05,2024-02-08,No
215079,02440180,Shortage,"TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL","TARO PHARMACEUTICALS INC",CLINDA/BENZOYL,"CLINDAMYCIN; BENZOYL PEROXIDE","1%; 5%",45,"TOPICAL; TOPICAL",Resolved,GEL,D10AF,"ANTI-ACNE PREPARATIONS FOR TOPICAL USE",,2023-11-22,2024-01-12,2024-01-04,"Disruption of the manufacture of the drug.",2024-01-05,2024-02-08,No
215082,02245523,Shortage,"TARO-CLOBETASOL CREAM USP, 0.05%","TARO PHARMACEUTICALS INC",CLOBETASOL,"CLOBETASOL PROPIONATE",0.05%,454,"TOPICAL; TOPICAL",Resolved,CREAM,D07AD,"CORTICOSTEROIDS, PLAIN",,2023-10-02,2024-01-19,2024-01-16,"Disruption of the manufacture of the drug.",2024-01-05,2024-02-08,No
215085,02245522,Shortage,"TARO-CLOBETASOL TOPICAL SOLUTION USP, 0.05%","TARO PHARMACEUTICALS INC",CLOBETASOL,"CLOBETASOL PROPIONATE",0.05%,60mL,"TOPICAL; TOPICAL",Resolved,SOLUTION,D07AD,"CORTICOSTEROIDS, PLAIN",,2024-01-02,2024-01-12,2024-01-05,"Disruption of the manufacture of the drug.",2024-01-05,2024-02-08,No
215088,02497506,Shortage,TARO-CLOMIPRAMINE,"TARO PHARMACEUTICALS INC",CLOMIPRAMINE,"CLOMIPRAMINE HYDROCHLORIDE",25MG,90,ORAL,Resolved,CAPSULE,N06AA,ANTIDEPRESSANTS,,2023-12-08,2024-02-09,2024-01-31,"Disruption of the manufacture of the drug.",2024-01-05,2024-02-08,No
215021,02463571,Shortage,"TARO-GLICLAZIDE MR","SUN PHARMA CANADA INC",GLICLAZIDE,GLICLAZIDE,30MG,30,"ORAL; ORAL",Resolved,"TABLET (EXTENDED-RELEASE)",A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2023-12-11,2025-03-28,2025-05-09,"Disruption of the manufacture of the drug.",2024-01-05,2025-05-20,No
215033,02402610,Shortage,TARO-LANSOPRAZOLE,"SUN PHARMA CANADA INC",LANSOPRAZOLE,LANSOPRAZOLE,15MG,100,"ORAL; ORAL",Resolved,"CAPSULE (DELAYED RELEASE)",A02BC,"DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",,2023-12-01,2024-01-12,2024-01-16,"Disruption of the manufacture of the drug.",2024-01-05,2024-02-08,No
216303,02328933,Shortage,"TECHNETIUM TC 99M TSC","GE HEALTHCARE CANADA INC","Kit for the Preparation of Technetium Tc 99m Sulfur Colloid Injection","SODIUM THIOSULFATE",2MG,"5 kit package","ORAL; INTRAVENOUS; INTRAPERITONEAL; ORAL; INTRAVENOUS; INTRAPERITONEAL",Resolved,"POWDER FOR SOLUTION; KIT; SOLUTION",V09XX,,,2024-01-17,2024-06-01,2024-06-03,"Requirements related to complying with good manufacturing practices.",2024-01-17,2024-06-04,No
216049,02194333,Shortage,"TEGRETOL SUSPENSION","NOVARTIS PHARMACEUTICALS CANADA INC","TEGRETOL SUSPENSION 100MG/5ML 450 ML",CARBAMAZEPINE,100MG,"450 ML","ORAL; ORAL",Resolved,SUSPENSION,N03AF,ANTIEPILEPTICS,2023-10-16,2023-10-17,2024-02-26,2024-02-21,"Disruption of the manufacture of the drug.",2024-01-15,2024-02-22,No
218129,02280205,Shortage,TEVA-BETAHISTINE,"TEVA CANADA LIMITED","BETAHISTINE 24MG TAB","BETAHISTINE HYDROCHLORIDE",24MG,100,"ORAL; ORAL",Resolved,TABLET,N07CA,"ANTIVERTIGO PREPARATIONS",,2024-01-30,2024-05-10,2024-04-24,"Disruption of the manufacture of the drug.",2024-02-01,2024-04-25,No
218966,02270226,Shortage,TEVA-BICALUTAMIDE,"TEVA CANADA LIMITED","BICALUTAMIDE 50MG TAB",BICALUTAMIDE,50MG,"PP 30","ORAL; ORAL",Resolved,TABLET,L02BB,"HORMONE ANTAGONISTS AND RELATED AGENTS",,2024-02-07,2024-03-20,2024-02-14,"Disruption of the manufacture of the drug.",2024-02-08,2024-02-15,No
215743,02439654,Shortage,"TEVA-BUPROPION XL","TEVA CANADA LIMITED","BUPROPION XL 150MG SR TAB","BUPROPION HYDROCHLORIDE",150MG,500,"ORAL; ORAL",Resolved,"TABLET (EXTENDED-RELEASE)",N06AX,ANTIDEPRESSANTS,,2024-01-10,2024-02-20,2024-02-21,"Disruption of the manufacture of the drug.",2024-01-11,2024-02-22,No
215746,02439662,Shortage,"TEVA-BUPROPION XL","TEVA CANADA LIMITED","BUPROPION XL 300MG SR TAB","BUPROPION HYDROCHLORIDE",300MG,500,"ORAL; ORAL",Resolved,"TABLET (EXTENDED-RELEASE)",N06AX,ANTIDEPRESSANTS,,2024-01-10,2024-02-20,2024-02-21,"Disruption of the manufacture of the drug.",2024-01-11,2024-02-22,No
220267,02366320,Shortage,TEVA-CANDESARTAN,"TEVA CANADA LIMITED","TEVA-CANDESARTAN 16MG TAB","CANDESARTAN CILEXETIL",16MG,PP30,"ORAL; ORAL",Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2024-02-20,2025-03-10,2024-12-18,"Disruption of the manufacture of the drug.",2024-02-22,2024-12-19,No
217237,02366339,Shortage,TEVA-CANDESARTAN,"TEVA CANADA LIMITED","CANDESARTAN 32MG TABS","CANDESARTAN CILEXETIL",32MG,"pp 30","ORAL; ORAL",Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2024-01-24,2024-02-20,2024-02-07,"Disruption of the manufacture of the drug.",2024-01-25,2024-02-08,No
219687,00583421,Shortage,TEVA-CEPHALEXIN,"TEVA CANADA LIMITED","CEPHALEXIN 500MG TAB",CEPHALEXIN,500MG,500,"ORAL; ORAL",Resolved,TABLET,J01DB,"OTHER BETA-LACTAM ANTIBACTERIALS",,2023-12-06,2024-04-20,2024-03-26,"Disruption of the manufacture of the drug.",2024-02-15,2024-03-28,No
218943,00583421,Shortage,TEVA-CEPHALEXIN,"TEVA CANADA LIMITED","CEPHALEXIN 500MG TAB",CEPHALEXIN,500MG,100's,"ORAL; ORAL",Resolved,TABLET,J01DB,"OTHER BETA-LACTAM ANTIBACTERIALS",,2024-02-07,2024-03-31,2024-03-26,"Disruption of the manufacture of the drug.",2024-02-08,2024-03-28,No
217220,00342106,Shortage,"TEVA-CEPHALEXIN 125","TEVA CANADA LIMITED","CEPHALEXIN SUSP 125MG/5ML",CEPHALEXIN,125MG,100ml,"ORAL; ORAL",Resolved,"POWDER FOR SUSPENSION",J01DB,"OTHER BETA-LACTAM ANTIBACTERIALS",,2023-09-12,2024-03-10,2024-03-10,"Disruption of the manufacture of the drug.",2024-01-25,2024-03-18,No
220977,00342092,Shortage,"TEVA-CEPHALEXIN 250","TEVA CANADA LIMITED","CEPHALEXIN SUSP 250MG/5ML",CEPHALEXIN,250MG,100ML,"ORAL; ORAL",Resolved,"POWDER FOR SUSPENSION",J01DB,"OTHER BETA-LACTAM ANTIBACTERIALS",,2024-02-28,2024-05-20,2024-03-22,"Disruption of the manufacture of the drug.",2024-02-29,2024-05-23,No
218960,02241710,Shortage,TEVA-CLINDAMYCIN,"TEVA CANADA LIMITED","CLINDAMYCIN 300MG CAPS",CLINDAMYCIN,300MG,100,"ORAL; ORAL",Resolved,CAPSULE,J01FF,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",,2024-02-07,2024-04-20,2024-04-03,"Disruption of the manufacture of the drug.",2024-02-08,2024-04-05,No
215704,01910272,Shortage,TEVA-CLOBETASOL,"TEVA CANADA LIMITED","CLOBETASOL 0.05% CREAM","CLOBETASOL PROPIONATE",0.05%,450g,"TOPICAL; TOPICAL",Resolved,CREAM,D07AD,"CORTICOSTEROIDS, PLAIN",,2024-01-10,,2024-08-28,"Disruption of the manufacture of the drug.",2024-01-11,2024-08-30,No
216466,02429349,Shortage,"TEVA-DILTIAZEM XC","TEVA CANADA LIMITED","DILTIAZEM XC 300MG TAB","DILTIAZEM HYDROCHLORIDE",300MG,100,ORAL,Resolved,"TABLET (EXTENDED-RELEASE)",C08DB,"SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",,2024-01-18,2024-05-10,2024-05-08,"Disruption of the manufacture of the drug.",2024-01-18,2024-05-09,No
215740,02429330,Shortage,"TEVA-DILTIAZEM XC","TEVA CANADA LIMITED","DILTIAZEM XC 240MG TAB","DILTIAZEM HYDROCHLORIDE",240MG,100,ORAL,Resolved,"TABLET (EXTENDED-RELEASE)",C08DB,"SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",,2024-01-10,2024-05-10,2024-05-08,"Disruption of the manufacture of the drug.",2024-01-11,2024-05-09,No
220980,01912070,Shortage,TEVA-DOMPERIDONE,"TEVA CANADA LIMITED","DOMPERIDONE 10MG TAB",DOMPERIDONE,10MG,500,"ORAL; ORAL",Resolved,TABLET,A03FA,PROPULSIVES,,2024-02-28,2024-05-20,2024-05-15,"Disruption of the manufacture of the drug.",2024-02-29,2024-05-16,No
215751,02456753,Shortage,TEVA-DULOXETINE,"TEVA CANADA LIMITED","DULOXETINE HCL 30MG CAPS",DULOXETINE,30MG,"30 BLIST","ORAL; ORAL",Resolved,"CAPSULE (DELAYED RELEASE)",N06AX,ANTIDEPRESSANTS,,2024-01-10,2024-11-20,2024-11-13,"Disruption of the manufacture of the drug.",2024-01-11,2024-11-14,No
218946,00608882,Shortage,TEVA-EMTEC-30,"TEVA CANADA LIMITED",EMTEC-30,"CODEINE PHOSPHATE; ACETAMINOPHEN","30MG; 300MG",500,"ORAL; ORAL",Resolved,TABLET,N02AJ,OPIOIDS,,2024-02-07,2024-03-20,2024-03-06,"Disruption of the manufacture of the drug.",2024-02-08,2024-03-07,No
215754,02463229,Shortage,TEVA-EVEROLIMUS,"TEVA CANADA LIMITED","TEVA-EVEROLIMUS 2.5MG TABS",EVEROLIMUS,2.5MG,30,"ORAL; ORAL","Actual shortage",TABLET,L01EG,,,2024-01-10,,,"Disruption of the manufacture of the drug.",2024-01-11,2024-01-18,No
218980,02354101,Shortage,TEVA-EZETIMIBE,"TEVA CANADA LIMITED","EZETIMIBE 10MG TAB",EZETIMIBE,10MG,"PP 30","ORAL; ORAL","Actual shortage",TABLET,C10AX,"LIPID MODIFYING AGENTS, PLAIN",,2024-02-07,,,"Disruption of the manufacture of the drug.",2024-02-08,2024-02-08,No
218132,02282941,Shortage,TEVA-FENTANYL,"TEVA CANADA LIMITED","FENTANYL TDS 25MCG/H PATCH",FENTANYL,25MCG,5,"TRANSDERMAL; TRANSDERMAL",Resolved,PATCH,N02AB,OPIOIDS,,2024-01-30,2024-05-31,2024-05-29,"Disruption of the manufacture of the drug.",2024-02-01,2024-05-30,No
218134,02282941,Shortage,TEVA-FENTANYL,"TEVA CANADA LIMITED","FENTANYL TDS 25MCG/H PATCH",FENTANYL,25MCG,5,"TRANSDERMAL; TRANSDERMAL",Resolved,PATCH,N02AB,OPIOIDS,,2024-01-30,2024-01-30,2024-01-30,"Disruption of the manufacture of the drug.",2024-02-01,2024-02-01,No
218137,02282968,Shortage,TEVA-FENTANYL,"TEVA CANADA LIMITED","FENTANYL TDS 50MCG/H PATCH",FENTANYL,50MCG,5,"TRANSDERMAL; TRANSDERMAL",Resolved,PATCH,N02AB,OPIOIDS,,2024-01-30,2024-05-31,2024-05-29,"Disruption of the manufacture of the drug.",2024-02-01,2024-05-30,No
217223,02282984,Shortage,TEVA-FENTANYL,"TEVA CANADA LIMITED","FENTANYL TDS 100MCG/H PATCH",FENTANYL,100MCG,5,"TRANSDERMAL; TRANSDERMAL",Resolved,PATCH,N02AB,OPIOIDS,,2024-01-24,2024-05-10,2024-05-08,"Disruption of the manufacture of the drug.",2024-01-25,2024-05-09,No
220983,02299232,Shortage,TEVA-FLUVASTATIN,"TEVA CANADA LIMITED","FLUVASTATIN 40MG CAP",FLUVASTATIN,40MG,100,"ORAL; ORAL",Resolved,CAPSULE,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2024-02-28,2024-09-10,2024-09-18,"Disruption of the manufacture of the drug.",2024-02-29,2024-09-19,No
218940,00337749,Shortage,TEVA-FUROSEMIDE,"TEVA CANADA LIMITED","FUROSEMIDE 40MG TAB",FUROSEMIDE,40MG,100's,"ORAL; ORAL",Resolved,TABLET,C03CA,"HIGH-CEILING DIURETICS",,2024-02-07,2025-02-10,2025-01-29,"Disruption of the manufacture of the drug.",2024-02-08,2025-01-30,No
216460,01913670,Shortage,TEVA-GLYBURIDE,"TEVA CANADA LIMITED","GLYBURIDE 2.5MG TAB",GLYBURIDE,2.5MG,100,"ORAL; ORAL",Resolved,TABLET,A10BB,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2024-01-17,2024-02-20,2024-02-28,"Disruption of the manufacture of the drug.",2024-01-18,2024-07-03,No
217234,02316390,Shortage,TEVA-IRBESARTAN,"TEVA CANADA LIMITED","IRBESARTAN 75MG TABLETS",IRBESARTAN,75MG,100,"ORAL; ORAL",Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2024-01-24,,2024-03-28,"Disruption of the manufacture of the drug.",2024-01-25,2024-04-01,No
218963,02254786,Shortage,TEVA-LATANOPROST,"TEVA CANADA LIMITED","LATANOPROST EYE DROP SOL'N",LATANOPROST,50MCG,0.005%,"OPHTHALMIC; OPHTHALMIC",Resolved,SOLUTION,S01EE,"ANTIGLAUCOMA PREPARATIONS AND MIOTICS",,2024-02-07,2024-08-20,2024-08-27,"Disruption of the manufacture of the drug.",2024-02-08,2024-08-30,No
220264,02257734,Shortage,TEVA-METFORMIN,"TEVA CANADA LIMITED","ACT-METFORMIN 850MG FC TAB","METFORMIN HYDROCHLORIDE",850MG,100,"ORAL; ORAL",Resolved,TABLET,A10BA,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",,2024-02-20,2024-04-30,2024-04-30,"Disruption of the manufacture of the drug.",2024-02-22,2024-05-09,No
219684,00648043,Shortage,TEVA-METOPROLOL,"TEVA CANADA LIMITED","METOPROLOL 100MG FC TAB","METOPROLOL TARTRATE",100MG,500,"ORAL; ORAL",Resolved,TABLET,C07AB,"BETA BLOCKING AGENTS",,2023-12-13,2024-04-20,2024-04-17,"Disruption of the manufacture of the drug.",2024-02-15,2024-04-18,No
215701,00648043,Shortage,TEVA-METOPROLOL,"TEVA CANADA LIMITED","METOPROLOL 100MG FC TAB","METOPROLOL TARTRATE",100MG,100,"ORAL; ORAL",Resolved,TABLET,C07AB,"BETA BLOCKING AGENTS",,2024-01-10,2024-04-20,2024-04-17,"Disruption of the manufacture of the drug.",2024-01-11,2024-04-18,No
220986,02248130,Shortage,TEVA-MOMETASONE,"TEVA CANADA LIMITED","MOMETASONE 0.1% OINTMENT","MOMETASONE FUROATE",0.1%,50G,"TOPICAL; TOPICAL",Resolved,OINTMENT,D07AC,"CORTICOSTEROIDS, PLAIN",,2024-02-28,2024-12-20,2024-12-18,"Disruption of the manufacture of the drug.",2024-02-29,2024-12-19,No
215760,02475863,Shortage,TEVA-MOMETASONE,"TEVA CANADA LIMITED","MOMETASONE FURO SPRAY 50MCG","MOMETASONE FUROATE",50MCG,18gm,"NASAL; NASAL",Resolved,"SPRAY, METERED DOSE",R01AD,"DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE",,2024-01-10,2024-07-31,2024-07-30,"Disruption of the manufacture of the drug.",2024-01-11,2024-08-01,No
218123,00589861,Shortage,TEVA-NAPROXEN,"TEVA CANADA LIMITED","NAPROXEN 500MG TAB",NAPROXEN,500MG,100,"ORAL; ORAL",Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2024-01-30,2024-04-30,2024-04-24,"Disruption of the manufacture of the drug.",2024-02-01,2024-04-25,No
218126,00589861,Shortage,TEVA-NAPROXEN,"TEVA CANADA LIMITED","NAPROXEN 500MG TAB",NAPROXEN,500MG,500,"ORAL; ORAL",Resolved,TABLET,M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2024-01-30,2024-05-10,2024-05-08,"Disruption of the manufacture of the drug.",2024-02-01,2024-05-09,No
215719,02243313,Shortage,"TEVA-NAPROXEN EC","TEVA CANADA LIMITED","NAPROXEN-EC 375MG TAB",NAPROXEN,375MG,100,"ORAL; ORAL",Resolved,"TABLET (ENTERIC-COATED)",M01AE,"ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",,2024-01-10,2024-03-10,2024-03-06,"Disruption of the manufacture of the drug.",2024-01-11,2024-03-18,No
219677,02231016,Shortage,TEVA-NITROFURANTOIN,"TEVA CANADA LIMITED","NITROFURANTOIN 100MG CAPS",NITROFURANTOIN,100MG,100,"ORAL; ORAL",Resolved,CAPSULE,J01XE,"OTHER ANTIBACTERIALS",,2024-02-14,2024-05-31,2024-05-29,"Disruption of the manufacture of the drug.",2024-02-15,2024-05-30,No
218952,02194201,Shortage,TEVA-NYSTATIN,"TEVA CANADA LIMITED","NYSTATIN 100MU/ML DROPS",NYSTATIN,100000UNIT,100ml,"ORAL; ORAL",Resolved,SUSPENSION,A07AA,INTESTINALANTIINFECTIVES,,2024-02-07,2024-07-10,2024-06-18,"Disruption of the manufacture of the drug.",2024-02-08,2024-06-20,No
218955,02194201,Shortage,TEVA-NYSTATIN,"TEVA CANADA LIMITED","TEVA-NYSTATIN 100MU/ML DROPS",NYSTATIN,100000UNIT,1L,"ORAL; ORAL",Resolved,SUSPENSION,A07AA,INTESTINALANTIINFECTIVES,,2024-02-07,2025-03-20,2025-03-19,"Disruption of the manufacture of the drug.",2024-02-08,2025-03-20,No
217226,02295415,Shortage,TEVA-OMEPRAZOLE,"TEVA CANADA LIMITED","OMEPRAZOLE 20MG TABLETS",OMEPRAZOLE,20MG,"100 & 500","ORAL; ORAL",Resolved,"TABLET (DELAYED-RELEASE)",A02BC,"DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",,2024-01-24,2024-03-20,2024-03-20,"Disruption of the manufacture of the drug.",2024-01-25,2024-03-21,No
217229,02295407,Shortage,TEVA-OMEPRAZOLE,"TEVA CANADA LIMITED","OMEPRAZOLE 10MG TABLETS",OMEPRAZOLE,10MG,100,"ORAL; ORAL",Resolved,"TABLET (DELAYED-RELEASE)",A02BC,"DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",,2024-01-24,2024-03-20,2024-03-08,"Disruption of the manufacture of the drug.",2024-01-25,2024-03-14,No
217231,02295407,Shortage,TEVA-OMEPRAZOLE,"TEVA CANADA LIMITED","OMEPRAZOLE 10MG TABLETS",OMEPRAZOLE,10MG,100,"ORAL; ORAL",Resolved,"TABLET (DELAYED-RELEASE)",A02BC,"DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",,2024-01-24,2024-06-20,2024-06-18,"Disruption of the manufacture of the drug.",2024-01-25,2024-06-20,No
216457,00608165,Shortage,TEVA-OXYCOCET,"TEVA CANADA LIMITED","OXYCOCET TABLETS UD BLST","ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE","325MG; 5MG",100,"ORAL; ORAL",Resolved,TABLET,N02AJ,OPIOIDS,,2024-01-17,2024-03-31,2024-03-06,"Disruption of the manufacture of the drug.",2024-01-18,2024-03-07,No
215757,02464039,Shortage,TEVA-PERINDOPRIL/INDAPAMIDE,"TEVA CANADA LIMITED","PERIN/INDA 8MG/2.5MG TABS","INDAPAMIDE; PERINDOPRIL ERBUMINE","2.5MG; 8MG",100,"ORAL; ORAL",Resolved,TABLET,C09BA,"ACE INHIBITORS, COMBINATIONS",,2024-01-10,2024-02-20,2024-01-18,"Disruption of the manufacture of the drug.",2024-01-11,2024-01-19,No
218983,02395487,Shortage,"TEVA-QUETIAPINE XR","TEVA CANADA LIMITED","QUETIAPINE XR 400MG TAB",QUETIAPINE,400MG,60,"ORAL; ORAL",Resolved,"TABLET (EXTENDED-RELEASE)",N05AH,ANTIPSYCHOTICS,,2024-02-07,2024-03-20,2024-03-06,"Disruption of the manufacture of the drug.",2024-02-08,2024-03-07,No
216497,02298384,Shortage,TEVA-RISEDRONATE,"TEVA CANADA LIMITED","RISEDRONATE 30MG TABL","RISEDRONATE SODIUM",30MG,30,"ORAL; ORAL",Resolved,TABLET,M05BA,"DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",,2024-01-18,,2025-04-07,"Disruption of the manufacture of the drug.",2024-01-18,2025-04-29,No
219671,02507218,Shortage,TEVA-RIVAROXABAN,"TEVA CANADA LIMITED","RIVAROXABAN 15MG TAB",RIVAROXABAN,15MG,3x10,ORAL,Resolved,TABLET,B01AF,"ANTITHROMBOTIC AGENTS",,2024-02-14,2024-05-31,2024-05-31,"Disruption of the manufacture of the drug.",2024-02-15,2024-07-03,No
218977,02316846,Shortage,TEVA-ROPINIROLE,"TEVA CANADA LIMITED","ROPINIROLE 0.25MG FC TAB",ROPINIROLE,0.25MG,100,"ORAL; ORAL",Resolved,TABLET,N04BC,"DOPAMINERGIC AGENTS",,2024-02-07,2024-10-20,2024-10-10,"Disruption of the manufacture of the drug.",2024-02-08,2024-10-11,No
215731,02354616,Shortage,TEVA-ROSUVASTATIN,"TEVA CANADA LIMITED","ROSUVASTATIN 10MG TAB",ROSUVASTATIN,10MG,"pp 3","ORAL; ORAL",Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2024-01-10,2024-02-10,2024-01-30,"Disruption of the manufacture of the drug.",2024-01-11,2024-02-01,No
220261,02173360,Shortage,"TEVA-SALBUTAMOL STERINEBS P.F.","TEVA CANADA LIMITED","TEVA-SALBUTAMOL 2MG/ML NEBS",SALBUTAMOL,2MG,20x2.5ml,"INHALATION; INHALATION","Actual shortage",SOLUTION,R03AC,"ADRENERGICS, INHALANTS",,2024-02-20,2025-07-01,,"Disruption of the manufacture of the drug.",2024-02-22,2025-02-28,Yes
215707,01926934,Shortage,"TEVA-SALBUTAMOL STERINEBS P.F.","TEVA CANADA LIMITED","SALBUTAMOL 1MG/ML NEBS",SALBUTAMOL,1MG,"20 X 2.5ML","INHALATION; INHALATION","Actual shortage",SOLUTION,R03AC,"ADRENERGICS, INHALANTS",,2024-01-10,2025-08-10,,"Disruption of the manufacture of the drug.",2024-01-11,2025-05-15,Yes
215716,02240481,Shortage,TEVA-SERTRALINE,"TEVA CANADA LIMITED","SERTRALINE 100MG CAPS",SERTRALINE,100MG,100,"ORAL; ORAL",Resolved,CAPSULE,N06AB,ANTIDEPRESSANTS,,2024-01-10,2024-03-10,2024-01-30,"Disruption of the manufacture of the drug.",2024-01-11,2024-02-01,No
218971,02308738,Shortage,TEVA-SILDENAFIL,"TEVA CANADA LIMITED","SILDENAFIL 25MG TAB",SILDENAFIL,25MG,"PP 4","ORAL; ORAL",Resolved,TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",,2024-02-07,2024-03-31,2024-03-20,"Disruption of the manufacture of the drug.",2024-02-08,2024-03-21,No
215722,02250179,Shortage,TEVA-SIMVASTATIN,"TEVA CANADA LIMITED","SIMVASTATIN 40MG TAB",SIMVASTATIN,40MG,100,"ORAL; ORAL",Resolved,TABLET,C10AA,"LIPID MODIFYING AGENTS, PLAIN",,2024-01-10,2024-07-10,2024-07-03,"Disruption of the manufacture of the drug.",2024-01-11,2024-07-04,No
219038,00851973,Shortage,TEVA-TAMOXIFEN,"TEVA CANADA LIMITED","TAMOXIFEN 20MG TABS",TAMOXIFEN,20MG,"PP 30's and 100's","ORAL; ORAL","Actual shortage",TABLET,L02BA,"HORMONE ANTAGONISTS AND RELATED AGENTS",,2024-02-07,,,"Other (Please describe in comments)",2024-02-09,2024-05-23,No
215728,02320185,Shortage,TEVA-TELMISARTAN,"TEVA CANADA LIMITED","TELMISARTAN 80MG TAB",TELMISARTAN,80MG,500,"ORAL; ORAL",Resolved,TABLET,C09CA,"ANGIOTENSIN II ANTAGONISTS, PLAIN",,2024-01-10,2024-04-30,2024-04-24,"Disruption of the manufacture of the drug.",2024-01-11,2024-04-25,No
218986,02441160,Shortage,TEVA-TEMOZOLOMIDE,"TEVA CANADA LIMITED","TEMOZOLOMIDE 5MG CAPS",TEMOZOLOMIDE,5MG,5,"ORAL; ORAL","Actual shortage",CAPSULE,L01AX,ALKYLATINGAGENTS,,2024-02-07,2025-07-15,,"Disruption of the manufacture of the drug.",2024-02-08,2025-05-13,No
215734,02395290,Shortage,TEVA-TEMOZOLOMIDE,"TEVA CANADA LIMITED","TEMOZOLOMIDE 140MG CAPS",TEMOZOLOMIDE,140MG,5,"ORAL; ORAL","Actual shortage",CAPSULE,L01AX,ALKYLATINGAGENTS,,2024-01-10,2025-06-20,,"Disruption of the manufacture of the drug.",2024-01-11,2025-05-15,No
220989,00849650,Shortage,TEVA-TOPILENE,"TEVA CANADA LIMITED","TOPILENE 0.05% CREAM",BETAMETHASONE,0.05%,50G,"TOPICAL; TOPICAL",Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2024-02-28,2024-07-17,2024-07-17,"Disruption of the manufacture of the drug.",2024-02-29,2024-07-18,No
218949,00849650,Shortage,TEVA-TOPILENE,"TEVA CANADA LIMITED","TOPILENE 0.05% CR",BETAMETHASONE,0.05%,15g,"TOPICAL; TOPICAL",Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2024-02-07,2024-07-17,2024-07-17,"Disruption of the manufacture of the drug.",2024-02-08,2024-07-18,No
220992,00804991,Shortage,TEVA-TOPISONE,"TEVA CANADA LIMITED","TOPISONE 0.05% CREAM",BETAMETHASONE,0.05%,50G,"TOPICAL; TOPICAL",Resolved,CREAM,D07AC,"CORTICOSTEROIDS, PLAIN",,2024-02-28,2024-07-17,2024-07-17,"Disruption of the manufacture of the drug.",2024-02-29,2024-07-18,No
215713,02237250,Shortage,TEVA-TRYPTOPHAN,"TEVA CANADA LIMITED","TRYPTOPHAN 1G TAB",TRYPTOPHAN,1G,100,"ORAL; ORAL",Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2024-01-10,2024-03-10,2024-03-06,"Disruption of the manufacture of the drug.",2024-01-11,2024-03-18,No
219674,02357534,Shortage,TEVA-VALACYCLOVIR,"TEVA CANADA LIMITED","VALACYCLOVIR 500MG TAB",VALACYCLOVIR,500MG,100,"ORAL; ORAL",Resolved,TABLET,J05AB,"DIRECT ACTING ANTIVIRALS",,2024-02-14,2024-04-10,2024-03-09,"Disruption of the manufacture of the drug.",2024-02-15,2024-04-11,No
216024,02466015,Shortage,"TRANEXAMIC ACID INJECTION","AURO PHARMA INC","TRANEXAMIC ACID INJECTION","TRANEXAMIC ACID",100MG,"5 ML",INTRAVENOUS,Resolved,SOLUTION,B02AA,ANTIFIBRINOLYTICS,,2024-01-15,2024-04-30,2024-04-29,"Demand increase for the drug.",2024-01-15,2024-04-30,No
220686,02348799,Shortage,TRAZODONE,"SANIS HEALTH INC",TRAZODONE,"TRAZODONE HYDROCHLORIDE",150MG,100,"ORAL; ORAL",Resolved,TABLET,N06AX,ANTIDEPRESSANTS,,2024-02-26,2024-04-26,2024-04-22,"Disruption of the manufacture of the drug.",2024-02-27,2024-04-23,No
215236,02508087,Shortage,"TRI-CIRA 21","APOTEX INC","NORGESTIMATE / ETHINYL ESTRADIOL","ETHINYL ESTRADIOL; NORGESTIMATE; ETHINYL ESTRADIOL; NORGESTIMATE; ETHINYL ESTRADIOL; NORGESTIMATE","0.035MG; 0.25MG; 0.035MG; 0.215MG; 0.035MG; 0.18MG","21 BLS",ORAL,Resolved,TABLET,G03AB,,,2024-01-02,2024-02-09,2024-02-01,"Disruption of the manufacture of the drug.",2024-01-05,2024-02-02,No
216046,00511234,Shortage,"TROMBOJECT 1%","OMEGA LABORATORIES LIMITED","Sodium Tetradecyl Sulfate Injection","SODIUM TETRADECYL SULFATE",10MG,"10 x 2mL vial / fiole","INTRAVENOUS; INTRAVENOUS",Resolved,SOLUTION,C05BB,"ANTIVARICOSE THERAPY",,2024-01-23,2024-04-07,2024-04-07,"Disruption of the manufacture of the drug.",2024-01-15,2024-04-11,No
215772,02078600,Shortage,"ULTRAVIST 300","BAYER INC",IOPROMIDE,IOPROMIDE,62%,150mL,"INTRAVASCULAR; INTRAVASCULAR",Resolved,SOLUTION,V08AB,"X-RAY CONTRAST MEDIA, IODINATED",2024-02-15,2024-01-29,2024-06-26,2024-05-30,"Disruption of the manufacture of the drug.",2024-01-12,2024-06-03,No
218759,02078619,Shortage,"ULTRAVIST 370","BAYER INC",IOPROMIDE,IOPROMIDE,77%,"500 mL","INTRAVASCULAR; INTRAVASCULAR",Resolved,SOLUTION,V08AB,"X-RAY CONTRAST MEDIA, IODINATED",2024-02-15,2024-01-29,2024-05-03,2024-04-30,"Disruption of the manufacture of the drug.",2024-02-07,2024-05-06,No
215779,02078619,Shortage,"ULTRAVIST 370","BAYER INC",IOPROMIDE,IOPROMIDE,77%,50mL,"INTRAVASCULAR; INTRAVASCULAR",Resolved,SOLUTION,V08AB,"X-RAY CONTRAST MEDIA, IODINATED",2024-02-15,2024-01-29,2024-08-30,2024-08-20,"Disruption of the manufacture of the drug.",2024-01-12,2024-08-21,No
215787,02078619,Shortage,"ULTRAVIST 370","BAYER INC",IOPROMIDE,IOPROMIDE,77%,100mL,"INTRAVASCULAR; INTRAVASCULAR",Resolved,SOLUTION,V08AB,"X-RAY CONTRAST MEDIA, IODINATED",2024-02-15,2024-01-29,2024-04-26,2024-05-02,"Disruption of the manufacture of the drug.",2024-01-12,2024-05-06,No
215790,02078619,Shortage,"ULTRAVIST 370","BAYER INC",IOPROMIDE,IOPROMIDE,77%,"200 mL","INTRAVASCULAR; INTRAVASCULAR",Resolved,SOLUTION,V08AB,"X-RAY CONTRAST MEDIA, IODINATED",2024-02-15,2024-01-29,2024-04-02,2024-03-13,"Disruption of the manufacture of the drug.",2024-01-12,2024-03-14,No
220653,02454645,Shortage,VALACYCLOVIR,"SANIS HEALTH INC",VALACYCLOVIR,VALACYCLOVIR,500MG,100,"ORAL; ORAL",Resolved,TABLET,J05AB,"DIRECT ACTING ANTIVIRALS",,2024-02-26,2024-11-08,2024-11-06,"Disruption of the manufacture of the drug.",2024-02-27,2024-11-07,No
214848,02245777,Shortage,VALCYTE,"CHEPLAPHARM ARZNEIMITTEL GMBH",VALGANCICLOVIR,VALGANCICLOVIR,450MG,"60 tablets","ORAL; ORAL",Resolved,TABLET,J05AB,"DIRECT ACTING ANTIVIRALS",2024-01-05,,2024-02-05,2024-01-31,"Delay in shipping of the drug.",2024-01-04,2024-02-01,No
217125,02229702,Shortage,VAQTA,"MERCK CANADA INC","hepatitis A vaccine, purified inactivated Suspension for injection","HEPATITIS A VACCINE, INACTIVATED",50UNIT,"50U/1ML 1DOSE VIAL (ADULT)","INTRAMUSCULAR; INTRAMUSCULAR",Resolved,SUSPENSION,J07BC,"VIRAL VACCINES",,2024-01-24,2024-04-01,2024-03-18,"Demand increase for the drug.",2024-01-24,2024-03-19,No
220279,02229702,Shortage,VAQTA,"MERCK CANADA INC","hepatitis A vaccine, purified inactivated Suspension for injection","HEPATITIS A VACCINE, INACTIVATED",50UNIT,"25U/0.5ML 1DOSE VIAL (PED)","INTRAMUSCULAR; INTRAMUSCULAR",Resolved,SUSPENSION,J07BC,"VIRAL VACCINES",,2024-02-22,2024-04-01,2024-03-01,"Demand increase for the drug.",2024-02-22,2024-03-02,No
218999,02520397,Shortage,VARDENAFIL,"SANIS HEALTH INC",VARDENAFIL,VARDENAFIL,10MG,4,ORAL,"Avoided shortage",TABLET,G04BE,"OTHER UROLOGICALS, INCL ANTISPASMODICS",2024-03-06,,2024-04-30,2024-02-28,"Disruption of the manufacture of the drug.",2024-02-08,2024-02-28,No
217414,02145774,Shortage,"VISIPAQUE 320","GE HEALTHCARE CANADA INC","iodixanol injection USP",IODIXANOL,652MG,"50 mL","INTRAVENOUS; INTRA-ARTERIAL; INTRAVENOUS; INTRA-ARTERIAL",Resolved,SOLUTION,V08AB,"X-RAY CONTRAST MEDIA, IODINATED",2024-01-31,2024-02-01,2024-02-13,2024-02-14,"Demand increase for the drug.",2024-01-26,2024-02-15,No
217420,02145774,Shortage,"VISIPAQUE 320","GE HEALTHCARE CANADA INC","iodixanol injection USP",IODIXANOL,652MG,"200 mL","INTRAVENOUS; INTRA-ARTERIAL; INTRAVENOUS; INTRA-ARTERIAL",Resolved,SOLUTION,V08AB,"X-RAY CONTRAST MEDIA, IODINATED",2024-02-01,2024-02-01,2024-02-21,2024-02-23,"Demand increase for the drug.",2024-01-26,2024-02-24,No
214845,02242367,Shortage,VISUDYNE,"CHEPLAPHARM ARZNEIMITTEL GMBH",VERTEPORFIN,VERTEPORFIN,15MG,"15 mg vial (1X15ML)","INTRAVENOUS; INTRAVENOUS",Resolved,"POWDER FOR SOLUTION",S01LA,"OCULAR VASCULAR DISORDER AGENTS",2024-01-09,,2024-02-29,2024-02-29,"Delay in shipping of the drug.",2024-01-04,2024-03-01,No
219763,00816078,Shortage,"VITAMIN B1","SANDOZ CANADA INCORPORATED","VITAMIN B1","THIAMINE HYDROCHLORIDE",100MG,1ML,"INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR",Resolved,SOLUTION,A11DA,"VIT B1,PLAIN AND IN COMB WITH VITAMIN B6 AND B12",,2024-02-08,2024-06-03,2024-06-17,"Demand increase for the drug.",2024-02-15,2024-07-29,No
220802,02439603,Shortage,VYVANSE,"TAKEDA CANADA INC","Lisdexamfetamine dimesylate capsules","LISDEXAMFETAMINE DIMESYLATE",10MG,"Bottles of 100's","ORAL; ORAL",Resolved,CAPSULE,N06BA,"PSYCHOSTIMULANTS AND NOOTROPICS",2024-02-27,2024-02-27,2024-03-31,2024-03-15,"Delay in shipping of the drug.",2024-02-27,2024-03-18,No
215480,00271373,Shortage,WINPRED,"AA PHARMA INC",WINPRED,PREDNISONE,1MG,"100 BTL","ORAL; ORAL",Resolved,TABLET,H02AB,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",2024-01-09,,2024-02-02,2024-01-30,"Disruption of the manufacture of the drug.",2024-01-10,2024-01-31,No
215603,02316986,Shortage,XARELTO,"BAYER INC",RIVAROXABAN,RIVAROXABAN,10MG,50's,"ORAL; ORAL",Resolved,TABLET,B01AF,"ANTITHROMBOTIC AGENTS",2024-01-26,2024-02-01,2024-02-15,2024-02-12,"Demand increase for the drug.",2024-01-11,2024-02-13,No
215608,02510162,Shortage,XARELTO,"BAYER INC",RIVAROXABAN,RIVAROXABAN,51.7MG,"100 mL",ORAL,Resolved,"GRANULES FOR SUSPENSION",B01AF,"ANTITHROMBOTIC AGENTS",2024-01-12,2024-01-12,2024-02-09,2024-02-05,"Demand increase for the drug.",2024-01-11,2024-02-06,No
220293,02242868,Shortage,XYLAC,"PENDOPHARM DIVISION OF PHARMASCIENCE INC",Xylac,LOXAPINE,2.5MG,"100 tabs","ORAL; ORAL",Resolved,TABLET,N05AH,ANTIPSYCHOTICS,,2024-02-22,2024-05-17,2024-05-09,"Disruption of the manufacture of the drug.",2024-02-22,2024-05-10,No
217529,00001791,Shortage,"XYLOCAINE 1% W EPINEPHRINE 1:100000","ASPEN PHARMACARE CANADA INC.","lidocaine HCI 1% w/epin. 1:100M 10x20mL MD Vial","EPINEPHRINE; LIDOCAINE HYDROCHLORIDE","0.01MG; 10MG","10 vials","BLOCK/INFILTRATION; BLOCK/INFILTRATION",Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2024-01-16,2024-02-20,2024-02-06,"Disruption of the manufacture of the drug.",2024-01-29,2024-02-07,No
220858,00001791,Shortage,"XYLOCAINE 1% W EPINEPHRINE 1:100000","ASPEN PHARMACARE CANADA INC.","lidocaine HCI 1% w/epin. 1:100M 10x20mL MD Vial","EPINEPHRINE; LIDOCAINE HYDROCHLORIDE","0.01MG; 10MG","10 vials","BLOCK/INFILTRATION; BLOCK/INFILTRATION","Avoided shortage",SOLUTION,N01BB,"ANESTHETICS, LOCAL",2024-06-17,,2024-06-30,2024-06-14,"Disruption of the manufacture of the drug.",2024-02-28,2024-06-14,No
218682,02302438,Shortage,"XYLOCAINE 2%","ASPEN PHARMACARE CANADA INC.","lidocaine HCI 2% Plain 10x20mL MD Vial","LIDOCAINE HYDROCHLORIDE",20MG,"10 vials","BLOCK/INFILTRATION; BLOCK/INFILTRATION",Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",,2024-01-24,2024-02-26,2024-02-26,"Disruption of the manufacture of the drug.",2024-02-06,2024-02-27,No
220855,02373130,Shortage,"XYLOCAINE 2% WITH EPINEPHRINE 1:200000","ASPEN PHARMACARE CANADA INC.","lidocaine HCI 2% w/epin. 1:200M 10x20mL MD Vial","EPINEPHRINE; LIDOCAINE HYDROCHLORIDE","0.005MG; 20MG","10 vials","BLOCK/INFILTRATION; BLOCK/INFILTRATION",Resolved,SOLUTION,N01BB,"ANESTHETICS, LOCAL",2024-06-24,,2024-06-30,2024-06-24,"Delay in shipping of the drug.",2024-02-28,2024-06-25,No
215319,02387433,Shortage,"YAZ PLUS","BAYER INC","Drospirenone/ estradiol/ Levomefolate Calcium","LEVOMEFOLATE CALCIUM; LEVOMEFOLATE CALCIUM; ETHINYL ESTRADIOL; DROSPIRENONE","0.451MG; 0.451MG; 0.02MG; 3.00MG",28's,"ORAL; ORAL","Avoided shortage",TABLET,G03AA,"HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",2024-01-19,,2024-01-26,2024-01-18,"Other (Please describe in comments)",2024-01-08,2024-01-18,No
218391,02410788,Shortage,"ZAMINE 21","APOTEX INC","DROSPIRENONE / ETHINYL ESTRADIOL","ETHINYL ESTRADIOL; DROSPIRENONE","0.03MG; 3MG","21 BLS",ORAL,Resolved,TABLET,G03AA,"HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",,2024-01-30,2024-04-05,2024-03-28,"Disruption of the manufacture of the drug.",2024-02-02,2024-03-29,No
217475,02410796,Shortage,"ZAMINE 28","APOTEX INC","DROSPIRENONE / ETHINYL ESTRADIOL","ETHINYL ESTRADIOL; DROSPIRENONE","0.03MG; 3MG","28 BLS",ORAL,Resolved,TABLET,G03AA,"HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",,2024-01-23,2024-03-08,2024-03-07,"Disruption of the manufacture of the drug.",2024-01-26,2024-03-08,No
216942,02049384,Shortage,ZESTRIL,"SEARCHLIGHT PHARMA INC",ZESTRIL,LISINOPRIL,20MG,"100 Tablets","ORAL; ORAL",Resolved,TABLET,C09AA,"ACE INHIBITORS, PLAIN",2024-03-01,2024-04-05,2024-09-15,2024-11-06,"Shortage of an inactive ingredient or component.",2024-01-22,2024-11-11,No
